US20140135810A1 - Occlusive devices - Google Patents
Occlusive devices Download PDFInfo
- Publication number
- US20140135810A1 US20140135810A1 US14/079,587 US201314079587A US2014135810A1 US 20140135810 A1 US20140135810 A1 US 20140135810A1 US 201314079587 A US201314079587 A US 201314079587A US 2014135810 A1 US2014135810 A1 US 2014135810A1
- Authority
- US
- United States
- Prior art keywords
- aneurysm
- components
- expandable
- component
- intrasaccular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
- A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12159—Solid plugs; being solid before insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12163—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a string of elements connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
Definitions
- the present disclosure generally relates to a system and method for delivering and deploying a medical device within a vessel, more particularly, it relates to a system and method for delivering and deploying an endoluminal therapeutic device within the vasculature of a patient to embolize and occlude aneurysms, particularly, cerebral aneurysms.
- Walls of the vasculature may develop areas of pathological dilatation called aneurysms.
- aneurysms have thin, weak walls that are prone to rupturing.
- Aneurysms can be the result of the vessel wall being weakened by disease, injury or a congenital abnormality.
- Aneurysms could be found in different parts of the body with the most common being abdominal aortic aneurysms and brain or cerebral aneurysms in the neurovasculature.
- abdominal aortic aneurysms and brain or cerebral aneurysms in the neurovasculature When the weakened wall of an aneurysm ruptures, it can result in death, especially if it is a cerebral aneurysm that ruptures.
- Aneurysms are generally treated by excluding the weakened part of the vessel from the arterial circulation.
- such reinforcement is done in many ways including: (i) surgical clipping, where a metal clip is secured around the base of the aneurysm; (ii) packing the aneurysm with small, flexible wire coils (micro-coils); (iii) using embolic materials to “fill” or “pack” an aneurysm; (iv) using detachable balloons or coils to occlude the parent vessel that supplies the aneurysm; and (v) intravascular stenting.
- a guiding catheter having a distal tip is percutaneously introduced into the vascular system of a patient.
- the guiding catheter is advanced within the vessel until its distal tip is proximate the stenosis or aneurysm.
- a guidewire positioned within an inner lumen of a second, inner catheter and the inner catheter are advanced through the distal end of the guiding catheter.
- the guidewire is then advanced out of the distal end of the guiding catheter into the vessel until the distal portion of the guidewire carrying the compressed stent is positioned at the point of the lesion within the vessel.
- the stent may be released and expanded so that it supports the vessel.
- Systems and procedures for treating aneurysms can include an intrasaccular device having one or more expandable components that can be inserted into an aneurysm to facilitate a thrombotic, healing effect.
- the components can have a specific characteristics, including porosity, composition, material, shape, size, interconnectedness, inter-engagement, coating, etc. These characteristics can be selected in order to achieve a desired treatment or placement of the intrasaccular device.
- the intrasaccular device can comprise a single component having two or more sections that have an average porosity that is different from each other. In some embodiments, the intrasaccular device can comprise multiple components that each have an average porosity. In either embodiment, the intrasaccular device can be arranged within an aneurysm according to a desired porosity profile. The intrasaccular device can be repositioned as necessary within the aneurysm during expansion.
- the intrasaccular device can optionally comprise one or more components having a desired shape, which can allow a clinician to implant an intrasaccular device tailored to the aneurysm.
- a plurality of individual, independent components can operate collectively to form a composite unit having one or more desired characteristics.
- Such components can have an interlocking structure, which can include a framing component, according to some embodiments.
- the intrasaccular device when used with a framing component, can enable expandable components to be securely retained within an aneurysm.
- a framing component can comprise a foam or braided structure. Further, one or more expandable components can be inserted into a cavity of or formed by the framing component.
- the intrasaccular device can also be configured to provide a plurality of interconnected expandable components, extending in linear, planar, or three-dimensional arrays or matrices. These arrays or matrices can be deployed in whole or in part into a target aneurysm, allowing a clinician to select portions of the array or matrix for implantation.
- a device for treatment of an aneurysm comprising a foam component having first and second sections, the first section having an average porosity different from an average porosity of the second section, the component being expandable from a compressed configuration to an expanded configuration when released into an aneurysm from a catheter.
- Embodiment 1 The device of Embodiment 1, wherein the component is adapted to expand upon exposure to a thermal agent.
- Embodiment 1 wherein the component is adapted to expand upon exposure to a chemical agent.
- the component further comprises a third section coupled to the second section, the third section having an average porosity different from the porosity of the second section.
- the device of Embodiment 1 further comprising a transition zone between the first and second sections, the transition zone having an average porosity intermediate the porosities of the first and second sections.
- the component comprises a substantially spherical shape that is divided crosswise into the first and second sections.
- a shape of the component is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 25 wherein the foam component and the second foam component are different sizes from each other.
- Embodiment 25 wherein the foam component and the second foam component are different shapes from each other.
- Embodiment 25 further comprising a plurality of additional foam components having substantially spherical shapes.
- a system for treatment of an aneurysm comprising a plurality of foam components being expandable from a compressed configuration to an expanded configuration when released into an aneurysm from a catheter, each of the plurality of components having an average porosity that is different from an average porosity of another of the plurality of components, the plurality of components being positionable within the aneurysm to form a composite foam component having a composite porosity configured to provide a therapeutic effect.
- each of a first group of the plurality of components comprises a first average porosity
- each of a second group of the plurality of components comprises a second average porosity different from the first average porosity
- Embodiment 31 wherein the first average porosity is between about 1 ⁇ m and about 100 ⁇ m, and the second average porosity is between about 100 ⁇ m and about 200 ⁇ m.
- Embodiment 30 wherein a shape of at least one of the plurality of components is substantially spherical.
- a shape of at least one of the plurality of components is selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- each of the plurality of components is interconnected to another of the plurality of components via a filament.
- each of the plurality of components is interconnected to at least two others of the plurality of components.
- Embodiment 30 wherein the plurality of components is self-expanding to assume the expanded configuration thereof.
- Embodiment 30 wherein the plurality of components is adapted to expand upon exposure to a thermal agent.
- Embodiment 30 wherein the plurality of components is adapted to expand upon exposure to a chemical agent.
- Embodiment 30 wherein at least one of the plurality of components comprises a bioactive coating.
- Embodiment 30 wherein at least one of the plurality of components comprises a thrombogenic drug.
- Embodiment 30 wherein at least one of the plurality of components comprises an expansion-limiting coating configured to control an expansion rate of the component.
- each of the plurality of components is different shapes from another of the plurality.
- a device for treatment of an aneurysm comprising a foam component having a region of variable average porosity and a radiopaque marker, the marker being visible under imaging and positionable relative to the region so as to facilitate identification and orientation of the component when implanted into the aneurysm from a catheter, the component being expandable from a compressed configuration to an expanded configuration when released into the aneurysm.
- the device of Embodiment 46 wherein the region comprises a first section and a second section having an average porosity different from an average porosity of the first material.
- the region further comprises a third section adjacent to the second section, the third section having an average porosity different from the porosity of the second section.
- Embodiment 48 wherein the second section is coupled to the third section by chemical bonding, by thermal bonding, or by mechanical crimping.
- the region comprises a first material and a second material different from the first material, the first and second materials being coupled to each other.
- the region further comprises a third material different from the first material.
- the marker comprises a material blended into the component such that the component is visible under imaging.
- Embodiment 53 wherein the marker comprises bisumuth or tantalum blended with a foam material to form the component.
- the marker comprises a coating or a material that is bonded or mechanically coupled to the component.
- a shape of the component is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- the device of Embodiment 57 further comprising a second foam component having a shape selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- a second foam component having a shape selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 58 wherein the foam component and the second foam component are different sizes from each other.
- Embodiment 58 wherein the foam component and the second foam component are different shapes from each other.
- Embodiment 58 wherein the foam component and the second foam component have mating structures configured to abut each other in a complementary configuration and restrict at least degrees of freedom of motion of each of the foam component and the second foam component.
- Embodiment 58 further comprising a plurality of additional foam components having substantially spherical shapes.
- a method for treatment of an aneurysm comprising: advancing a foam component through a catheter lumen, the component comprising a first section having a different average porosity than an average porosity of a second section; releasing the component into the aneurysm; allowing the component to expand from a compressed configuration to an expanded configuration within the aneurysm; and positioning the component within the aneurysm such that the first section is positioned away from the aneurysm neck and the second section is positioned adjacent to a neck of the aneurysm.
- Embodiment 63 wherein the positioning comprises maintaining a position of the component relative to the aneurysm neck during expansion to the expanded configuration.
- Embodiment 63 wherein the aneurysm is disposed adjacent at bifurcation of a parent vessel into two efferent vessels, and wherein the positioning further comprises positioning the second section adjacent to the bifurcation and permitting flow through the bifurcation and into at least one of the first or second efferent vessels.
- Embodiment 66 wherein the first section comprises an average porosity of between about 1 ⁇ m and about 150 ⁇ m.
- Embodiment 66 wherein the second section comprises an average porosity of between about 100 ⁇ m and about 200 ⁇ m.
- the component further comprises a third section disposed between the first and second sections, the third section having an average porosity different than the porosity of the second section, wherein the positioning comprises positioning the component such that the first section is positioned at a fundus of the aneurysm and the third section is positioned between the fundus and the aneurysm neck.
- Embodiment 63 wherein the positioning comprises aligning a radiopaque marker relative to the aneurysm to position the second section adjacent to the aneurysm neck.
- Embodiment 70 wherein the aligning comprises aligning the marker with a fundus of the aneurysm.
- Embodiment 63 further comprising injecting a liquid embolic material into the aneurysm after positioning the component.
- Embodiment 63 further comprising implanting a support structure into the aneurysm before releasing the component into the aneurysm, and wherein the releasing comprises releasing the component through a wall of the support structure into the aneurysm.
- Embodiment 73 wherein the support structure comprises a substantially enclosed interior cavity, and the releasing further comprises releasing the component into the interior cavity.
- a system for treatment of an aneurysm comprising: a first foam component being expandable from a compressed configuration to an expanded configuration when released into the aneurysm, the first component having a first shape when in the expanded configuration; and a second foam component, separate from and freely movable relative to the first component, being expandable from a compressed configuration to an expanded configuration when released into the aneurysm, the second component having a second shape when in the expanded configuration; wherein at least one of the first and second shapes is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 75 further comprising a third foam component, the third component having a third shape different from the first shape.
- Embodiment 78 wherein the third shape is substantially spherical.
- Embodiment 75 further comprising third, fourth, and fifth foam components, each of the third, fourth, and fifth components having shapes different from those of the first and second shapes.
- Embodiment 75 further comprising third, fourth, and fifth foam components, each of the third, fourth, and fifth components having sizes different from those of the first and second components.
- Embodiment 84 wherein in the complementary configuration, the first component restricts at least two degrees of freedom of motion of the second component.
- Embodiment 84 wherein in the complementary configuration, the first component restricts at least three degrees of freedom of motion of the second component.
- Embodiment 87 wherein the first component restricts four, five, or six degrees of freedom of motion of the second component.
- Embodiment 84 wherein in the complementary configuration, the first and second components are interconnected to form a composite structure.
- Embodiment 84 wherein in the complementary configuration, the first and second components are interconnected to form a composite structure, and wherein the first and second components have different average porosities from each other.
- Embodiment 84 further comprising a third foam component having a third mating structure configured to abut at least the first mating structure, wherein in the complementary configuration, the first component restricts at least two degrees of freedom of motion of the third component.
- Embodiment 91 wherein the first component restricts four, five, or six degrees of freedom of motion of the third component.
- Embodiment 75 wherein the first and second components have different average porosities from each other.
- Embodiment 75 wherein the component further comprises a bioactive coating.
- Embodiment 75 wherein the component further comprises an expansion-limiting coating configured to control an expansion rate of the component.
- a system for treatment of an aneurysm comprising a plurality of separate and independently expandable components each being expandable from a compressed configuration to an expanded configuration when released into the aneurysm, each of the components having shapes different from each other, wherein the shapes are selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 98 The system of Embodiment 98, wherein the components are different sizes from each other.
- Embodiment 98 further comprising at least one additional component that is substantially spherical.
- Embodiment 98 further comprising a plurality of additional components that are substantially spherical.
- Embodiment 98 wherein at least two of the components have mating structures configured to abut each other in a complementary configuration for restricting freedom of motion of the components.
- Embodiment 103 wherein the components each have mating structures configured to abut each other in a complementary configuration.
- Embodiment 104 wherein in the complementary configuration, the components are interconnected to form a composite structure.
- Embodiment 103 wherein in the complementary configuration, the components are interconnected to form a composite structure, and wherein the components have different porosities from each other.
- a method for treatment of an aneurysm comprising: positioning a distal opening of a catheter adjacent to an aneurysm; and releasing a plurality of separate and independently foam components into the aneurysm; wherein shapes of the plurality of components are selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 107 wherein the releasing comprises releasing the plurality of components based on a shape of the aneurysm.
- Embodiment 108 further comprising selecting the plurality of components based on the shape of the aneurysm.
- Embodiment 107 wherein the releasing comprises interconnecting at least two components to create a composite structure.
- the releasing comprises releasing the plurality of components into the aneurysm to fill the aneurysm such that as a composite, the plurality of components provides a lower porosity adjacent to a neck of the aneurysm relative to a fundus of the aneurysm.
- Embodiment 107 further comprising imaging the aneurysm.
- Embodiment 112 wherein the imaging comprises determining a shape of the aneurysm to select the plurality of components.
- Embodiment 112 further comprising repositioning a first of the plurality of components within the aneurysm after the first component has been released into the aneurysm.
- Embodiment 114 wherein the repositioning comprises repositioning the first component such that the plurality of components, as a composite, is arranged within the aneurysm to provide a lower porosity adjacent to a neck of the aneurysm relative to a fundus of the aneurysm.
- Embodiment 107 further comprising, prior to releasing the plurality of components into the aneurysm, implanting a framing device into the aneurysm.
- Embodiment 116 wherein the releasing comprises releasing the plurality of components into a cavity of the framing device.
- a method for treatment of an aneurysm comprising: positioning a distal opening of a catheter adjacent to the aneurysm; and advancing a framing device into the aneurysm, the framing device having an interior cavity and an exterior surface for contacting a wall of the aneurysm; and while at least a portion of the device exterior surface is in contact with the aneurysm wall, releasing at least one expandable component into the device cavity; wherein the framing device comprises at least one of a foam or a braided structure.
- Embodiment 118 wherein the aneurysm is a saccular aneurysm and before releasing the at least one expandable component, the device is expanded such that the exterior surface contacts an inner surface of the aneurysm having a cross-sectional profile greater than a passing profile of a neck of the aneurysm.
- Embodiment 118 wherein the releasing comprises causing the device to expand into contact with the aneurysm wall.
- Embodiment 118 wherein the device comprises a substantially closed three-dimensional expanded shape.
- Embodiment 118 wherein the component comprises at least one of a foam, a coil, or a braided structure.
- Embodiment 121 wherein the three-dimensional shape is selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, non-spherical surface of revolution, and combinations thereof.
- Embodiment 118 wherein the device comprises for quadrants, and the releasing comprises causing at least a portion of each quadrant to contact the aneurysm wall.
- Embodiment 124 wherein the device comprises a substantially spherical expanded shape.
- Embodiment 118 wherein the device comprises an opening to the device cavity, and the releasing comprises injecting the at least one expandable component into the device cavity through the device aperture.
- Embodiment 126 wherein the device comprises a braided material and the opening is an opening formed between filaments of the braided material.
- Embodiment 126 wherein the framing device has a closed end and an open end opposite the closed end, the open end forming the opening, and wherein the releasing advancing comprises aligning the opening with a neck of the aneurysm.
- the open end comprises a plurality of filament ends extending into the device cavity and forming the opening, the plurality of filament ends collectively forming a tubular portion extending into the device cavity
- the releasing comprises permitting the at least one expandable component to expand within the device cavity such that the tubular portion is deflected into contact with an inner wall of the device, thereby closing the opening.
- Embodiment 118 wherein the releasing comprises releasing a plurality of expandable components into the aneurysm such that as a composite, the plurality of expandable components provides a lower average porosity adjacent to a neck of the aneurysm relative to an average porosity at a fundus of the aneurysm.
- the at least one expandable component comprises a shape selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 118 wherein the releasing comprises releasing at least one coil into the device cavity.
- Embodiment 118 wherein the releasing comprises releasing at least one expandable component into the device cavity.
- the at least one expandable component comprises an expandable composite comprising first and second portions having different porosities from each other.
- a method for treatment of an aneurysm comprising: implanting a stent into a lumen of a parent vessel from which an aneurysm arises such that the stent extends across at least a portion of the aneurysm; and releasing at least one expandable component into an inner volume of the aneurysm between a wall of the aneurysm and an outer surface of the stent; wherein the expandable component comprises at least one of a foam or a braided structure.
- Embodiment 135 wherein the at least one expandable component comprises a plurality of expandable components, and the releasing comprises releasing the plurality based on relative sizes of the expandable components.
- Embodiment 139 further comprising selecting the at least one expandable component based on the shape of the inner volume.
- the at least one expandable component comprises a shape selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 135 wherein the at least one expandable component comprises a first portion having an average porosity greater than that of a second portion thereof, and the releasing comprises positioning the at least one expandable component such that the first portion abuts an outer surface of the stent device and the second portion extends along an inner wall of the aneurysm.
- Embodiment 135, wherein the releasing comprises releasing a plurality of expandable components into the inner volume.
- Embodiment 135 wherein the aneurysm inner volume extends around a circumference of the stent device, and the releasing comprises depositing a plurality of expandable components into the inner volume around the circumference of the stent device.
- Embodiment 144 wherein at least one of the plurality of expandable components comprises a flat or cylindrically shaped surface, and the releasing comprises positioning the at least one of the plurality of expandable components such that the flat or cylindrically shaped surface substantially conforms to an outer surface of the stent device.
- a system for treatment of an aneurysm comprising: an intrasaccular device comprising first and second expandable components adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm, the first and second components being interconnected by a non-helical coupling such that the first and second components can be advanced as an interconnected unit, into the aneurysm; wherein the first component comprises at least one of a shape or an average porosity different from a shape or an average porosity of the second component.
- Embodiment 146 wherein the first component shape is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 146 wherein the second component comprises a substantially spherical shape.
- Embodiment 146 wherein at least one of the first or second components comprises a foam or a braided structure.
- Embodiment 146 wherein at least one of the first or second components comprises a coil.
- Embodiment 146 wherein the first component comprises an average porosity of between about 1 ⁇ m and about 100 ⁇ m and the second component comprises an average porosity of between about 100 ⁇ m and about 200 ⁇ m
- Embodiment 146 further comprising a third component interconnected with the second component such that the first, second, and third components are interconnected in series.
- Embodiment 146 wherein the coupling has a preset shape such that in an expanded position, the first and second components are spaced relative to each other at a preset orientation.
- Embodiment 146 further comprising an introducer sheath configured to receive the device therein such that the device can be loaded into the guide catheter for delivery to the aneurysm.
- a system for treatment of an aneurysm comprising: an intrasaccular device comprising at least three expandable components adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm, each of the at least three components being interconnected to at least two of the at least three components such that at least three expandable components can be advanced as an interconnected unit, into the aneurysm.
- Embodiment 156 wherein the at least three expandable components comprises at least four expandable components.
- Embodiment 157 wherein at least two of the at least four expandable components is interconnected with at least three of the at least four expandable components such that the device comprises a multi-planar shape.
- Embodiment 156 The system of Embodiment 156, wherein the at least three components are interconnected by filaments.
- Embodiment 156 wherein at least three components are interconnected by filaments having preset shapes such that in an expanded position, the at least three components are spaced relative to each other at a preset orientation.
- Embodiment 156 wherein the device comprises at least one central expandable component positioned such that, when the device is in an expanded configuration, the central expandable component is centrally interconnected with a plurality of the expandable components.
- Embodiment 161 wherein the at least one central expandable component has an expanded size greater than an expanded size of each remaining one of the plurality of components.
- Embodiment 161 wherein the at least one central expandable component has an average porosity greater than an average porosity of each remaining one of the plurality of the components.
- Embodiment 158 wherein the multi-planar shape comprises a polyhedron.
- Embodiment 164 wherein the multi-planar shape comprises a pyramid.
- Embodiment 164 wherein the multi-planar shape comprises a prism.
- a first component of the at least three components comprises a shape or an average porosity different than that of a second component of the at least three components.
- Embodiment 156 wherein the first component shape is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- Embodiment 156 wherein the second component comprises a substantially spherical shape.
- Embodiment 156 wherein the first component comprises an average porosity of between about 1 ⁇ m and about 100 ⁇ m, and the second component comprises an average porosity of between about 100 ⁇ m and about 200 ⁇ m.
- Embodiment 156 further comprising an introducer sheath configured to receive the device therein such that the device can be loaded into the guide catheter for delivery to the aneurysm.
- a method for treatment of an aneurysm comprising: advancing an intrasaccular device toward the aneurysm through a lumen of a catheter, the device comprising a plurality of expandable components each adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm from the catheter, each of the plurality of components being interconnected by a coupling.
- Embodiment 172 further comprising: advancing the device into the aneurysm such that a first component is disposed within the aneurysm and a second component, interconnected with the first component by the coupling, is disposed within the catheter lumen; severing the coupling between the first and second components to release the first component into the aneurysm; retaining the second component within the lumen; and withdrawing the catheter.
- Embodiment 172 further comprising advancing a plurality of expandable components into the aneurysm prior to the severing.
- Embodiment 172 wherein the severing comprises proximally withdrawing the catheter relative to a second catheter such that the coupling between the first and second components is pinched between a distal end of the catheter and a rim of the second catheter.
- Embodiment 172 wherein the plurality of expandable components is arranged in descending size, and the advancing comprises allowing an initial expandable component deployed into the aneurysm to expand prior to advancing a subsequent expandable component into the aneurysm.
- Embodiment 177 wherein the advancing comprises observing a fit of expanded components within the aneurysm to determine whether to advance additional components into the aneurysm.
- Embodiment 178 wherein the device comprises a radiopaque material.
- each of the plurality of expandable components of the device comprises a radiopaque material.
- FIG. 1 is a schematic illustration depicting an aneurysm within a blood vessel, into which an intrasaccular device has been implanted, according to some embodiments.
- FIG. 2 is a schematic view of reticulated foam, which can be used in the intrasaccular device accordance with some embodiments.
- FIG. 3 is a schematic view an intrasaccular device having a specific porosity, according to some embodiments.
- FIG. 4 is a schematic view of an intrasaccular device comprising two portions having different porosities, according to some embodiments.
- FIG. 5 is an enlarged view of a transition zone of the intrasaccular device shown in FIG. 4 , wherein the transition zone comprises an immediate transition between different porosities, according to some embodiments.
- FIG. 6 is an enlarged view of the transition zone of the intrasaccular device shown in FIG. 4 , wherein the transition zone comprises a gradual transition between different porosities, according to some embodiments.
- FIG. 7 is a schematic view of an intrasaccular device comprising three portions arranged in a specific porosity profile, according to some embodiments.
- FIG. 8 is a schematic view of an intrasaccular device comprising three portions arranged in a specific porosity profile, according to some embodiments.
- FIG. 9 is a schematic view of an intrasaccular device comprising four portions having different porosities, according to some embodiments.
- FIG. 10 is a schematic view of an intrasaccular device having channels extending therethrough, according to some embodiments.
- FIG. 11 is a schematic view of an intrasaccular device having a channel extending therethrough, according to some embodiments.
- FIGS. 12A-12R are views illustrating alternate configurations for the foam structures of the intrasaccular device
- FIGS. 13-15 illustrate hollow structures of an intrasaccular device, according to some embodiments.
- FIGS. 16-18 illustrate interlocking structures of an intrasaccular device, according to some embodiments.
- FIGS. 19-21 illustrate alternate embodiments of the intrasaccular device incorporating coated foam structures.
- FIG. 22-25 illustrate a delivery system and a procedure for delivering an intrasaccular device, according to some embodiments.
- FIG. 26 illustrates an intrasaccular device having a radiopaque material and positioned within an aneurysm, according to some embodiments.
- FIGS. 27-30 illustrate intrasaccular devices positioned within an aneurysm based on a porosity profile, according to some embodiments.
- FIGS. 31A-34 illustrate alternative engagement mechanisms for the delivery system shown in FIG. 22 , for engaging one or more expandable components, according to some embodiments.
- FIG. 35 illustrates a delivery system for delivering an intrasaccular device, according to some embodiments.
- FIG. 36 illustrates a delivery system for delivering an intrasaccular device comprising a plurality of expandable components, according to some embodiments.
- FIG. 37 illustrates a delivery system, advanceable along a guide wire, for delivering an intrasaccular device comprising a plurality of expandable components, according to some embodiments.
- FIG. 38 illustrates an intrasaccular device having a specific shape and a radiopaque material positioned within a saccular aneurysm, according to some embodiments.
- FIG. 39 illustrates an intrasaccular device comprising a plurality of expandable components positioned within a saccular aneurysm, according to some embodiments.
- FIG. 40 illustrates an intrasaccular device comprising a plurality of interlocking expandable components positioned within a saccular aneurysm, according to some embodiments.
- FIG. 41 illustrates an intrasaccular device comprising a plurality of expandable components positioned within a saccular aneurysm, according to some embodiments.
- FIG. 42 illustrates an intrasaccular device comprising a plurality of expandable components extending across a fusiform aneurysm, according to some embodiments.
- FIG. 43 illustrates a schematic view of a procedure in which an embolic liquid and an intrasaccular device comprising single expandable component are inserted into an aneurysm, according to some embodiments.
- FIG. 44 illustrates a schematic view of a procedure in which an embolic liquid and an intrasaccular device comprising a plurality of expandable components are inserted into an aneurysm, according to some embodiments.
- FIG. 45 illustrates a delivery procedure for delivering coils or foam within an interior of an intrasaccular framing device, according to some embodiments.
- FIG. 46 illustrates a partial cross-sectional view of the intrasaccular framing device as similarly shown in FIG. 45 , packed with coils, according to some embodiments.
- FIG. 47 illustrates a partial cross-sectional view of the intrasaccular framing device as similarly shown in FIG. 45 , packed with at least one foam component, according to some embodiments.
- FIG. 48 illustrates another embodiment of an intrasaccular framing device, packed with at least one foam component, according to some embodiments.
- FIG. 49 illustrates yet another embodiment of an intrasaccular framing device, packed with at least one foam component, according to some embodiments.
- FIGS. 50-52 are schematic views of different intrasaccular framing devices, according to some embodiments.
- FIGS. 53-56 illustrate embodiments of the intrasaccular device incorporating a strip of foam structures.
- FIGS. 57A-57C illustrate cross-sectional shapes that can be employed, alone or in combination with each other, in the intrasaccular structures shown in FIGS. 53-56 .
- FIG. 58A illustrates an embodiment of an intrasaccular device comprising a plurality of interconnected expandable components in a compressed state, according to some embodiments.
- FIG. 58B illustrates the intrasaccular device of FIG. 58A comprising a plurality of interconnected expandable components in an expanded state, according to some embodiments.
- FIG. 59A illustrates an embodiment of an intrasaccular device comprising a layer of interconnected expandable components in a compressed state, according to some embodiments.
- FIG. 59B illustrates another embodiment of an intrasaccular device comprising a layer of interconnected expandable components in a compressed state, according to some embodiments.
- FIG. 60A illustrates an embodiment of an intrasaccular device comprising a three-dimensional array of interconnected expandable components in a compressed state, according to some embodiments.
- FIG. 60B illustrates another embodiment of an intrasaccular device comprising a three-dimensional array of interconnected expandable components in a compressed state, according to some embodiments.
- FIG. 61-63 illustrate a delivery system and procedure for delivering a plurality of interconnected expandable components, according to some embodiments.
- Intrasaccular implant devices and procedures for treating aneurysms can be improved by manipulating one or more physical characteristics of the implant material. Such characteristics can include the porosity, composition, material, shape, size, interconnectedness, inter-engagement, coating, etc. By modifying one or more such characteristics, the morphology or attributes of a target aneurysm and orientation of any connecting arteries can be specifically considered and addressed to achieve superior treatment.
- the porosity, composition, or material of the intrasaccular device can facilitate in the treatment of an aneurysm.
- the intrasaccular device can comprise an expandable component.
- the intrasaccular device can expand from a first, compressed configuration to a second, expanded configuration when released into the aneurysm.
- the intrasaccular device can comprise an expandable component having an average porosity that changes from a first end of the component to a second end opposite the first end.
- the intrasaccular device can comprise a composite structure having first and second sections or materials having different porosities.
- the first and second sections can be separated by a transition zone.
- the transition zone can comprise an immediate change in porosity or a gradual transition in which the porosity spatially varies between a first porosity and a second porosity from one end of the transition zone to another, opposite end of the transition zone.
- porosity can generally refer to an average porosity, which can be sampled across a given portion or section of an expandable component. “Porosity” can be defined as the ratio of the volume of the pores of in a component to the volume of the component as a whole. Porosity can be measured by a fluid displacement test. For example, liquid or gas testing can be used, as necessary or desirable, according to skill in the art. In some embodiments, a chromatography chamber can be used to measure displacement of a gas within the chamber, enabling the calculation of an average porosity of a given intrasaccular device or portion thereof. Other methods and systems can be used to measure porosity of portions of or the entirety of an expandable component.
- a composite structure of the intrasaccular device can comprise three materials having different porosities. Further, the composite structure of the intrasaccular device can comprise for, five, six, or more different materials having different porosities.
- one or more of intrasaccular devices can be released into a target aneurysm and, in some embodiments, specifically oriented relative to the aneurysm ostium or neck and/or one or more perforating vessels (e.g., perforating arteries or arterioles) adjacent to the aneurysm.
- perforating vessels e.g., perforating arteries or arterioles
- the intrasaccular device can be repositioned within the aneurysm as the device is expanding.
- the repositioning of the device can allow a clinician to position a lower porosity section of the device adjacent to the neck of the aneurysm.
- the repositioning of the device can also allow a clinician to position a higher average porosity section of the device adjacent to one or more perforating vessels (e.g., perforating arteries or arterials) adjacent to the aneurysm.
- the repositioning of the device can also allow a clinician to position a lower porosity portion of the device adjacent to a bifurcation.
- the repositioning of the device can also allow a clinician to position a higher average porosity portion of the device toward or in the fundus of the aneurysm.
- Intrasaccular implant devices and procedures for treating aneurysms disclosed herein can also comprise manipulating a shape or size of the intrasaccular device.
- a single expandable component having a specific or selected shape or size which can be tailored to the shape or size of the aneurysm, can be implanted into an aneurysm.
- multiple expandable components, each having such a specific or selected shape or size can also be implanted into an aneurysm.
- the shape or size of the expandable component(s) can be selected from a variety of spherical or non-spherical shapes. Each shape can be solid or hollow.
- a composite intrasaccular device can be provided that comprises at least two mating expandable components (e.g., a plurality of interconnectable or engageable expandable components).
- Each of the expandable components can comprise one or more engagement structures configured to interact with a corresponding engagement structure of another mating expandable component.
- the mating expandable components can each comprise an engagement structure configured to interact with a corresponding engagement structure of another mating expandable component.
- the mating expandable components can be delivered into the aneurysm and arranged in situ such that the engagement structures are aligned and interconnected appropriately such that the expandable components are mated.
- the mating of the expandable components can interlock the components as a unit. For example, expansion of a portion of a component within a recess of another component can cause the components to be interlocked with each other. Further, in some embodiments, the mating components can restrict at least one degree of freedom of movement of another component.
- the target aneurysm can be imaged and analyzed in order to determine a three-dimensional shape of the aneurysm. Based on the shape of the target aneurysm, one or more expandable components can be selected, having a unique porosity, composition, material, shape, size, interconnectedness, inter-engagement, or coating, etc.
- Imaging devices can include 3-D CTA or MRI (MRA) imaging, through which the size and shape of the aneurysm can be ascertained. Such imaging can provide a basis for selection of one or more correspondingly shaped intrasaccular device(s) for insertion within the aneurysm. Different combinations of expandable components or their characteristics can be used.
- the intrasaccular device can have a predetermined configuration, whether or not the intrasaccular device has only a single or multiple expandable components.
- the predetermined configuration can be based on typical aneurysm shapes, thereby allowing selection of a specific intrasaccular device.
- individual components of an intrasaccular device can also be arranged based on their properties. Accordingly, the clinician can determine the shape of the aneurysm and create a desired intrasaccular device configuration for treating the aneurysm.
- an expandable component of an intrasaccular device may be molded or manufactured into a variety of geometrical or partial geometrical shapes.
- the shape or size of the expandable component(s) can be selected from a variety of spherical or non-spherical shapes, including, cylinders, hemispheres, noodles, polyhedrons (e.g., cuboids (types), tetrahedrons (e.g.
- spheroids prolate spheroids
- oblate spheroids plates (e.g., discs, polygonal plates), bowls (e.g, an open container, such as a hollow, hemispherical container or other open, hollow containers, whether hemispherical, rounded, or otherwise), hollow structures (e.g., a container of any shape with an inner cavity or void, which can be, for example, greater in size than a width of any of the walls of the structure), clover shapes (a plurality of radially extending protrusions, having rounded or smooth corners), non-spherical surfaces of revolution (e.g., toruses, cones, cylinders, or other shapes rotated about a center point or a coplanar axis), and combinations thereof.
- Each shape(s) can be solid or hollow.
- At least a portion of the intrasaccular device can comprise a coating or material for enhancing therapeutic, expansive, or imaging properties or characteristics of at least one or every expandable component of the intrasaccular device.
- the intrasaccular device can be configured such that an expandable component thereof is coated with a biocompatible material to promote endothelialization or provide a therapeutic effect.
- the expandable component can also comprise an expansion-limiting coating that slows expansion of the component from its natural rate of expansion to a slower rate of expansion such that in the process of expanding, the position of the component can be adjusted within the aneurysm or the component can be removed from the aneurysm, if necessary.
- polymers that can be used as expansion-limiting coatings can include hydrophobic polymers, organic non-polar polymers, PTFE, polyethylene, polyphenylene sulfide, oils, and other similar materials.
- Various delivery systems and procedures can be implemented for delivering an intrasaccular device comprising one or more expandable components, as discussed herein. Further, a system and method are provided for delivery of an intrasaccular device to an aneurysm and/or recapturing the device for removal or repositioning.
- Intrasaccular implant devices and procedures for treating aneurysms can comprise interconnecting individual components of the intrasaccular device.
- a plurality of expandable components can be interconnected along a wire, filament, or other disconnectable or breakable material.
- the expandable components can be connected in a linear configuration, a planar matrix, or in a three-dimensional matrix.
- the expandable components of such interconnected linear, planar, or three-dimensional matrices can be sized and configured in accordance with desired porosity, size, shape, radiopacity, or other characteristics disclosed herein.
- interconnected expandable components can be released into an aneurysm.
- the interconnected components can be preconfigured (e.g., a plurality of components can be joined together to form a single, unitary device, or a select plurality of components can be removed from a larger strand or array of components) prior to implantation and later inserted into a delivery catheter. Thereafter, the entire strand or assembly of interconnected expandable components of the intrasaccular device can be ejected or released into the aneurysm and allowed to expand within the aneurysm.
- an entire strand or array of components can be loaded into a delivery catheter, and while implanting and observing the packing behavior, a clinician can determine that a select portion of the interconnected expandable components is sufficient for a given aneurysm. Thereafter, the select portion of the interconnected expandable components can be broken or cut in situ so as to be released into the aneurysm.
- a single expandable component can be used alone to fill the aneurysm and provide a desired packing density
- a plurality of expandable components can also be used to fill the aneurysm and provide a desired packing density.
- a liquid embolic and/or a framing component can be used in combination with one or more expandable components to facilitate delivery, engagement with the aneurysm, or increase of the packing density. Any of these embodiments can allow increased packing density to avoid recanalization of the aneurysm.
- FIG. 1 illustrates an embodiment of an intrasaccular device 10 positioned within an aneurysm 12 in a blood vessel 14 .
- the intrasaccular device 10 can be particularly adapted for use in the tortuous neurovasculature of a subject for at least partial deployment in a cerebral aneurysm.
- a cerebral aneurysm may present itself in the shape of a berry, i.e., a so-called berry or saccular aneurysm, which is a bulge in the neurovascular vessel.
- Berry aneurysms may be located at bifurcations or other branched vessels.
- Other types of aneurysms, including fusiform aneurysms, can also be treated using embodiments of the intrasaccular devices disclosed herein.
- the intrasaccular device 10 can comprise at least one expandable component.
- the intrasaccular device 10 can comprise a plurality of expandable components.
- a given expandable component of the intrasaccular device 10 can have one or more different characteristics than another of the expandable components of the intrasaccular device 10 .
- An expandable component can be formed from a material that can be highly compressed and later expanded when released into the aneurysm and contacted by a fluid, such as a fluid within the aneurysm.
- the expandable component can be formed at least in part of biocompatible, solid foam.
- “foam” can include a solid or semisolid gel, a swellable material (whether swellable upon hydration or swellable/self-expanding without hydration), a material having pores and interstices.
- “Foam” can include hydrophobic or hydrophilic materials.
- “Foam” can also include materials that can be highly compressed and configured to expand upon contact with a fluid, upon exposure to a thermal agent, upon exposure to a chemical agent, or self-expanding, upon release from engagement with the delivery mechanism.
- the foam material can be configured to expand by about two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, seventeen, eighteen, nineteen, twenty, or more times its collapsed size when expanding to its expanded size.
- FIG. 2 illustrates a schematic view of a foam material 20 .
- Suitable foam materials can comprise biocompatible foams such as a PVA (polyvinyl alcohol). Further, suitable foam materials can comprise reticulated foam. “Reticulated” foam can, in some embodiments, comprise a random arrangement of holes that has irregular shapes and sizes or a nonrandom arrangement of holes that has regular, patterned shapes and sizes. Suitable foam is also known under the trade name PacFoam, made available through UFP Technologies of Costa Mesa, Calif.
- the foam material from which the expandable component is formed can be configured to include at least about 20 pores per inch (“PPI”), at least about 30 PPI, at least about 40 PPI, at least about 50 PPI, at least about 60 PPI, at least about 70 PPI, or at least about 80 PPI, or combinations thereof.
- PPI pores per inch
- PVA polyvinyl alcohol
- PEG polyethylene glycol
- PVP polyvinyl pyrrolidone
- the porosity of the expandable component may vary along any portion(s) thereof, including any combination of pore sizes of 1 micron or greater. Further, the pore sizes can range from about 1 ⁇ m to about 400 ⁇ m, from about 5 ⁇ m to about 300 ⁇ m, from about 8 ⁇ m to about 200 ⁇ m, from about 10 ⁇ m to about 150 ⁇ m, from about 15 ⁇ m to about 80 ⁇ m, or in some embodiments, from about 20 ⁇ m to about 50 ⁇ m. Further, at least a portion or section of the device can comprise an average porosity of between about 1 ⁇ m and about 150 ⁇ m. Further, at least a portion or section can comprise an average porosity of between about 100 ⁇ m and about 200 ⁇ m.
- At least a portion or section can comprise an average porosity of between about 200 ⁇ m and about 300 ⁇ m.
- each section or portion can have an average porosity within any of the ranges discussed above.
- an expandable component of the intrasaccular device in a compressed state, may be compressed down to 50%, 40%, 30%, 20%, 10% or less of its expanded state (which can be measured by its maximum diameter or cross-sectional dimension) for delivery through a standard microcatheter.
- the foam material can be configured to expand by about two to twenty times its collapsed size when expanding to its expanded size.
- a chemical may be introduced within the lumen of the delivery catheter for delivery to the intrasaccular device.
- the delivery catheter may include a separate lumen for introduction of the catalyst.
- Thermally expansive foam may be activated through introduction of heated saline or some other suitable biocompatible fluid through any of the aforementioned lumens of the delivery catheter.
- a heating element may be incorporated within the delivery catheter to deliver heat to the foam structure to cause corresponding expansion.
- a suitable heating element identified schematically as reference numeral, may include resistive element(s), a microwave antenna, radio-frequency means, ultrasonic means or the like.
- the expandable component can be configured to provide a specific porosity profile.
- the porosity profile can comprise a single, consistent average porosity throughout the entire expandable component, or multiple average porosity zones, portions, or materials having different average porosities that are joined to form a composite expandable component.
- the embodiment illustrated in FIG. 3 can be configured to have a low average porosity structure.
- low porosity structures are illustrated in the figures using hexagonal patterns with larger spaces compared to hexagonal patterns with smaller spaces, which are used to illustrate medium and high porosity structures.
- Low porosity structures can provide higher packing densities, which can facilitate thrombogenesis by providing higher resistance to flow therethrough.
- such structures When such low porosity structures are implanted into an aneurysm, such structures can substantially pack the aneurysm with a relatively high packing density, thereby isolating the aneurysm from the parent vessel and minimizing blood flow velocity within the aneurysm while supporting the aneurysm wall.
- high porosity structures can also support the aneurysm wall, beneficially aid in healing and thrombogenesis for select aneurysm morphologies, permit flow to other vessels (e.g., branch vessels, perforating arteries, or arterioles), and/or permit the introduction of other materials, such as a liquid embolic, etc.
- composite, variable, or multi-porosity expandable components can advantageously allow the intrasaccular device to mimic natural function of the vasculature while promoting healing through thrombogenesis, pressure moderation or reduction, or aneurysm deflation.
- the single expandable component can be configured to advantageously secure the intrasaccular device within a wide-neck aneurysm by facilitating engagement with a sufficient amount of the aneurysm wall, thereby avoiding dislodgement or herniation of the device from the aneurysm into the parent vessel.
- FIG. 3 illustrates an expandable component 50 having a relatively less dense or high porosity due to a larger pore size.
- the foam component 50 can permit some blood flow therethrough to maintain branch vessels while still providing support for the aneurysm wall.
- the expandable component 50 or a portion of the expandable component 50 can be packed with a liquid embolic during or subsequent to placement of the intrasaccular device. The injection of a liquid embolic can increase the overall packing density within the expandable component 50 .
- OnyxTM liquid embolic system manufactured by Covidien LP, Irvine, Calif.
- OnyxTM liquid embolic system is a non-adhesive liquid used in the treatment of brain arteriovenous malformations.
- OnyxTM liquid embolic system is comprised of an EVOH (ethylene vinyl alcohol) copolymer dissolved in DMSO (dimethyl sulfoxide), and suspended micronized tantalum powder to provide contrast for visualization under fluoroscopy.
- EVOH ethylene vinyl alcohol
- DMSO dimethyl sulfoxide
- Other liquid embolic solutions are also envisioned.
- FIGS. 4-9 illustrate additional embodiments of expandable components.
- FIG. 4 illustrates an expandable component 60 having first and second portions 62 , 64 .
- the first and second portions 62 , 64 can be formed from different materials.
- the first portion 62 can comprise a higher average porosity first material
- the second portion 64 can comprise a lower average porosity second material.
- the first and second portions 62 , 64 can be coupled to each other by any chemical, thermal, or mechanical bonding methods known in the art or arising hereafter.
- the first and second portions 62 , 64 can be permanently attached to each other or releasably, upon expansion, attached to each other.
- FIGS. 5-6 illustrate enlarged views of a transition zone 66 of the expandable component 60 of FIG. 4 .
- FIG. 5 illustrates that a transition zone 66 a can comprise an immediate, abrupt transition between the porosities of the first and second portions 62 , 64 .
- the transition zone 66 a provides an open flow pathway between the first and second portions 62 , 64 .
- the transition zone 66 a may not act as a barrier to fluid flow.
- the transition zone 66 a can provide at least a partial or full barrier to fluid flow between the first and second portions 62 , 64 .
- the composite structure of the expandable component 60 may incorporate individual, separately formed segments or sections of material that are later joined together to create a composite unit or whole.
- the individual segments or first and second portions 62 , 64 may comprise the same material (such as any of those mentioned herein), or incorporate a combination of different materials.
- the first and second portions 62 , 64 may be bonded by any chemical, thermal, or mechanical methods known in the art.
- FIG. 6 illustrates that a transition zone 66 b can comprise an intermediate portion 68 having an average porosity that is higher than the average porosity of the second section 64 , but lower than the average porosity of the first section 62 .
- the transition zone 66 b provides an open flow pathway between the first, second, and/or intermediate portions 62 , 64 , 68 .
- the transition zone 66 b may not act as a barrier to fluid flow.
- the transition zone 66 b can provide at least a partial or full barrier to fluid flow between the first, second, and/or intermediate portions 62 , 64 , 68 .
- the intermediate portion 68 can have a porosity that gradually transitions spatially from a low porosity to a high porosity, or vice versa.
- the transition zone 66 b can be formed by varying the gas used in the fabrication of the variable porosity structure.
- regions within the blank can be identified based on an average porosity and the expandable component can be trimmed therefrom. In some embodiments, certain regions can be identified that have a porosity that varies spatially from one end of the region to another, opposite end.
- FIGS. 7-9 illustrate schematic views of additional embodiments of expandable components shown in FIGS. 1-4 . These figures illustrate expandable components that each include a composite structure having two or more foam segments with different respective porosities (or pore densities), sizes, and/or shapes.
- FIG. 7 illustrates an expandable component 80 having first, second, and third portions 82 , 84 , 86 .
- the second portion 84 can comprise a lower porosity than the first and third portions 82 , 86 .
- the first and third portions 82 , 86 can comprise the same porosity (e.g., the first and third portions 82 , 86 can comprise the same material or be formed or cut from the same material).
- the first and third portions 82 , 86 can comprise different porosities (e.g., the first and third portions 82 , 86 can comprise different materials or be formed or cut from different materials).
- the first, second, and third portions 82 , 84 , 86 can comprise different sizes and/or shapes or have substantially identical sizes and/or shapes. Size and shape characteristics can be configured as discussed below, in accordance with some embodiments.
- FIG. 8 similarly illustrates an expandable component 90 having first, second, and third portions 92 , 94 , 96 .
- the second portion 94 comprises a higher porosity than the first and third sections 92 , 96 .
- FIG. 9 also illustrates expandable component 100 having first, second, third, and fourth sections 102 , 104 , 106 , 108 , which can each have distinct porosities, shapes, and/or sizes.
- the porosity, size, or shape of the portions of the expandable components 90 , 100 can be configured as similarly discussed above with respect to FIG. 7 . Accordingly, the discussion of such characteristics will not be repeated except to indicate that FIGS. 8-9 illustrate that some embodiments can incorporate varied porosities, sizes, and shapes different from those illustrated FIG. 7 .
- the foam composites may be formed to provide different support and/or flow profiles.
- a material such as bismuth or tantalum, can be blended with the foam to provide radiopacity.
- radiopaque markers can be attached to the foam by bonding or mechanically crimping them to the foam.
- only a single expandable component would be required for introduction into an aneurysm. In some embodiments, this may prove advantageous over conventional methodologies such as the insertion of, for example, multiple embolic coils, by significantly reducing time for performance of the embolization procedure.
- multiple expandable components can be provided for insertion into an aneurysm.
- a plurality of expandable components having different average porosities, can be implanted into an aneurysm and have a composite or cumulative porosity profile spatially across the aneurysm, which can allow the plurality of expandable components to operate as a unit in much the same way as a single expandable component, if packing the same aneurysm itself, would operate.
- the expandable components can be arranged and positioned within a lumen of the catheter or otherwise arrange for delivery into the aneurysm. The size of each expandable component can be compressed to a fraction of its normal, expanded size and delivered into the target aneurysm.
- the expandable component(s) can include one or more flow regions.
- the flow region can be used alone or combination with any of the variable porosity profiles disclosed herein, including those illustrated in FIGS. 4-9 .
- FIGS. 10-11 illustrate expandable components having at least one flow region.
- FIG. 10 illustrates an expandable component 30 having a pair of flow regions 32 formed in a body 34 .
- FIG. 11 similarly illustrates another embodiment of an expandable component 40 having a single flow region 42 formed in a body 44 .
- the body 34 , 44 can have a substantially constant porosity that impedes fluid flow and generally promotes thrombogenesis, the flow regions 32 , 42 can be configured such that fluid flow through the flow regions is possible.
- the flow regions 32 , 42 of the expandable components 30 , 40 can provide a flow path for blood or enable performance of a secondary procedure, such as the introduction of an embolic, anti-inflammatory, antibiotic, or thrombogenic agent and/or permit deployment of embolic coils within the expandable components 30 , 40 .
- Either of these components 30 , 40 may allow blood to communicate to a side branch vessel through areas of the expandable component with large porosity while still providing stasis in the aneurysm.
- the flow regions 32 , 42 can comprise a passage, channel, or elongate void within the body 34 , 44 . Further, in embodiments wherein the flow regions 32 , 42 comprise a material, the material of the flow regions 32 , 42 can have a much higher porosity than that of the surrounding areas within the body 34 , 44 .
- FIGS. 10-11 illustrate only single or dual flow regions, some embodiments can be configured to comprise three, four, or more flow regions formed therein.
- the flow region can be separated from other portions of the body by a partial or full barrier.
- the flow region can comprise a lumen formed through the body and the lumen can comprise an inner wall (not shown) extending therealong.
- the inner wall can comprise a continuous surface.
- the inner wall can also comprise one or more perforations extending through the wall, by which the lumen of the flow region is in fluid communication with the surrounding areas of the body.
- the flow region can provide isolated flow through the body or a flow that is in communication with other areas of the body of the expandable component.
- FIGS. 12A-12R illustrate various examples of shapes that can be used in accordance with some embodiments. Variations, whether by proportions, combinations, or other modifications of the disclosed shapes can be made, as taught herein. Without limitation, the shapes illustrated in FIGS. 12A-12R can comprise a sphere 120 , a hemisphere 121 , a cuboid 122 , a pyramid 123 , an octahedron 124 , an octagonal prism 125 , a pentagonal prism 126 , a coil 127 , a prolate spheroid 128 , an oblate spheroid 129 , a clover plate 130 , a star plate 131 , a paraboloid of revolution 132 , a hollow sphere 133 , a bowl 134 , a torus 135 , a cylinder 136 , a cone 137 , or combinations thereof.
- an intrasaccular device can be provided that comprises first and second expandable components of which at least one has a shape selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof. Additional expandable components can be provided that have substantially spherical shapes.
- an intrasaccular device can comprise first and second expandable components having different shapes. Further, the first and second expandable components can have different sizes. A third expandable component can be used, which can have the same or different sizes or shapes compared to either or both of the first and second expandable components. Thus, the first, second, and third expandable components can each have a different size and/or shape compared to each other. Such principles can apply to additional components, such as fourth, fifth, sixth components, and so forth.
- Hollow expandable components can comprise braided structures (e.g., braided spheres), foam structures, and the like.
- a hollow expandable component can be released into the aneurysm by itself or in combination with other occlusive material, such as a liquid embolic, additional expandable components, or coils.
- FIGS. 13-15 illustrate hollow structures that can be used in accordance with embodiments of an intrasaccular device.
- FIGS. 13-15 each illustrates an intrasaccular device 150 a , 150 b , 150 c .
- Each device 150 a , 150 b , 150 c can comprise a shape having a hollow body 152 a , 152 b , 152 c , which can in turn define a cavity 154 a , 154 b , 154 c .
- the hollow body 152 a , 152 b , 152 c can be advantageous at least because it can enable the intrasaccular devices 150 a , 150 b , 150 c to have a more compact compressed state than a corresponding intrasaccular device (having an equivalent size when expanded) that is not hollow. Further, because the body 152 a , 152 b , 152 c is hollow, the intrasaccular devices 150 a , 150 b , 150 c can provide greater packing volumes within the aneurysm while using less material.
- the intrasaccular device 150 a , 150 b , 150 c can be compressed, comparatively, to a smaller size in its compressed state, the intrasaccular device 150 a , 150 b , 150 c can be delivered through a smaller microcatheter.
- the intrasaccular device 150 a , 150 b , 150 c can be configured to comprise an aperture 156 a , 156 b , 156 c in communication with the cavity 154 a , 154 b , 154 c to permit introduction of, e.g., at least one additional expandable component, a liquid embolic, or embolic coils to further pack and/or support the aneurysm.
- the clinician may perforate the intrasaccular device 150 a , 150 b , 150 c before or during the procedure. In such a capacity or procedure, the intrasaccular device 150 a , 150 b , 150 c can function as an intrasaccular framing device.
- the intrasaccular device 150 a , 150 b , 150 c can be expanded within the aneurysm such that the intrasaccular device 150 a , 150 b , 150 c extends across the neck of the aneurysm with the aperture 156 a , 156 b , 156 c being accessible through the neck (see e.g., FIGS. 40 and 44 ).
- the intrasaccular device extends across the neck, it may not touch or contact the neck of the aneurysm.
- the intrasaccular device 150 a , 150 b , 150 c can be oriented such that the open end faces the fundus of the aneurysm and the closed end (including the aperture 156 a , 156 b , 156 c ) extends across the neck of the aneurysm.
- the aperture 156 a , 156 b , 156 c may permit the introduction of a second smaller expandable component having a hollow interior.
- a third expandable component, smaller than the second expandable component, may then be introduced into the hollow interior of the second expandable component. Additional smaller foam structures may be added in a similar manner.
- FIGS. 13 , 14 , and 15 illustrate spheroid, ellipsoid and prism-shaped foam structures 402 , respectively.
- the intrasaccular device 150 a , 150 b , 150 c may receive any of the aforedescribed solid foam structures of the prior embodiments until the cavity 154 a , 154 b , 154 c is packed to the desired capacity.
- FIGS. 16-18 illustrate interlocking structures of an intrasaccular device, according to some embodiments.
- FIGS. 16-17 illustrate a composite intrasaccular device 160 a , 160 b having first and second portions or components 162 a , 162 b , 164 a , 164 b .
- the first and second portions 162 a , 162 b , 164 a , 164 b can comprise respective engagement structures 166 a , 166 b , 168 a , 168 b.
- the intrasaccular devices 160 a , 160 b shown in FIGS. 16-17 can be configured such that the respective engagement structures 166 a , 166 b , 168 a , 168 b provide a loose fit with each other when the first and second portions 162 a , 162 b , 164 a , 164 b are in their expanded states.
- the protrusions of the respective engagement structures 166 a , 166 b , 168 a , 168 b can be oversized relative to the recess of the respective engagement structures 166 a , 166 b , 168 a , 168 b , such that the protrusion expands to create an interference fit inside the recess, thereby securing the first portion 162 a , 162 b relative to the second portion 164 a , 164 b in the expanded states.
- the protrusion and recess can be guided towards each other as the first and second portions 162 a , 162 b , 164 a , 164 b expand within the aneurysm.
- other engagement structures can be provided, such as a ball and socket, slots, pins, etc.
- such interconnecting portions can be configured to restrict at least two degrees of freedom of motion of the opposing portion.
- Motion can be restricted in two or more of the following directions: up-and-down translation, forward and backward translation, left and right translation, side to side pivoting or rolling, left and right rotating or yawing, and forward and backwards tilting or pitching.
- at least three degrees of the freedom of motion of a portion can be restricted.
- the interconnection between portions of such embodiments can restrict four, five, or all six degrees of freedom of motion of a given portion.
- FIG. 18 illustrates an intrasaccular device 180 having a plurality of interconnecting portions 182 , 184 , 186 .
- These interconnecting portions 182 , 184 , 186 can be configured to abut each other in a complementary configuration, such as to provide a composite structure.
- the interconnecting portions 182 , 184 , 186 can be configured to restrict at least two, three, four, five, or six degrees of freedom of motion of another component.
- the mating expandable components such as those embodiments illustrated in FIGS. 16-18 can be delivered into the aneurysm and arranged in situ such that the engagement structures are aligned and interconnected appropriately such that the expandable components are mated.
- the mating of the expandable components can interlock the components as a composite structure or unit, as in FIG. 16 .
- At least a portion of the intrasaccular device can comprise a coating or material for enhancing therapeutic, expansive, or imaging properties or characteristics of at least one or every expandable component of the intrasaccular device.
- the intrasaccular device can be configured such that an expandable component thereof is coated with a biocompatible material to promote endothelialization or provide a therapeutic effect.
- FIG. 19 illustrates an alternate embodiment of the present disclosure.
- the intrasaccular device 190 comprising an expandable component 192 that can be coated and/or embedded with at least one coating 194 , such as a bioactive material or agent.
- the coating 194 may include thrombogenic coatings such as fibrin, fibrinogen or the like, anti-thrombogenic coatings such as heparin (and derivatives thereof), urukinase or t-PA, and endothelial promoting coatings or facilitators such as, e.g., VEGF and RGD peptide, and/or combinations thereof.
- Drug eluting coatings and a drug eluting foam composite, such as anti-inflammatory or antibiotic, coatings are also envisioned.
- These drug eluting components may include nutrients, antibiotics, anti-inflammatory agents, antiplatelet agents, anesthetic agents such as lidocaine, and anti-proliferative agents, e.g. taxol derivatives such as paclitaxel. Hydrophilic, hygroscopic, and hydrophobic materials/agents are also envisioned.
- the expandable component can also comprise an expansion-limiting coating that slows expansion of the component from its natural rate of expansion to a slower rate of expansion such that in the process of expanding, the position of the component can be adjusted within the aneurysm or the component can be removed from the aneurysm, if necessary.
- polymers that can be used as expansion-limiting coatings can include hydrophobic polymers, organic non-polar polymers, PTFE, polyethylene, polyphenylene sulfide, oils, and other similar materials.
- an intrasaccular device 200 can comprise a non-thrombogenic coating 202 may be applied to a lower half 204 of the expandable component 206 to minimize clotting at this location.
- a non-thrombogenic coating 202 may be applied to a lower half 204 of the expandable component 206 to minimize clotting at this location.
- Such coatings may be desirable in aneurysms located at a bifurcation such that blood flow to branch arteries is permitted through the segment of the foam structure having the non-thrombogenic coating.
- the coated area 202 may be a different color than the remaining portion of the expandable component 206 to assist the surgeon in identifying this area.
- the coated area 202 can also comprise radiopaque material to assist the surgeon in visualization and placement of the expandable component 206 in a desired orientation relative to the aneurysm.
- the expandable component 206 can have radiopacity characteristics either by adding radiopaque filler to the material (which in some embodiments comprises a foam material), such as bismuth, or attaching radiopaque markers.
- a radiopaque material can be attached to the expandable component 206 , such as by dipping, spraying, or otherwise mechanically, chemically, or thermally attached, injected into, or blended into to the expandable component 206 .
- FIG. 21 illustrates another embodiment of the intrasaccular devices illustrated in FIGS. 19-20 .
- an intrasaccular device 220 is shown that comprises has a star-shaped expandable component 222 which may be partially or fully coated and/or embedded with a material 224 , such as any of the aforedescribed agents.
- the star shape can provide increased surface area due to the presence of the undulations 226 in the outer surface of the expandable component 222 .
- the expandable component Once the expandable component is delivered into the aneurysm, it can expand back to its full size or expanded state, confined within the neck of the aneurysm with minimal herniation within the parent vessel.
- the foam could be self-expandable, chemically expandable, thermally expandable, or expandable in response to pH changes or to light.
- Shape memory foams such as polyurethane foam can be used.
- Various delivery systems and procedures can be implemented for delivering an intrasaccular device comprising one or more expandable components, as discussed herein. Further, a system and method are provided for delivery of an intrasaccular device to an aneurysm and/or recapturing the device for removal or repositioning.
- FIGS. 22-25 illustrate a delivery system and a procedure for implanting an intrasaccular device.
- a delivery catheter 300 is advanced within a vessel 302 until a distal end 304 of the delivery catheter 300 is positioned adjacent to a target site, such as an aneurysm 306 .
- a carrier assembly 320 can be configured to engage an intrasaccular device 330 and deliver the intrasaccular device 330 into the aneurysm 306 .
- the carrier assembly 320 can comprise a core member 322 and an engagement member 324 .
- the core member 322 can be interconnected with the engagement member 324 .
- the engagement member 324 can comprise at least two arm members 340 having a closed position (see FIG. 22 ) and an open position (see FIG. 23 ). In the closed position, the arm members 340 can be engaged with at least a portion of the intrasaccular device 330 to facilitate distal advancement and retention of the intrasaccular device 330 within the lumen of the catheter 300 .
- the carrier assembly 320 disposed within a lumen of the delivery catheter 300 , can be advanced distally through the catheter 300 until reaching the distal end 304 of the catheter 300 . Upon reaching the distal end 304 , the carrier assembly 320 can be actuated to release an intrasaccular device 330 into the aneurysm 306 , as shown in FIG. 23 .
- the arm members 340 can be spring-loaded or configured to spring open from the closed position upon being advanced out of or distally beyond the distal end 304 of the catheter 300 .
- the arm members 340 can also be manually actuated using a proximal control mechanism, thereby allowing the arm members 340 to continue engaging the intrasaccular device 330 even after the arm members 340 have moved out of the lumen of the catheter 300 .
- a proximal control mechanism can comprise a proximally extending wire coupled to a first of the arm members 340 , the proximal retraction of which causes the first arm member 342 retract into the catheter 300 , thus releasing the intrasaccular device 330 .
- Various other control mechanisms such as those disclosed herein, can also be implemented in accordance with some embodiments.
- the intrasaccular device 330 can begin to expand.
- the clinician can carefully monitor the orientation of the intrasaccular device 330 relative to the neck or surrounding the vasculature of the aneurysm 306 .
- the clinician can position the intrasaccular device 330 by manually rotating, moving, maintaining the position of, or otherwise adjusting the position of the intrasaccular device 330 within the aneurysm 306 as the intrasaccular device 330 expands. This procedure is illustrated in FIGS. 24-25 .
- the clinician can contact the intrasaccular device 330 to ensure proper orientation of the intrasaccular device 330 within the aneurysm 306 .
- the position of the expandable device can be manipulated using various other deployment or delivery devices, such as those shown in FIGS. 31A-37 or FIGS. 61-63 .
- the intrasaccular device 330 can beneficially be coated with an expansion-limiting coating, such as those discussed above.
- the expansion-limiting coating can allow the intrasaccular device 332 slowly expand, thus providing the clinician with a greater, and in some cases, a specified or expected period of time after releasing the intrasaccular device 330 to adjust the position of the intrasaccular device 330 within the aneurysm 306 .
- FIG. 26 illustrates the placement of an intrasaccular device 370 within an aneurysm 306 .
- the intrasaccular device 370 can comprise a radiopaque material 372 .
- the radiopaque material 372 can be located at a specific end of the intrasaccular device 370 (in this case, on a first portion 374 of the intrasaccular device 370 , which has a lower porosity than a second portion 376 thereof).
- the intrasaccular device 370 is in an intermediate expanded state (i.e., it has not yet fully expanded), and as the device 370 expands, the clinician can adjust its position based on a visualization of the radiopaque material 372 .
- the clinician can visualize the orientation of different sections or portions of an intrasaccular device relative to the neck or surrounding vasculature of an aneurysm, and here, align the radiopaque material 372 with the neck 380 of the aneurysm 306 (or in some embodiments, a fundus of the aneurysm 306 ) in order to maintain the lower porosity first portion 374 of the intrasaccular device 370 adjacent to or extending across the aneurysm neck 380 .
- FIGS. 27-30 illustrate different aneurysm configurations and surrounding vasculature that may be treated best by achieving a specific orientation of an intrasaccular device within the aneurysm.
- FIG. 27 illustrates an intrasaccular device 390 oriented such that a low porosity section 392 thereof is positioned or extends across the neck 380 of the aneurysm 306 , with a higher porosity section 396 positioned in the fundus of the aneurysm 306 .
- FIG. 27 also provides an illustration of the final result of the process described above with respect to FIGS. 22-25 .
- the intrasaccular device 330 shown in FIGS. 22-25 can achieve the position or state of expansion illustrated in FIG. 27 .
- FIG. 28 illustrates an artery 500 having an aneurysm 502 and a perforating vessel 504 extending through the aneurysm 502 adjacent to a neck 506 of the aneurysm 502 .
- an intrasaccular device 520 can be positioned within the aneurysm 502 such that a high porosity section 522 extends across the neck 506 of the aneurysm 502 in order to permit blood flow into the perforating vessel 504 , as illustrated with arrows 530 .
- FIG. 29 illustrates an artery 550 having an aneurysm 552 and a perforating vessel 554 extending from the fundus of the aneurysm 552 .
- an intrasaccular device 560 can be positioned within the aneurysm 552 such that a first, high porosity section or channel 562 of the intrasaccular device 560 provides a fluid pathway for blood to flow through the neck 564 of the aneurysm 552 toward and into the perforator vessel 554 , as shown by arrow 570 .
- the intrasaccular device 560 can be configured to comprise one or more low porosity sections 572 , 574 that can tend to induce thrombosis and protect the aneurysm wall.
- FIG. 30 illustrates an intrasaccular device 590 oriented such that a low porosity section 592 thereof is positioned or extends across the neck 594 of an aneurysm 596 located at a vessel bifurcation. As illustrated, a higher porosity section 598 can be positioned in the fundus of the aneurysm 596 . Thus, flow through the bifurcation, as shown by arrows 600 can be diverted using the low porosity section 592 , thereby relieving pressure on the aneurysm 596 .
- engagement mechanisms for a delivery and recapture system as shown in FIG. 22 , are provided. These engagement mechanisms can provide secure engagement and release of one or more expandable components. Further, the system can recapture the device for removal or repositioning.
- the engagement mechanisms illustrated in FIGS. 31A-34 can move between closed and open positions in order to facilitate engagement with and delivery of an intrasaccular device into an aneurysm.
- FIGS. 31A-31B illustrate a system and method for delivery an intrasaccular device to an aneurysm and/or recapturing the device for removal or repositioning.
- the delivery system may include an introducer catheter or sheath 630 .
- a delivery/retrieval member 680 can be disposed within a lumen of the catheter 630 .
- the delivery/retrieval member 680 may include an elongated element 682 having a plurality of gripping elements 684 at one end.
- the delivery/retrieval member 680 can be dimensioned to traverse the longitudinal lumen of the introducer sheath 630 .
- the gripping elements 684 can be adapted to open and close about the intrasaccular device 650 . In some embodiments, the gripping elements 684 can be normally biased to an open position.
- the delivery/retrieval member 680 can comprise the Alligator Retrieval Device, manufactured by Covidien LP, generally represented in FIGS. 31A-31B .
- the Alligator Retrieval Device can include a flexible wire having a plurality of gripping arms or elements, e.g., four arms, at the distal end of the flexible wire.
- Other embodiments for the gripping elements 58 include a clover leaf design, fish hook design, or dissolvable coupling, as shown in FIGS. 31A-34 , respectively.
- an access catheter In use, an access catheter is advanced within the neurovasculature as is conventional in the art.
- a suitable microcatheter adaptable for navigation through the tortuous neurovascular space to access the treatment site is disclosed in commonly assigned U.S. Pat. No. 7,507,229, the entire contents of which are hereby incorporated herein.
- the gripping elements 684 of the delivery/retrieval member 680 are positioned about the intrasaccular device 650 ( FIG. 31A ), and the delivery/retrieval member 680 is withdrawn into the introducer sheath 630 such that the gripping elements 684 move inwardly during engagement with the inner wall surface of the introducer sheath 630 to compress the foam structure of the intrasaccular device 650 as depicted in FIG. 31B .
- the intrasaccular device 650 is withdrawn into the introducer sheath 630 .
- the introducer sheath 630 with the delivery/retrieval member 682 and intrasaccular device 650 positioned therein is advanced through the access catheter accessing the aneurysm.
- the access catheter may be removed if desired, or may be left in place. Thereafter, the introducer sheath 630 is oriented at the desired orientation with respect to the aneurysm. Any of the engagement devices illustrated herein can be used for both delivery and retrieval of expandable components.
- the delivery/retrieval member 682 is advanced through the introducer sheath 630 whereby upon clearing the distal end of the introducer sheath 630 the gripping elements 684 of the delivery/retrieval member 682 open to release the intrasaccular device 650 .
- the gripping elements 684 in the open configuration, and extended beyond the introducer sheath 630 , are positioned to circumscribe the intrasaccular device 650 within the vasculature.
- the delivery/retrieval member 682 is withdrawn into the introducer sheath 630 whereby the gripping elements 684 compress the foam material of the intrasaccular device 650 to permit reception of the device 650 within the lumen of the introducer sheath 630 . Thereafter, the intrasaccular device 650 can be removed from the neurovasculature or repositioned within the aneurysm by deployment of the delivery/retrieval member 682 in the manner discussed herein.
- FIGS. 32A-32B similarly illustrate an engagement mechanism 620 in the form of a “clover” pattern.
- the engagement mechanism 620 can be disposed within a catheter 630 and advanced distally until exiting the lumen of the catheter 630 at the distal end 632 .
- wire loops 640 of the engagement mechanism 620 can be released from engaging the intrasaccular device 650 .
- the intrasaccular device 650 may not tend to snag or stick to the wire loops 640 . Accordingly, the engagement mechanism 620 can provide fast and reliable disengagement with the intrasaccular device 650 .
- FIGS. 33A-33B illustrate another embodiment of an engagement mechanism 670 having a “fish hook” design, similar to the engagement mechanisms 324 , 620 can move between closed and open positions upon exiting a distal end 632 of the catheter 630 the engagement mechanism 670 can comprise a plurality of hooks 672 configured to pierce or otherwise at least partially penetrate the intrasaccular device 650 . Upon release, the hooks 672 can disengage from the intrasaccular device 650 in order to release the intrasaccular device 650 into the aneurysm.
- FIG. 34 illustrates an embodiment of a system in which a delivery member 690 is attached to an intrasaccular device 650 using a dissolvable coupling 692 .
- the dissolvable coupling 692 can extend between the intrasaccular device 650 and an aperture or engagement member of the delivery member 690 .
- engagement member of the delivery member 690 can engage the dissolvable coupling 692 using a hook, wire loop, or other elongate member, such as those disclosed in other delivery systems above.
- the dissolvable coupling 692 can be actuated by chemical corrosion (e.g., electrolytic detachment), thermal corrosion, pH changes, light changes, etc.
- the releasable connection 692 may be effected through an electrical, hydraulic or pneumatic connection where release of the intrasaccular device 650 is achieved through activation of any of these systems.
- any of the aforementioned means may be actuated to release the intrasaccular device 650 from the delivery member 690 .
- FIG. 35 illustrates a microcatheter delivery system for implanting an intrasaccular device 720 within the aneurysm.
- a delivery system 730 can comprise a delivery catheter 732 and pusher element 734 disposed within the delivery catheter 732 .
- the intrasaccular device 720 in its normal configuration and predetermined geometry can be compressed and positioned within the lumen of the delivery catheter 732 .
- the delivery catheter 732 may be introduced within the neurovasculature and advanced to the treatment site.
- the pusher element 734 is actuated by, e.g., advancing a handle or actuator operatively connected to the proximal end of the pusher element 734 to cause the distal or remote end of the pusher element 734 to eject the intrasaccular device 720 .
- the intrasaccular device 720 can expand to pack the aneurysm.
- the pusher element 734 can comprise a radiopaque material or component 736 disposed on a contact member 738 of the pusher element 734 .
- the radiopaque material 736 can enable the clinician to visualize the location of the intrasaccular device 720 to ensure proper positioning of the pusher element 734 within the lumen of the catheter 732 .
- FIG. 36 illustrates an alternate embodiment of the delivery system.
- system 760 includes introducer sheath 762 and delivery member 764 disposed within the introducer sheath 762 .
- the delivery member 764 may be a push rod advanceable within the introducer sheath 762 .
- the intrasaccular device of this disclosure includes a plurality of intrasaccular pellets 770 a , 770 b disposed within the introducer sheath 762 to be ejected in sequence via the delivery member 764 .
- the plurality of pellets can comprise a framing shape, which has been compressed and folded as a framing pellet 770 a .
- the pellet 770 a will be the last pellet to enter the aneurysm (after pellets 770 b ).
- the framing pellet 770 a can tend to expand so as to extend across a neck of the aneurysm (although not necessarily touching the ostium of the aneurysm.
- intrasaccular devices or pellets 770 a , 770 b may be smaller in dimension than the aforedescribed intrasaccular devices to enable multiple and strategic deployment within the aneurysm. Any of the embodiments of the aforedescribed intrasaccular devices may be incorporated within the pellets 770 a , 770 B. Further, the delivery member 764 can incorporate one or more radiopaque materials are components 772 to facilitate visualization of the location of the delivery member 764 within the sheath 762 .
- FIG. 37 illustrates another delivery system 790 , in accordance with some embodiments.
- the delivery system 790 can comprise an over-the-wire system having a guide member 792 comprising a guide wire lumen 794 .
- the guide member 792 can also comprise a delivery lumen 796 in which a push rod 798 can be disposed for axial movement therewithin an order to deliver an intrasaccular device comprising a plurality of expandable components 800 .
- Such an embodiment can allow the system 790 to define a minimal cross-sectional profile, thereby allowing the system 790 to extend into and through very narrow vessels to treat aneurysms in smaller vessels.
- FIGS. 38-42 illustrate various implementations of some of the embodiments disclosed herein.
- FIG. 38 illustrates an intrasaccular component 820 that has been implanted into an aneurysm 830 .
- the intrasaccular component 820 comprises a shape that is substantially an octahedron. Such a shape can be beneficial for securely anchoring the intrasaccular component 820 within the aneurysm 830 given the expanding waist and tapering ends that permit the intrasaccular component 820 to fit well within a berry or saccular aneurysm.
- the intrasaccular component 820 also comprises a radiopaque material or marker 822 for use in locating and positioning the intrasaccular component 820 within the aneurysm 830 .
- FIG. 39 illustrates an intrasaccular device 840 positioned within an aneurysm 830 .
- the intrasaccular device 840 comprises first and second expandable components 842 , 844 .
- the first expandable component 842 comprises a shape that is substantially conical or a paraboloid of revolution.
- the second expandable component 844 comprises a shape that is substantially hemispherical.
- the first and second expandable components 842 , 844 can comprise respective first and second mating surface 852 , 854 .
- both the first and second expandable components 842 , 844 When initially inserted into the aneurysm, prior to expansion, both the first and second expandable components 842 , 844 easily fit into the aneurysm 830 . Upon expansion, neither the first nor second expandable components 842 , 844 entirely packs the aneurysm 830 . Thus, if either of the first or second expandable components 842 , 844 were positioned by itself in the aneurysm 830 , significant movement and potential herniation of the respective component could occur from within the aneurysm 830 .
- first and second expandable components 842 , 844 expand within the aneurysm 830 , the first and second mating surfaces 852 , 854 can cause the first and second expandable components 842 , 844 to become aligned within the aneurysm 830 .
- alignment as illustrated in FIG. 39 , can tend to prevent dislocation of either the first or second expandable components 842 , 844 , thus securing the intrasaccular device 840 within the aneurysm 830 .
- an intrasaccular the first and second mating surfaces 852 , 854 can be substantially flat.
- some embodiments can be configured such that an intrasaccular device 860 , positioned within an aneurysm 830 , comprises first and second mating surfaces 870 , 872 of first and second expandable components 880 , 882 can comprise an engagement mechanism 884 .
- the engagement mechanism 884 can comprise engagement structures, such as a recess and a corresponding protrusion, as illustrated.
- the engagement mechanism 884 can comprise one of a variety of structures, such as one or more recesses and one or more corresponding protrusions, including hemispherical, cylindrical, conical, or other such geometric mating recesses and protrusions. Accordingly, the engagement mechanism 84 can tend to prevent slippage between the first and second mating surfaces 870 , 872 , thus tending to cause the first and second expandable components 880 , 882 to function as a composite unit.
- some embodiments of the intrasaccular device can comprise a hollow component that can be implanted into an aneurysm.
- a hollow component can be implanted into the aneurysm as a system, a single hollow component can also be set in place and later packed with one or more expandable components.
- the hollow component can act as a support or framing structure having an enclosed cavity configured to receive additional components therein.
- FIG. 41 illustrates an intrasaccular device 900 in the form of a hollow expandable component 902 that is implanted into an aneurysm 904 along with a plurality of expandable components 906 .
- the hollow component 902 can be in the form of a hollow hemispherical shell that can act as a support or framing structure for the aneurysm and additional expandable components placed therein.
- the hollow component 902 can have an outer surface 908 that is in contact against an inner wall 912 of the aneurysm 904 .
- the contact between the outer surface 908 and the aneurysm wall 912 can be along a portion of the aneurysm wall 912 that has a cross-sectional profile greater than the size of the opening or passing profile of the neck 920 of the aneurysm 904 . Further, contact between the outer surface 908 and the aneurysm wall 912 can be at least along the lower half of the aneurysm 904 .
- the outer surface 908 of the hollow component 902 can contact against a first section of the aneurysm wall 912 adjacent to the aneurysm neck 920 , as well as against a second section of the aneurysm wall 912 adjacent to the aneurysm dome 918 , opposite the aneurysm neck 920 .
- the aneurysm 904 or aneurysm wall 912 can be considered in terms of quadrants, and the outer surface 908 can contact at least three quadrants of the aneurysm wall 912 .
- the outer surface 908 can be caused to contact at least a portion of each quadrant of the aneurysm wall 912 .
- the contact of the outer surface 908 against the aneurysm wall 912 can tend to secure the hollow component 902 within the aneurysm 904 to avoid dislocation or herniation of any portion of the hollow component 902 from the aneurysm 904 .
- the expandable components 906 can be inserted or injected into a cavity of the hollow component 902 through an aperture 910 formed in a sidewall of the hollow component 902 .
- the aperture 910 can be sized such that the expandable components 906 can be inserted through the aperture 910 in their compressed state, but upon expansion, the expandable components 906 will be unable to exit through the aperture 910 .
- the expandable components 906 can position themselves during expansion such that irregular shapes of the dome 918 of the aneurysm 904 can be packed.
- the intrasaccular device 900 can provide a lower porosity adjacent to the neck 920 of the aneurysm 904 while having a relatively higher porosity adjacent to the dome 918 .
- the support or framing component can comprise a stent that extends along a lumen adjacent to an aneurysm.
- the aneurysm can be a saccular or berry, wide neck, or fusiform aneurysm.
- a stent can be used in combination with any of the variety of intrasaccular devices illustrated above, such as those shown in FIGS. 22-30 and 38 - 41 , which are shown as treating saccular aneurysms.
- the framing component can advantageously secure the intrasaccular device within a wide-neck aneurysm by facilitating engagement with a sufficient amount of the aneurysm wall to avoid dislodgement or herniation of the device from the aneurysm into the parent vessel.
- FIG. 42 illustrates an implementation of an intrasaccular device 940 in a method for treating a fusiform aneurysm 950 .
- the intrasaccular device 940 can comprise a stent 952 that extends across the aneurysm 950 .
- the stent 952 can be released at the target location using a catheter and any of a variety of release methods, such as balloon expansion or self-expansion.
- the stent 952 When expanded into contact against the inner wall of the lumen 954 , the stent 952 can isolate, separate, or divide the inner cavity 956 of the fusiform aneurysm 950 from a central portion of the lumen 954 .
- At least one expandable component 960 can be released into the inner cavity 956 between the inner wall of the aneurysm 950 and an outer surface 962 of the stent 952 .
- the expandable component(s) 960 can be inserted into the cavity 956 through an opening in a wall of the stent 952 (or if the stent 952 is braided, through an interstice of the braid).
- the expandable component(s) 960 can have one or more characteristics that improve the effectiveness of the intrasaccular device 940 . Further, the characteristics of the expandable component 960 can be selected based on the shape or configuration of the aneurysm 950 , as discussed above. As shown in FIG. 42 , the expandable components can have a specific shape to pack the cavity 956 (e.g., a sectioned sphere with a luminal void extending through the sections, thus providing a flatter cylindrically shaped surface that can abut the outer surface of the stent 952 ). However, any of a variety of other shapes can also be selected and inserted into the cavity 956 .
- a specific shape to pack the cavity 956 e.g., a sectioned sphere with a luminal void extending through the sections, thus providing a flatter cylindrically shaped surface that can abut the outer surface of the stent 952 .
- any of a variety of other shapes can also be selected and inserted into the cavity 9
- a material such as a liquid embolic (as discussed above), a drug, a radiopaque material, a contrast agent, or other agent can be injected or inserted into the aneurysm.
- the injection or insertion can occur prior to, concurrently with, or after expansion of the intrasaccular device within the aneurysm.
- the material can be absorbed into at least a portion of the intrasaccular device or pack any remaining voids within the aneurysm around the intrasaccular device.
- the injection of a liquid embolic can advantageously increase the overall packing density of the device.
- FIGS. 43 and 44 illustrate embodiments in which a liquid embolic is inserted into the aneurysm in combination with an intrasaccular device.
- FIG. 43 illustrates that a material 980 (e.g., a liquid embolic, drug, radiopaque material, contrast agent, or other agent) is being inserted into an aneurysm 982 along with an intrasaccular device 984 .
- the intrasaccular device 984 can have a high porosity, which can allow the material 980 to penetrate the intrasaccular device 984 .
- FIG. 44 illustrates injection of a material 990 into an aneurysm 992 .
- the material 990 can flow into the aneurysm 982 into the interstice is formed between expandable components of the intrasaccular device 994 .
- the components of the intrasaccular device 994 can have a lower porosity such that the material 998 may not tend to penetrate the components of the intrasaccular device 994 as much as in the embodiment illustrated in FIG. 43 .
- various materials can be injected or inserted into the aneurysm to supplement or complement the treatment provided by an intrasaccular device.
- FIGS. 45-52 illustrate additional embodiments of an intrasaccular device that uses a support or framing component or structure in combination with secondary expandable components.
- FIGS. 45-46 illustrates an embodiment in which an aneurysm 1000 is treated using an intrasaccular device 1100 a , which comprises a framing structure 1102 a having a closed end 1104 and an open end 1106 .
- the framing structure 1102 a can be formed from a braided material.
- the closed end 1104 of the framing structure is sealed via a clamp 1108 , an adhesive, or may be heat welded via known techniques.
- the closed end 1104 may be inverted relative to the remaining framing structure 1102 a and depend inwardly within the interior thereof.
- the open end 1106 of the framing structure 1102 a may be in diametrical opposed relation to the closed end 1104 .
- the individual filaments ends 1110 of the framing structure at the open end 1106 also may be inverted and disposed within the interior of the framing structure 1102 a.
- FIG. 45 depicts the introduction of the coils through the open end 1106 of the framing structure 1102 a .
- Suitable braid materials, structures, and method for manufacturing the framing structure 1102 a are disclosed in commonly assigned U.S. Pat. No. 6,168,622 to Mazzocchi, U.S. Pat. No. 8,142,456, issued Mar. 27, 2012, U.S. Patent Application Publication No. 2011/0319926, filed on Nov. 11, 2010, and U.S. Patent Application Publication No. 2012/0330341, filed on Jun. 22, 2011, the entireties of each of which are incorporated herein by reference.
- Braid materials may include stainless steel, nitinol cobalt chromium or the like.
- an intrasaccular device 1100 b , 1100 c , 1100 d can comprise a framing structure 1102 b , 1150 , 1160 that can be packed with at least one expandable component 1130 , 1140 (e.g., a foam component).
- an expandable component 1130 , 1140 e.g., a foam component.
- the foam can advantageously provide a higher packing density compared to traditional coil packing and accomplish this in a single device.
- the framing structure 1102 a combined with coils, an expandable component, or other materials, can also provide the benefit of providing good neck coverage while preventing embolic devices from herniating into the parent artery. Additionally, the use of such a system can also increase packing volume efficiency and achieve stasis.
- the framing structure 1102 a may provide a support or scaffold for the supplemental intrasaccular components or materials, including coils, expandable components, or other materials (e.g., a liquid embolic, drug, radiopaque material, contrast agent, or other agent).
- the coils 1120 or expandable component 1130 may contain or be coated with bioactive coating that promotes specific clinical theory such as endothelialization, thrombosis, etc.
- a braided device 1200 can comprise a single-layer outer portion 1202 that is formed by inverting a tubular braid such that an inner portion 1204 of the braid extends through a center portion of the device 1200 . Ends of the inner and outer portions 1202 , 1204 meet at a first end 1206 . Although the filament ends of the inner and outer portions 1202 , 1204 can remain free (as tufts) or unbundled, the first end 1206 can comprise a hub or coupling device 1208 that bundles the inner and outer portions 1202 , 1204 together. In some embodiments, the hub or coupling device 1208 can be recessed within an interior of the device 1200 , although it is shown protruding in FIG. 50 .
- FIG. 51 illustrates another embodiment of a framing structure in which a braided device 1230 comprises at least one layer 1232 extending around the periphery of the device 1230 .
- the device 1230 can comprise first and second ends 1234 , 1236 that can be inverted or recessed into the device 1232 formed a smooth outer surface for the device 1230 .
- the first and second ends 134 , 136 can be open or closed.
- the first and second ends 1234 , 1236 can comprise coupling devices 1240 , 1242 , which close both ends 1234 , 1236 .
- one or both of the first and second ends 1234 , 1236 can also be open, such that the filaments ends thereof are free and unbundled.
- FIG. 52 illustrates yet another embodiment of the framing structure in which a braided device 1250 comprises a dual layer shell 1252 having a substantially closed end 1254 and an open end 1256 .
- the open end 1256 can be inverted or recessed into the device 1250 .
- the procedure of implanting coils, an expandable component, or other materials into the framing structure 1102 a , 1150 , 1160 can be performed by either inserting a catheter 1112 , such as a distal end 1114 thereof, between filaments of the framing structure (see FIG. 48 ) or into an open end of the framing structure (see FIGS. 45 and 49 ).
- the open end or widest interstices of the framing structure can be positioned at the neck of the aneurysm so as to facilitate insertion of the distal end 1114 of the catheter 1112 into the open end or between the filaments (i.e., into an interstice) of the framing structure.
- the braid pattern can be properly aligned to facilitate entry of the materials into the framing structure.
- the framing structure can comprise a radiopaque material or component that facilitates visualization and enables the clinician to align the framing structure as needed within the aneurysm.
- the open end can collapse onto itself or onto an inner surface of the framing structure as the coils, expandable component, or other materials settle or expand within the cavity of the framing structure.
- the distal end 1114 of the catheter 1112 can be withdrawn, thus allowing the open tube portion 1162 to close onto itself in response to expansive forces from the expanding component(s) or materials. Further, in some embodiments, as illustrated in FIG.
- an open end 1256 can define a generally tubular portion that can be deflected into contact with the inner wall of the framing structure when at least one expandable component is released into and expand within the cavity of the framing structure. As such, the open end can tend to self-seal, thus preventing herniation of the coils, expandable component, or other materials disposed within the framing structure.
- the composite effect of the coils, expandable component, and/or other materials inserted into the framing structure can provide the advantages and benefits discussed above with respect to various other expandable components.
- the clinician can determine and control various intrasaccular implant characteristics, including porosity, composition, material, shape, size, interconnectedness, inter-engagement, coating, etc.
- systems or kits having a framing structure and at least one coil, expandable component, and/or other material can be provided.
- Intrasaccular implant devices and procedures for treating aneurysms can be improved by interconnecting individual components of the intrasaccular device.
- a plurality of expandable components can be interconnected along a wire, filament, or other disconnectable or breakable material.
- the expandable components can be connected in a linear configuration (see FIGS. 53-58C ), a planar matrix (see FIGS. 59A-60B ), or in a three-dimensional matrix (see FIGS. 61A-61B ).
- the expandable components of such interconnected linear, planar, or three-dimensional matrices can be sized and configured in accordance with desired porosity, size, shape, radiopacity, or other characteristics disclosed herein, which will not be repeated here for brevity.
- interconnected expandable components can be released into an aneurysm.
- the interconnected components can be preconfigured (e.g., a select number of components can be removed from a larger strand or array of components) prior to implantation and later inserted into a delivery catheter. Thereafter, the entire strand or assembly of interconnected expandable components of the intrasaccular device can be released into the aneurysm.
- an entire strand or array of components (which would, in their expanded state, exceed the available space in the aneurysm) can be loaded into a delivery catheter, and while implanting and observing the packing behavior, a clinician can determine that a select portion of the interconnected expandable components is sufficient for a given aneurysm. Thereafter, the select portion of the interconnected expandable components can be broken or cut in situ so as to be released into the aneurysm.
- an intrasaccular device 1300 a , 1300 b , 1300 c , 1300 d can comprise a strip of expandable components 1302 a , 1302 b , 1302 c , 1302 d .
- the strip 1302 a , 1302 b , 1302 c , 1302 d may include spaces or breaks separating adjacent expandable components to facilitate selective detachment of expandable components.
- the configuration of the strip 1302 a , 1302 b , 1302 c , 1302 d permits the clinician to either detach a desired number of expandable components needed for the procedure before initiating the procedure or detaching a desired number of components in situ.
- Intrasaccular devices having interconnected expandable components can be delivered with or without a supporting or framing structure.
- the expandable components 1302 a , 1302 b , 1302 c , 1302 d may be interconnected along one or more strings, filaments, carriers, indentations, reduced size sections, or perforation lines (which may include or be devoid of a filament or string) 1304 a , 1304 b , 1304 c , 1304 d .
- FIG. 53 illustrates an intrasaccular device 1300 a having a plurality of indentations or 1304 a (which can also include or be substituted by perforation lines) that separate adjacent expandable components.
- FIG. 53 illustrates an intrasaccular device 1300 a having a plurality of indentations or 1304 a (which can also include or be substituted by perforation lines) that separate adjacent expandable components.
- FIGS. 55-56 can include filaments or reduced diameter expandable portions 1304 c , 1304 d that interconnect adjacent expandable components.
- the strings, filaments, carriers, indentations, reduced size sections, or perforation lines extending between adjacent expandable components can enhance pushability of the intrasaccular device 1300 a , 1300 b , 1300 c , 1300 d into the aneurysm.
- the expandable components of the intrasaccular device 1300 a , 1300 b , 1300 c , 1300 d can comprise one or more cross-sectional profiles, such as a rectangle shape 1320 (see FIG. 57A ), a square shape 1330 (see FIG. 57B ), or a round, e.g., circular, shape 1340 (see FIG. 57C ).
- Various other cross-sectional profiles can be provided, such as polygons having three, five, six, seven or eight sides, star shapes, clover shapes, and the like.
- a single intrasaccular device can comprise expandable components that have different cross-sectional shapes or that have identical cross-sectional shapes, according to some embodiments.
- consecutive expandable components of an intrasaccular device 1300 a , 1300 b , 1300 c , 1300 d can descend in size, which can allow selection of a subset of the expandable components of the intrasaccular device 1300 a , 1300 b , 1300 c , 1300 d based on a specific target aneurysm size or shape.
- FIGS. 58A-60B illustrate additional embodiments of intrasaccular devices that can have nonlinear configurations.
- FIG. 58A illustrates an embodiment of an intrasaccular device 1400 comprising a layer or planar array of a plurality of interconnected expandable components 1402 in a compressed state, according to some embodiments.
- the expandable components 1402 can be interconnected by one or more strings, filaments, carriers, indentations, reduced size sections, or perforation lines (which may include or be devoid of a filament or string) 1406 .
- the expandable components 1402 can have the same or different shapes, sizes, or material properties as each other. For example, as illustrated in FIGS.
- the intrasaccular device 1400 can comprise a central expandable component 1404 having an expanded size that is much greater than the expanded sizes of surrounding expandable components 1402 .
- the intrasaccular device 1400 when released into an aneurysm, can expand into a configuration in which the central component 1404 is anchored in the aneurysm 1420 by the surrounding expandable components 1402 .
- surrounding or anchoring expandable components can be interconnected with other components in a matrix to enhance the fit or engagement of the intrasaccular device within an aneurysm.
- surrounding expandable components can have characteristics different from those of the central expandable component, such as having coatings or other properties that beneficially affect the efficacy of the intrasaccular device within the aneurysm.
- FIG. 59A-59B illustrate embodiments of intrasaccular devices 1450 , 1460 comprising a layer, ring, or planar array of interconnected expandable components 1452 , 1462 in a compressed state.
- the expandable components 1452 , 1462 can be interconnected by one or more strings, filaments, carriers, indentations, reduced size sections, or perforation lines (which may include or be devoid of a filament or string) 1454 , 1464 .
- each of the expandable components 1452 , 1462 can be connected to at least two other expandable components 1452 , 1462 .
- FIG. 60A-60B illustrate embodiments of intrasaccular devices 1480 , 1490 comprising a three-dimensional or multi-planar array of interconnected expandable components 1482 , 1492 in a compressed state.
- the expandable components 1482 , 1492 can be interconnected by one or more strings, filaments, carriers, indentations, reduced size sections, or perforation lines (which may include or be devoid of a filament or string) 1484 , 1494 .
- each of the expandable components 1482 , 1492 can be connected to at least two other expandable components 1482 , 1492 to create a three-dimensional array.
- a three-dimensional array can have expandable components that each have characteristics different from those of other components, such as having coatings or other properties that beneficially affect the efficacy of the intrasaccular device within the aneurysm.
- intrasaccular devices having strip configurations can allow a clinician to quickly and readily assess a target aneurysm and tailor an intrasaccular device specifically for the procedure.
- the customization of an intrasaccular device strip can be done before implantation or in situ. Further, the interconnectedness of the components tends to ensure that no component is lost.
- FIGS. 61-63 illustrate a delivery system and procedure for delivering a strip of interconnected expandable components, according to some embodiments.
- the configuration of the strip 1302 a , 1302 b , 1302 c , 1302 d permits the clinician to detach a desired number of expandable components needed for the procedure.
- a clinician Prior to initiating the implantation of an strip of interconnected intrasaccular device, a clinician, through imaging means, can determine the size and dimension of an aneurysm 1500 . Once the dimensioning is determined, the clinician can determine decide upon a configuration for the intrasaccular device or strip 1502 of interconnected expandable components to be implanted. As shown in FIG. 61 , the strip 1502 can be delivered using an implant delivery assembly 1504 , which can comprise a catheter 1506 and a pusher component 1508 .
- the clinician can prepare the strip 1502 by separating any unnecessary expandable components there from prior to inserting the strip 1502 into the delivery assembly 1504 . Thereafter, the strip 1502 is then introduced within the aneurysm in accordance with any of the aforedescribed methodologies.
- the clinician can load a strip 1502 into the catheter 1506 before trimming any expandable components from the strip 1502 .
- the clinician can then push the strip 1502 out through a distal end 1510 of the catheter 1506 , which causes the individual expandable components 1520 to begin to expand within the aneurysm 1500 .
- the clinician can determine whether additional expandable components 1520 should be deployed into the aneurysm 1500 . If needed, the pusher component 1508 can be moved distally to urge one or more additional expandable components 1520 out of the catheter 1506 .
- the clinician can break or separate the strip 1502 by separating the respective expandable components 1520 via trimming or tearing along the breaks, indentations or score lines and separating the expandable components 1520 .
- the breaking or separating of adjacent expandable components can be performed by actuating the cutting device 1540 .
- the cutting device 1540 can comprise a second catheter 1542 that is nested within the catheter 1506 .
- the second catheter 1542 can comprise a distal portion 1544 having an opening 1546 that extends from a side of the second catheter 1542 .
- the distal portion 1544 can have a rounded shape that can guide the expandable components 1520 out through the opening 1546 .
- the second catheter 1542 can be retracted proximally relative to the catheter 1506 , thus causing the opening 1546 to close against the distal end 1510 of the catheter 1506 , thereby severing a tie or filament extending between adjacent expandable components 1520 .
- distal portion 1544 of the second catheter 1542 can be further withdrawn into the catheter 1506 and the delivery assembly 1504 can be removed from the target site.
- any of the embodiments can comprise an average porosity that varies spatially, any of the variety of disclosed shapes, any of the various disclosed materials or coatings, any of the disclosed 2-D or 3-D interconnected configurations, any of the disclosed inter-engagement configurations or structures, any of the disclosed delivery systems, etc.
- the apparatus and methods discussed herein are not limited to the deployment and use of a medical device or stent within the vascular system but may include any number of further treatment applications.
- Other treatment sites may include areas or regions of the body including any hollow anatomical structures.
- the phrase “at least one of” preceding a series of items, with the term “and” or “or” to separate any of the items, modifies the list as a whole, rather than each member of the list (i.e., each item).
- the phrase “at least one of” does not require selection of at least one of each item listed; rather, the phrase allows a meaning that includes at least one of any one of the items, and/or at least one of any combination of the items, and/or at least one of each of the items.
- phrases “at least one of A, B, and C” or “at least one of A, B, or C” each refer to only A, only B, or only C; any combination of A, B, and C; and/or at least one of each of A, B, and C.
- top should be understood as referring to an arbitrary frame of reference, rather than to the ordinary gravitational frame of reference.
- a top surface, a bottom surface, a front surface, and a rear surface may extend upwardly, downwardly, diagonally, or horizontally in a gravitational frame of reference.
Abstract
A system for treatment of an aneurysm includes an intrasaccular device that can be delivered using a catheter. The device can include at least one expandable structure adapted to transition from a compressed configuration to an expanded configuration when released into the aneurysm. The expandable structure can have a specific shape or porosity. Multiple expandable structures can also be used, in which case each of the expandable structures can have a unique shape or porosity profile. The morphology of the aneurysm and orientation of any connecting arteries can determine the type, size, shape, number, and porosity profile of the expandable structure used in treating the aneurysm.
Description
- This application claims the benefit of U.S. Provisional Application No. 61/725,768, filed Nov. 13, 2012, the entirety of which is incorporated herein by reference.
- 1. Field of the Inventions
- The present disclosure generally relates to a system and method for delivering and deploying a medical device within a vessel, more particularly, it relates to a system and method for delivering and deploying an endoluminal therapeutic device within the vasculature of a patient to embolize and occlude aneurysms, particularly, cerebral aneurysms.
- 2. Description of the Related Art
- Walls of the vasculature, particularly arterial walls, may develop areas of pathological dilatation called aneurysms. As is well known, aneurysms have thin, weak walls that are prone to rupturing. Aneurysms can be the result of the vessel wall being weakened by disease, injury or a congenital abnormality. Aneurysms could be found in different parts of the body with the most common being abdominal aortic aneurysms and brain or cerebral aneurysms in the neurovasculature. When the weakened wall of an aneurysm ruptures, it can result in death, especially if it is a cerebral aneurysm that ruptures.
- Aneurysms are generally treated by excluding the weakened part of the vessel from the arterial circulation. For treating a cerebral aneurysm, such reinforcement is done in many ways including: (i) surgical clipping, where a metal clip is secured around the base of the aneurysm; (ii) packing the aneurysm with small, flexible wire coils (micro-coils); (iii) using embolic materials to “fill” or “pack” an aneurysm; (iv) using detachable balloons or coils to occlude the parent vessel that supplies the aneurysm; and (v) intravascular stenting.
- In conventional methods of introducing a compressed stent into a vessel and positioning it within in an area of stenosis or an aneurysm, a guiding catheter having a distal tip is percutaneously introduced into the vascular system of a patient. The guiding catheter is advanced within the vessel until its distal tip is proximate the stenosis or aneurysm. A guidewire positioned within an inner lumen of a second, inner catheter and the inner catheter are advanced through the distal end of the guiding catheter. The guidewire is then advanced out of the distal end of the guiding catheter into the vessel until the distal portion of the guidewire carrying the compressed stent is positioned at the point of the lesion within the vessel. Once the compressed stent is located at the lesion, the stent may be released and expanded so that it supports the vessel.
- Additional features and advantages of the subject technology will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the subject technology. The advantages of the subject technology will be realized and attained by the structure particularly pointed out in the written description and embodiments hereof as well as the appended drawings.
- Systems and procedures for treating aneurysms can include an intrasaccular device having one or more expandable components that can be inserted into an aneurysm to facilitate a thrombotic, healing effect. The components can have a specific characteristics, including porosity, composition, material, shape, size, interconnectedness, inter-engagement, coating, etc. These characteristics can be selected in order to achieve a desired treatment or placement of the intrasaccular device.
- The intrasaccular device can comprise a single component having two or more sections that have an average porosity that is different from each other. In some embodiments, the intrasaccular device can comprise multiple components that each have an average porosity. In either embodiment, the intrasaccular device can be arranged within an aneurysm according to a desired porosity profile. The intrasaccular device can be repositioned as necessary within the aneurysm during expansion.
- The intrasaccular device can optionally comprise one or more components having a desired shape, which can allow a clinician to implant an intrasaccular device tailored to the aneurysm. A plurality of individual, independent components can operate collectively to form a composite unit having one or more desired characteristics. Such components can have an interlocking structure, which can include a framing component, according to some embodiments.
- The intrasaccular device, when used with a framing component, can enable expandable components to be securely retained within an aneurysm. A framing component can comprise a foam or braided structure. Further, one or more expandable components can be inserted into a cavity of or formed by the framing component.
- Additionally, the intrasaccular device can also be configured to provide a plurality of interconnected expandable components, extending in linear, planar, or three-dimensional arrays or matrices. These arrays or matrices can be deployed in whole or in part into a target aneurysm, allowing a clinician to select portions of the array or matrix for implantation.
- The subject technology is illustrated, for example, according to various aspects described below. Various examples of aspects of the subject technology are described as numbered embodiments (1, 2, 3, etc.) for convenience. These are provided as examples and do not limit the subject technology. It is noted that any of the dependent embodiments may be combined in any combination with each other or one or more other independent embodiments, to form an independent embodiment. The other embodiments can be presented in a similar manner. The following is a non-limiting summary of some embodiments presented herein:
- A device for treatment of an aneurysm, comprising a foam component having first and second sections, the first section having an average porosity different from an average porosity of the second section, the component being expandable from a compressed configuration to an expanded configuration when released into an aneurysm from a catheter.
- The device of Embodiment 1, wherein the component is self-expanding to assume the expanded configuration thereof.
- The device of Embodiment 1, wherein the component is adapted to expand upon exposure to a thermal agent.
- The device of Embodiment 1, wherein the component is adapted to expand upon exposure to a chemical agent.
- The device of Embodiment 1, wherein the first section comprises a first material and the second section comprises a second material different from the first material, the first and second sections being coupled to each other.
- The device of Embodiment 5, wherein the first section is coupled to the second section by chemical bonding, by thermal bonding, or by mechanical crimping.
- The device of Embodiment 1, wherein the component further comprises a third section coupled to the second section, the third section having an average porosity different from the porosity of the second section.
- The device of Embodiment 7, wherein the third material is different from the first material.
- The device of Embodiment 7, wherein the second section is coupled to the third section using an adhesive.
- The device of Embodiment 7, wherein the second section comprises a second material and the third section comprises a third material different from the second material.
- The device of Embodiment 7, wherein the third section porosity is different from the first section porosity.
- The device of Embodiment 11, wherein the first section comprises an average porosity of between about 1 μm and about 150 μm, and the third section comprises an average porosity of between 150 μm and about 300 μm.
- The device of Embodiment 1, further comprising a transition zone between the first and second sections, the transition zone having an average porosity intermediate the porosities of the first and second sections.
- The device of Embodiment 13, wherein the transition zone porosity varies spatially from about that of the first section to about that of the second section.
- The device of Embodiment 13, wherein the porosity in the first and second sections each spatially varies progressively from an end of the first section to an opposite end of the second section.
- The device of Embodiment 13, wherein the transition zone porosity decreases from the porosity of the first section to the porosity of the second section.
- The device of Embodiment 1, wherein in the expanded configuration, the component comprises a substantially spherical shape that is divided crosswise into the first and second sections.
- The device of Embodiment 17, wherein the first and second sections correspond to first and second hemispheres of the substantially spherical shape.
- The device of Embodiment 17, further comprising a third section coupled to the second section, the first, second, and third sections collectively forming the substantially spherical shape.
- The device of Embodiment 1, wherein the component further comprises a bioactive coating.
- The device of
Embodiment 20, wherein the bioactive coating comprises a thrombogenic drug. - The device of Embodiment 1, wherein the component further comprises an expansion-limiting coating configured to control an expansion rate of the component.
- The device of Embodiment 1, wherein the first section comprises an average porosity of between about 1 μm and about 100 μm, and the second section comprises an average porosity of between about 100 μm and about 200 μm.
- The device of Embodiment 1, wherein a shape of the component is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The device of Embodiment 24, further comprising a second foam component having a shape selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The device of
Embodiment 25, wherein the foam component and the second foam component are different sizes from each other. - The device of
Embodiment 25, wherein the foam component and the second foam component are different shapes from each other. - The device of
Embodiment 25, wherein the foam component and the second foam component have mating structures configured to abut each other in a complementary configuration and restrict at least degrees of freedom of motion of each of the foam component and the second foam component. - The device of
Embodiment 25, further comprising a plurality of additional foam components having substantially spherical shapes. - A system for treatment of an aneurysm, comprising a plurality of foam components being expandable from a compressed configuration to an expanded configuration when released into an aneurysm from a catheter, each of the plurality of components having an average porosity that is different from an average porosity of another of the plurality of components, the plurality of components being positionable within the aneurysm to form a composite foam component having a composite porosity configured to provide a therapeutic effect.
- The system of
Embodiment 30, wherein each of a first group of the plurality of components comprises a first average porosity, and each of a second group of the plurality of components comprises a second average porosity different from the first average porosity. - The system of Embodiment 31, wherein the first average porosity is between about 1 μm and about 100 μm, and the second average porosity is between about 100 μm and about 200 μm.
- The system of
Embodiment 30, wherein a shape of at least one of the plurality of components is substantially spherical. - The system of
Embodiment 30, wherein a shape of at least one of the plurality of components is selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof. - The system of
Embodiment 30, wherein each of the plurality of components is interconnected to another of the plurality of components via a filament. - The system of Embodiment 35, wherein each of the plurality of components is interconnected to at least two others of the plurality of components.
- The system of
Embodiment 30, wherein the plurality of components is self-expanding to assume the expanded configuration thereof. - The system of
Embodiment 30, wherein the plurality of components is adapted to expand upon exposure to a thermal agent. - The system of
Embodiment 30, wherein the plurality of components is adapted to expand upon exposure to a chemical agent. - The system of
Embodiment 30, wherein at least one of the plurality of components comprises a bioactive coating. - The system of
Embodiment 30, wherein at least one of the plurality of components comprises a thrombogenic drug. - The system of
Embodiment 30, wherein at least one of the plurality of components comprises an expansion-limiting coating configured to control an expansion rate of the component. - The system of
Embodiment 30, wherein each of the plurality of components is different sizes from another of the plurality. - The system of
Embodiment 30, wherein each of the plurality of components is different shapes from another of the plurality. - The system of
Embodiment 30, wherein a first of the plurality of components and a second of the plurality of components have mating structures configured to abut each other in a complementary configuration and restrict at least degrees of freedom of motion of each of the first and second of the plurality of components. - A device for treatment of an aneurysm, comprising a foam component having a region of variable average porosity and a radiopaque marker, the marker being visible under imaging and positionable relative to the region so as to facilitate identification and orientation of the component when implanted into the aneurysm from a catheter, the component being expandable from a compressed configuration to an expanded configuration when released into the aneurysm.
- The device of Embodiment 46, wherein the region comprises a first section and a second section having an average porosity different from an average porosity of the first material.
- The device of Embodiment 47, wherein the region further comprises a third section adjacent to the second section, the third section having an average porosity different from the porosity of the second section.
- The device of Embodiment 48, wherein the second section is coupled to the third section by chemical bonding, by thermal bonding, or by mechanical crimping.
- The device of Embodiment 48, wherein the third section porosity is different from the first section porosity.
- The device of Embodiment 46, wherein the region comprises a first material and a second material different from the first material, the first and second materials being coupled to each other.
- The device of Embodiment 51, wherein the region further comprises a third material different from the first material.
- The device of Embodiment 46, wherein the marker comprises a material blended into the component such that the component is visible under imaging.
- The device of Embodiment 53, wherein the marker comprises bisumuth or tantalum blended with a foam material to form the component.
- The device of Embodiment 46, wherein the marker is coupled to an exterior of the component.
- The device of Embodiment 55, wherein the marker comprises a coating or a material that is bonded or mechanically coupled to the component.
- The device of Embodiment 46, wherein a shape of the component is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The device of Embodiment 57, further comprising a second foam component having a shape selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The device of Embodiment 58, wherein the foam component and the second foam component are different sizes from each other.
- The device of Embodiment 58, wherein the foam component and the second foam component are different shapes from each other.
- The device of Embodiment 58, wherein the foam component and the second foam component have mating structures configured to abut each other in a complementary configuration and restrict at least degrees of freedom of motion of each of the foam component and the second foam component.
- The device of Embodiment 58, further comprising a plurality of additional foam components having substantially spherical shapes.
- A method for treatment of an aneurysm, comprising: advancing a foam component through a catheter lumen, the component comprising a first section having a different average porosity than an average porosity of a second section; releasing the component into the aneurysm; allowing the component to expand from a compressed configuration to an expanded configuration within the aneurysm; and positioning the component within the aneurysm such that the first section is positioned away from the aneurysm neck and the second section is positioned adjacent to a neck of the aneurysm.
- The method of Embodiment 63, wherein the positioning comprises rotating the component.
- The method of Embodiment 63, wherein the positioning comprises maintaining a position of the component relative to the aneurysm neck during expansion to the expanded configuration.
- The method of Embodiment 63, wherein the aneurysm is disposed adjacent at bifurcation of a parent vessel into two efferent vessels, and wherein the positioning further comprises positioning the second section adjacent to the bifurcation and permitting flow through the bifurcation and into at least one of the first or second efferent vessels.
- The method of
Embodiment 66, wherein the first section comprises an average porosity of between about 1 μm and about 150 μm. - The method of
Embodiment 66, wherein the second section comprises an average porosity of between about 100 μm and about 200 μm. - The method of Embodiment 63, wherein the component further comprises a third section disposed between the first and second sections, the third section having an average porosity different than the porosity of the second section, wherein the positioning comprises positioning the component such that the first section is positioned at a fundus of the aneurysm and the third section is positioned between the fundus and the aneurysm neck.
- The method of Embodiment 63, wherein the positioning comprises aligning a radiopaque marker relative to the aneurysm to position the second section adjacent to the aneurysm neck.
- The method of Embodiment 70, wherein the aligning comprises aligning the marker with a fundus of the aneurysm.
- The method of Embodiment 63, further comprising injecting a liquid embolic material into the aneurysm after positioning the component.
- The method of Embodiment 63, further comprising implanting a support structure into the aneurysm before releasing the component into the aneurysm, and wherein the releasing comprises releasing the component through a wall of the support structure into the aneurysm.
- The method of Embodiment 73, wherein the support structure comprises a substantially enclosed interior cavity, and the releasing further comprises releasing the component into the interior cavity.
- A system for treatment of an aneurysm, comprising: a first foam component being expandable from a compressed configuration to an expanded configuration when released into the aneurysm, the first component having a first shape when in the expanded configuration; and a second foam component, separate from and freely movable relative to the first component, being expandable from a compressed configuration to an expanded configuration when released into the aneurysm, the second component having a second shape when in the expanded configuration; wherein at least one of the first and second shapes is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The system of Embodiment 75, wherein the first and second shapes are different from each other.
- The system of Embodiment 75, wherein the first and second components are different sizes from each other.
- The system of Embodiment 75, further comprising a third foam component, the third component having a third shape different from the first shape.
- The system of Embodiment 78, wherein the third shape is substantially spherical.
- The system of Embodiment 78, wherein the first, second, and third components are different sizes from each other.
- The system of Embodiment 78, wherein the first, second, and third components have different shapes from each other.
- The system of Embodiment 75, further comprising third, fourth, and fifth foam components, each of the third, fourth, and fifth components having shapes different from those of the first and second shapes.
- The system of Embodiment 75, further comprising third, fourth, and fifth foam components, each of the third, fourth, and fifth components having sizes different from those of the first and second components.
- The system of Embodiment 75, wherein the first and second components have first and second mating structures configured to abut each other in a complementary configuration.
- The system of
Embodiment 84, wherein the mating structures can operate to restrict at least two degrees of freedom of motion of the other component. - The system of
Embodiment 84, wherein in the complementary configuration, the first component restricts at least two degrees of freedom of motion of the second component. - The system of
Embodiment 84, wherein in the complementary configuration, the first component restricts at least three degrees of freedom of motion of the second component. - The system of Embodiment 87, wherein the first component restricts four, five, or six degrees of freedom of motion of the second component.
- The system of
Embodiment 84, wherein in the complementary configuration, the first and second components are interconnected to form a composite structure. - The system of
Embodiment 84, wherein in the complementary configuration, the first and second components are interconnected to form a composite structure, and wherein the first and second components have different average porosities from each other. - The system of
Embodiment 84, further comprising a third foam component having a third mating structure configured to abut at least the first mating structure, wherein in the complementary configuration, the first component restricts at least two degrees of freedom of motion of the third component. - The system of Embodiment 91, wherein the first component restricts four, five, or six degrees of freedom of motion of the third component.
- The system of Embodiment 75, wherein the first and second components have different average porosities from each other.
- The system of Embodiment 75, wherein the first component comprises a first coating and the second component is substantially free of the first coating.
- The system of Embodiment 75, wherein the component further comprises a bioactive coating.
- The system of Embodiment 95, wherein the bioactive coating comprises a thrombogenic drug.
- The system of Embodiment 75, wherein the component further comprises an expansion-limiting coating configured to control an expansion rate of the component.
- A system for treatment of an aneurysm, comprising a plurality of separate and independently expandable components each being expandable from a compressed configuration to an expanded configuration when released into the aneurysm, each of the components having shapes different from each other, wherein the shapes are selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The system of Embodiment 98, wherein the components are different sizes from each other.
- The system of Embodiment 98, further comprising at least one additional component that is substantially spherical.
- The system of Embodiment 98, further comprising a plurality of additional components that are substantially spherical.
- The system of Embodiment 101, wherein the plurality of additional components are different sizes from each other.
- The system of Embodiment 98, wherein at least two of the components have mating structures configured to abut each other in a complementary configuration for restricting freedom of motion of the components.
- The system of Embodiment 103, wherein the components each have mating structures configured to abut each other in a complementary configuration.
- The system of
Embodiment 104, wherein in the complementary configuration, the components are interconnected to form a composite structure. - The system of Embodiment 103, wherein in the complementary configuration, the components are interconnected to form a composite structure, and wherein the components have different porosities from each other.
- A method for treatment of an aneurysm, comprising: positioning a distal opening of a catheter adjacent to an aneurysm; and releasing a plurality of separate and independently foam components into the aneurysm; wherein shapes of the plurality of components are selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The method of Embodiment 107, wherein the releasing comprises releasing the plurality of components based on a shape of the aneurysm.
- The method of
Embodiment 108, further comprising selecting the plurality of components based on the shape of the aneurysm. - The method of Embodiment 107, wherein the releasing comprises interconnecting at least two components to create a composite structure.
- The method of Embodiment 107, wherein the releasing comprises releasing the plurality of components into the aneurysm to fill the aneurysm such that as a composite, the plurality of components provides a lower porosity adjacent to a neck of the aneurysm relative to a fundus of the aneurysm.
- The method of Embodiment 107, further comprising imaging the aneurysm.
- The method of Embodiment 112, wherein the imaging comprises determining a shape of the aneurysm to select the plurality of components.
- The method of Embodiment 112, further comprising repositioning a first of the plurality of components within the aneurysm after the first component has been released into the aneurysm.
- The method of Embodiment 114, wherein the repositioning comprises repositioning the first component such that the plurality of components, as a composite, is arranged within the aneurysm to provide a lower porosity adjacent to a neck of the aneurysm relative to a fundus of the aneurysm.
- The method of Embodiment 107, further comprising, prior to releasing the plurality of components into the aneurysm, implanting a framing device into the aneurysm.
- The method of Embodiment 116, wherein the releasing comprises releasing the plurality of components into a cavity of the framing device.
- A method for treatment of an aneurysm, comprising: positioning a distal opening of a catheter adjacent to the aneurysm; and advancing a framing device into the aneurysm, the framing device having an interior cavity and an exterior surface for contacting a wall of the aneurysm; and while at least a portion of the device exterior surface is in contact with the aneurysm wall, releasing at least one expandable component into the device cavity; wherein the framing device comprises at least one of a foam or a braided structure.
- The method of Embodiment 118, wherein the aneurysm is a saccular aneurysm and before releasing the at least one expandable component, the device is expanded such that the exterior surface contacts an inner surface of the aneurysm having a cross-sectional profile greater than a passing profile of a neck of the aneurysm.
- The method of Embodiment 118, wherein the releasing comprises causing the device to expand into contact with the aneurysm wall.
- The method of Embodiment 118, wherein the device comprises a substantially closed three-dimensional expanded shape.
- The method of Embodiment 118, wherein the component comprises at least one of a foam, a coil, or a braided structure.
- The method of
Embodiment 121, wherein the three-dimensional shape is selected from the group consisting of spheres, cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, non-spherical surface of revolution, and combinations thereof. - The method of Embodiment 118, wherein the device comprises for quadrants, and the releasing comprises causing at least a portion of each quadrant to contact the aneurysm wall.
- The method of
Embodiment 124, wherein the device comprises a substantially spherical expanded shape. - The method of Embodiment 118, wherein the device comprises an opening to the device cavity, and the releasing comprises injecting the at least one expandable component into the device cavity through the device aperture.
- The method of
Embodiment 126, wherein the device comprises a braided material and the opening is an opening formed between filaments of the braided material. - The method of
Embodiment 126, wherein the framing device has a closed end and an open end opposite the closed end, the open end forming the opening, and wherein the releasing advancing comprises aligning the opening with a neck of the aneurysm. - The method of
Embodiment 128, wherein the open end comprises a plurality of filament ends extending into the device cavity and forming the opening, the plurality of filament ends collectively forming a tubular portion extending into the device cavity, wherein the releasing comprises permitting the at least one expandable component to expand within the device cavity such that the tubular portion is deflected into contact with an inner wall of the device, thereby closing the opening. - The method of Embodiment 118, wherein the releasing comprises releasing a plurality of expandable components into the aneurysm such that as a composite, the plurality of expandable components provides a lower average porosity adjacent to a neck of the aneurysm relative to an average porosity at a fundus of the aneurysm.
- The method of Embodiment 118, wherein the at least one expandable component comprises a shape selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The method of Embodiment 118, wherein the releasing comprises releasing at least one coil into the device cavity.
- The method of Embodiment 118, wherein the releasing comprises releasing at least one expandable component into the device cavity.
- The method of
Embodiment 133, wherein the at least one expandable component comprises an expandable composite comprising first and second portions having different porosities from each other. - A method for treatment of an aneurysm, comprising: implanting a stent into a lumen of a parent vessel from which an aneurysm arises such that the stent extends across at least a portion of the aneurysm; and releasing at least one expandable component into an inner volume of the aneurysm between a wall of the aneurysm and an outer surface of the stent; wherein the expandable component comprises at least one of a foam or a braided structure.
- The method of
Embodiment 135, wherein the aneurysm comprises a fusiform aneurysm. - The method of
Embodiment 135, wherein the aneurysm comprises a wide-neck aneurysm. - The method of
Embodiment 135, wherein the portion comprises a neck. - The method of
Embodiment 135, wherein the at least one expandable component comprises a plurality of expandable components, and the releasing comprises releasing the plurality based on relative sizes of the expandable components. - The method of Embodiment 139, further comprising selecting the at least one expandable component based on the shape of the inner volume.
- The method of Embodiment 140, wherein the at least one expandable component comprises a shape selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The method of
Embodiment 135, wherein the at least one expandable component comprises a first portion having an average porosity greater than that of a second portion thereof, and the releasing comprises positioning the at least one expandable component such that the first portion abuts an outer surface of the stent device and the second portion extends along an inner wall of the aneurysm. - The method of
Embodiment 135, wherein the releasing comprises releasing a plurality of expandable components into the inner volume. - The method of
Embodiment 135, wherein the aneurysm inner volume extends around a circumference of the stent device, and the releasing comprises depositing a plurality of expandable components into the inner volume around the circumference of the stent device. - The method of Embodiment 144, wherein at least one of the plurality of expandable components comprises a flat or cylindrically shaped surface, and the releasing comprises positioning the at least one of the plurality of expandable components such that the flat or cylindrically shaped surface substantially conforms to an outer surface of the stent device.
- A system for treatment of an aneurysm, comprising: an intrasaccular device comprising first and second expandable components adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm, the first and second components being interconnected by a non-helical coupling such that the first and second components can be advanced as an interconnected unit, into the aneurysm; wherein the first component comprises at least one of a shape or an average porosity different from a shape or an average porosity of the second component.
- The system of Embodiment 146, wherein the first component shape is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The system of Embodiment 146, wherein the second component comprises a substantially spherical shape.
- The system of Embodiment 146, wherein at least one of the first or second components comprises a foam or a braided structure.
- The system of Embodiment 146, wherein at least one of the first or second components comprises a coil.
- The system of Embodiment 146, wherein the first component comprises an average porosity of between about 1 μm and about 100 μm and the second component comprises an average porosity of between about 100 μm and about 200 μm
- The system of Embodiment 146, further comprising a third component interconnected with the second component such that the first, second, and third components are interconnected in series.
- The system of Embodiment 146, wherein the coupling interconnecting the first and second components comprises a filament.
- The system of Embodiment 146, wherein the coupling has a preset shape such that in an expanded position, the first and second components are spaced relative to each other at a preset orientation.
- The system of Embodiment 146, further comprising an introducer sheath configured to receive the device therein such that the device can be loaded into the guide catheter for delivery to the aneurysm.
- A system for treatment of an aneurysm, comprising: an intrasaccular device comprising at least three expandable components adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm, each of the at least three components being interconnected to at least two of the at least three components such that at least three expandable components can be advanced as an interconnected unit, into the aneurysm.
- The system of Embodiment 156, wherein the at least three expandable components comprises at least four expandable components.
- The system of Embodiment 157, wherein at least two of the at least four expandable components is interconnected with at least three of the at least four expandable components such that the device comprises a multi-planar shape.
- The system of Embodiment 156, wherein the at least three components are interconnected by filaments.
- The system of Embodiment 156, wherein at least three components are interconnected by filaments having preset shapes such that in an expanded position, the at least three components are spaced relative to each other at a preset orientation.
- The system of Embodiment 156, wherein the device comprises at least one central expandable component positioned such that, when the device is in an expanded configuration, the central expandable component is centrally interconnected with a plurality of the expandable components.
- The system of Embodiment 161, wherein the at least one central expandable component has an expanded size greater than an expanded size of each remaining one of the plurality of components.
- The system of Embodiment 161, wherein the at least one central expandable component has an average porosity greater than an average porosity of each remaining one of the plurality of the components.
- The system of Embodiment 158, wherein the multi-planar shape comprises a polyhedron.
- The system of Embodiment 164, wherein the multi-planar shape comprises a pyramid.
- The system of Embodiment 164, wherein the multi-planar shape comprises a prism.
- The system of Embodiment 156, wherein a first component of the at least three components comprises a shape or an average porosity different than that of a second component of the at least three components.
- The system of Embodiment 156, wherein the first component shape is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
- The system of Embodiment 156, wherein the second component comprises a substantially spherical shape.
- The system of Embodiment 156, wherein the first component comprises an average porosity of between about 1 μm and about 100 μm, and the second component comprises an average porosity of between about 100 μm and about 200 μm.
- The system of Embodiment 156, further comprising an introducer sheath configured to receive the device therein such that the device can be loaded into the guide catheter for delivery to the aneurysm.
- A method for treatment of an aneurysm, comprising: advancing an intrasaccular device toward the aneurysm through a lumen of a catheter, the device comprising a plurality of expandable components each adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm from the catheter, each of the plurality of components being interconnected by a coupling.
- The method of Embodiment 172, further comprising: advancing the device into the aneurysm such that a first component is disposed within the aneurysm and a second component, interconnected with the first component by the coupling, is disposed within the catheter lumen; severing the coupling between the first and second components to release the first component into the aneurysm; retaining the second component within the lumen; and withdrawing the catheter.
- The method of Embodiment 172, further comprising advancing a plurality of expandable components into the aneurysm prior to the severing.
- The method of Embodiment 172, wherein each of the plurality of components is interconnected in series by the coupling.
- The method of Embodiment 172, wherein the severing comprises proximally withdrawing the catheter relative to a second catheter such that the coupling between the first and second components is pinched between a distal end of the catheter and a rim of the second catheter.
- The method of Embodiment 172, wherein the plurality of expandable components is arranged in descending size, and the advancing comprises allowing an initial expandable component deployed into the aneurysm to expand prior to advancing a subsequent expandable component into the aneurysm.
- The method of Embodiment 177, wherein the advancing comprises observing a fit of expanded components within the aneurysm to determine whether to advance additional components into the aneurysm.
- The method of Embodiment 178, wherein the device comprises a radiopaque material.
- The method of Embodiment 178, wherein the couplings between the plurality of expandable components comprise a radiopaque material.
- The method of Embodiment 178, wherein each of the plurality of expandable components of the device comprises a radiopaque material.
- It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the subject technology.
- The accompanying drawings, which are included to provide further understanding of the subject technology and are incorporated in and constitute a part of this specification, illustrate aspects of the disclosure and together with the description serve to explain the principles of the subject technology.
-
FIG. 1 is a schematic illustration depicting an aneurysm within a blood vessel, into which an intrasaccular device has been implanted, according to some embodiments. -
FIG. 2 is a schematic view of reticulated foam, which can be used in the intrasaccular device accordance with some embodiments. -
FIG. 3 is a schematic view an intrasaccular device having a specific porosity, according to some embodiments. -
FIG. 4 is a schematic view of an intrasaccular device comprising two portions having different porosities, according to some embodiments. -
FIG. 5 is an enlarged view of a transition zone of the intrasaccular device shown inFIG. 4 , wherein the transition zone comprises an immediate transition between different porosities, according to some embodiments. -
FIG. 6 is an enlarged view of the transition zone of the intrasaccular device shown inFIG. 4 , wherein the transition zone comprises a gradual transition between different porosities, according to some embodiments. -
FIG. 7 is a schematic view of an intrasaccular device comprising three portions arranged in a specific porosity profile, according to some embodiments. -
FIG. 8 is a schematic view of an intrasaccular device comprising three portions arranged in a specific porosity profile, according to some embodiments. -
FIG. 9 is a schematic view of an intrasaccular device comprising four portions having different porosities, according to some embodiments. -
FIG. 10 is a schematic view of an intrasaccular device having channels extending therethrough, according to some embodiments. -
FIG. 11 is a schematic view of an intrasaccular device having a channel extending therethrough, according to some embodiments. -
FIGS. 12A-12R are views illustrating alternate configurations for the foam structures of the intrasaccular device; -
FIGS. 13-15 illustrate hollow structures of an intrasaccular device, according to some embodiments. -
FIGS. 16-18 illustrate interlocking structures of an intrasaccular device, according to some embodiments. -
FIGS. 19-21 illustrate alternate embodiments of the intrasaccular device incorporating coated foam structures. -
FIG. 22-25 illustrate a delivery system and a procedure for delivering an intrasaccular device, according to some embodiments. -
FIG. 26 illustrates an intrasaccular device having a radiopaque material and positioned within an aneurysm, according to some embodiments. -
FIGS. 27-30 illustrate intrasaccular devices positioned within an aneurysm based on a porosity profile, according to some embodiments. -
FIGS. 31A-34 illustrate alternative engagement mechanisms for the delivery system shown inFIG. 22 , for engaging one or more expandable components, according to some embodiments. -
FIG. 35 illustrates a delivery system for delivering an intrasaccular device, according to some embodiments. -
FIG. 36 illustrates a delivery system for delivering an intrasaccular device comprising a plurality of expandable components, according to some embodiments. -
FIG. 37 illustrates a delivery system, advanceable along a guide wire, for delivering an intrasaccular device comprising a plurality of expandable components, according to some embodiments. -
FIG. 38 illustrates an intrasaccular device having a specific shape and a radiopaque material positioned within a saccular aneurysm, according to some embodiments. -
FIG. 39 illustrates an intrasaccular device comprising a plurality of expandable components positioned within a saccular aneurysm, according to some embodiments. -
FIG. 40 illustrates an intrasaccular device comprising a plurality of interlocking expandable components positioned within a saccular aneurysm, according to some embodiments. -
FIG. 41 illustrates an intrasaccular device comprising a plurality of expandable components positioned within a saccular aneurysm, according to some embodiments. -
FIG. 42 illustrates an intrasaccular device comprising a plurality of expandable components extending across a fusiform aneurysm, according to some embodiments. -
FIG. 43 illustrates a schematic view of a procedure in which an embolic liquid and an intrasaccular device comprising single expandable component are inserted into an aneurysm, according to some embodiments. -
FIG. 44 illustrates a schematic view of a procedure in which an embolic liquid and an intrasaccular device comprising a plurality of expandable components are inserted into an aneurysm, according to some embodiments. -
FIG. 45 illustrates a delivery procedure for delivering coils or foam within an interior of an intrasaccular framing device, according to some embodiments. -
FIG. 46 illustrates a partial cross-sectional view of the intrasaccular framing device as similarly shown inFIG. 45 , packed with coils, according to some embodiments. -
FIG. 47 illustrates a partial cross-sectional view of the intrasaccular framing device as similarly shown inFIG. 45 , packed with at least one foam component, according to some embodiments. -
FIG. 48 illustrates another embodiment of an intrasaccular framing device, packed with at least one foam component, according to some embodiments. -
FIG. 49 illustrates yet another embodiment of an intrasaccular framing device, packed with at least one foam component, according to some embodiments. -
FIGS. 50-52 are schematic views of different intrasaccular framing devices, according to some embodiments. -
FIGS. 53-56 illustrate embodiments of the intrasaccular device incorporating a strip of foam structures. -
FIGS. 57A-57C illustrate cross-sectional shapes that can be employed, alone or in combination with each other, in the intrasaccular structures shown inFIGS. 53-56 . -
FIG. 58A illustrates an embodiment of an intrasaccular device comprising a plurality of interconnected expandable components in a compressed state, according to some embodiments. -
FIG. 58B illustrates the intrasaccular device ofFIG. 58A comprising a plurality of interconnected expandable components in an expanded state, according to some embodiments. -
FIG. 59A illustrates an embodiment of an intrasaccular device comprising a layer of interconnected expandable components in a compressed state, according to some embodiments. -
FIG. 59B illustrates another embodiment of an intrasaccular device comprising a layer of interconnected expandable components in a compressed state, according to some embodiments. -
FIG. 60A illustrates an embodiment of an intrasaccular device comprising a three-dimensional array of interconnected expandable components in a compressed state, according to some embodiments. -
FIG. 60B illustrates another embodiment of an intrasaccular device comprising a three-dimensional array of interconnected expandable components in a compressed state, according to some embodiments. -
FIG. 61-63 illustrate a delivery system and procedure for delivering a plurality of interconnected expandable components, according to some embodiments. - In the following detailed description, numerous specific details are set forth to provide a full understanding of the subject technology. It should be understood that the subject technology may be practiced without some of these specific details. In other instances, well-structures and techniques have not been shown in detail so as not to obscure the subject technology.
- Intrasaccular implant devices and procedures for treating aneurysms can be improved by manipulating one or more physical characteristics of the implant material. Such characteristics can include the porosity, composition, material, shape, size, interconnectedness, inter-engagement, coating, etc. By modifying one or more such characteristics, the morphology or attributes of a target aneurysm and orientation of any connecting arteries can be specifically considered and addressed to achieve superior treatment.
- According to some embodiments, the porosity, composition, or material of the intrasaccular device can facilitate in the treatment of an aneurysm. The intrasaccular device can comprise an expandable component. The intrasaccular device can expand from a first, compressed configuration to a second, expanded configuration when released into the aneurysm.
- Optionally, the intrasaccular device can comprise an expandable component having an average porosity that changes from a first end of the component to a second end opposite the first end. Optionally, the intrasaccular device can comprise a composite structure having first and second sections or materials having different porosities. For example, the first and second sections can be separated by a transition zone. The transition zone can comprise an immediate change in porosity or a gradual transition in which the porosity spatially varies between a first porosity and a second porosity from one end of the transition zone to another, opposite end of the transition zone.
- As used herein, “porosity” can generally refer to an average porosity, which can be sampled across a given portion or section of an expandable component. “Porosity” can be defined as the ratio of the volume of the pores of in a component to the volume of the component as a whole. Porosity can be measured by a fluid displacement test. For example, liquid or gas testing can be used, as necessary or desirable, according to skill in the art. In some embodiments, a chromatography chamber can be used to measure displacement of a gas within the chamber, enabling the calculation of an average porosity of a given intrasaccular device or portion thereof. Other methods and systems can be used to measure porosity of portions of or the entirety of an expandable component.
- In some embodiments, a composite structure of the intrasaccular device can comprise three materials having different porosities. Further, the composite structure of the intrasaccular device can comprise for, five, six, or more different materials having different porosities.
- According to some embodiments, one or more of intrasaccular devices can be released into a target aneurysm and, in some embodiments, specifically oriented relative to the aneurysm ostium or neck and/or one or more perforating vessels (e.g., perforating arteries or arterioles) adjacent to the aneurysm.
- In some embodiments, the intrasaccular device can be repositioned within the aneurysm as the device is expanding. The repositioning of the device can allow a clinician to position a lower porosity section of the device adjacent to the neck of the aneurysm. The repositioning of the device can also allow a clinician to position a higher average porosity section of the device adjacent to one or more perforating vessels (e.g., perforating arteries or arterials) adjacent to the aneurysm. The repositioning of the device can also allow a clinician to position a lower porosity portion of the device adjacent to a bifurcation. The repositioning of the device can also allow a clinician to position a higher average porosity portion of the device toward or in the fundus of the aneurysm.
- Intrasaccular implant devices and procedures for treating aneurysms disclosed herein can also comprise manipulating a shape or size of the intrasaccular device. According to some embodiments, a single expandable component having a specific or selected shape or size, which can be tailored to the shape or size of the aneurysm, can be implanted into an aneurysm. Further, multiple expandable components, each having such a specific or selected shape or size can also be implanted into an aneurysm. The shape or size of the expandable component(s) can be selected from a variety of spherical or non-spherical shapes. Each shape can be solid or hollow.
- According to some embodiments, a composite intrasaccular device can be provided that comprises at least two mating expandable components (e.g., a plurality of interconnectable or engageable expandable components). Each of the expandable components can comprise one or more engagement structures configured to interact with a corresponding engagement structure of another mating expandable component.
- For example, the mating expandable components can each comprise an engagement structure configured to interact with a corresponding engagement structure of another mating expandable component. The mating expandable components can be delivered into the aneurysm and arranged in situ such that the engagement structures are aligned and interconnected appropriately such that the expandable components are mated. In some embodiments, the mating of the expandable components can interlock the components as a unit. For example, expansion of a portion of a component within a recess of another component can cause the components to be interlocked with each other. Further, in some embodiments, the mating components can restrict at least one degree of freedom of movement of another component.
- According to some embodiments in which a plurality of expandable components is used, the expandable components (whether interconnected by wires or filaments, or not interconnected, thereby moving independently of each other) can be arranged in a pattern to provide a composite component. The composite component can provide desired characteristics that may be difficult to achieve in a single component formed from a single, continuous piece of material.
- A variety of delivery systems and procedures can be implemented to deliver an intrasaccular device having a specific size or shape and, in some embodiments, having a plurality of expandable components. Examples of these systems and procedures are discussed further herein.
- In accordance with some embodiments of the delivery procedure, the target aneurysm can be imaged and analyzed in order to determine a three-dimensional shape of the aneurysm. Based on the shape of the target aneurysm, one or more expandable components can be selected, having a unique porosity, composition, material, shape, size, interconnectedness, inter-engagement, or coating, etc. Imaging devices can include 3-D CTA or MRI (MRA) imaging, through which the size and shape of the aneurysm can be ascertained. Such imaging can provide a basis for selection of one or more correspondingly shaped intrasaccular device(s) for insertion within the aneurysm. Different combinations of expandable components or their characteristics can be used.
- Optionally, in some embodiments, the intrasaccular device can have a predetermined configuration, whether or not the intrasaccular device has only a single or multiple expandable components. The predetermined configuration can be based on typical aneurysm shapes, thereby allowing selection of a specific intrasaccular device. However, individual components of an intrasaccular device can also be arranged based on their properties. Accordingly, the clinician can determine the shape of the aneurysm and create a desired intrasaccular device configuration for treating the aneurysm.
- In some embodiments, an expandable component of an intrasaccular device may be molded or manufactured into a variety of geometrical or partial geometrical shapes.
- For example, in order to accommodate a variety of aneurysm configurations, the shape or size of the expandable component(s) can be selected from a variety of spherical or non-spherical shapes, including, cylinders, hemispheres, noodles, polyhedrons (e.g., cuboids (types), tetrahedrons (e.g. pyramids), octahedrons, prisms), coils, prolate spheroids, oblate spheroids, plates (e.g., discs, polygonal plates), bowls (e.g, an open container, such as a hollow, hemispherical container or other open, hollow containers, whether hemispherical, rounded, or otherwise), hollow structures (e.g., a container of any shape with an inner cavity or void, which can be, for example, greater in size than a width of any of the walls of the structure), clover shapes (a plurality of radially extending protrusions, having rounded or smooth corners), non-spherical surfaces of revolution (e.g., toruses, cones, cylinders, or other shapes rotated about a center point or a coplanar axis), and combinations thereof. Each shape(s) can be solid or hollow.
- In accordance with some embodiments, at least a portion of the intrasaccular device can comprise a coating or material for enhancing therapeutic, expansive, or imaging properties or characteristics of at least one or every expandable component of the intrasaccular device.
- In some embodiments, the intrasaccular device can be configured such that an expandable component thereof is coated with a biocompatible material to promote endothelialization or provide a therapeutic effect.
- Optionally, the expandable component can also comprise an expansion-limiting coating that slows expansion of the component from its natural rate of expansion to a slower rate of expansion such that in the process of expanding, the position of the component can be adjusted within the aneurysm or the component can be removed from the aneurysm, if necessary. Examples of polymers that can be used as expansion-limiting coatings can include hydrophobic polymers, organic non-polar polymers, PTFE, polyethylene, polyphenylene sulfide, oils, and other similar materials.
- Various delivery systems and procedures can be implemented for delivering an intrasaccular device comprising one or more expandable components, as discussed herein. Further, a system and method are provided for delivery of an intrasaccular device to an aneurysm and/or recapturing the device for removal or repositioning.
- Intrasaccular implant devices and procedures for treating aneurysms can comprise interconnecting individual components of the intrasaccular device. According to some embodiments, a plurality of expandable components can be interconnected along a wire, filament, or other disconnectable or breakable material. The expandable components can be connected in a linear configuration, a planar matrix, or in a three-dimensional matrix. The expandable components of such interconnected linear, planar, or three-dimensional matrices can be sized and configured in accordance with desired porosity, size, shape, radiopacity, or other characteristics disclosed herein.
- In some embodiments, methods are provided by which interconnected expandable components can be released into an aneurysm. The interconnected components can be preconfigured (e.g., a plurality of components can be joined together to form a single, unitary device, or a select plurality of components can be removed from a larger strand or array of components) prior to implantation and later inserted into a delivery catheter. Thereafter, the entire strand or assembly of interconnected expandable components of the intrasaccular device can be ejected or released into the aneurysm and allowed to expand within the aneurysm.
- However, in accordance with some embodiments, an entire strand or array of components can be loaded into a delivery catheter, and while implanting and observing the packing behavior, a clinician can determine that a select portion of the interconnected expandable components is sufficient for a given aneurysm. Thereafter, the select portion of the interconnected expandable components can be broken or cut in situ so as to be released into the aneurysm.
- Additionally, although in some embodiments, a single expandable component can be used alone to fill the aneurysm and provide a desired packing density, a plurality of expandable components can also be used to fill the aneurysm and provide a desired packing density. Optionally, a liquid embolic and/or a framing component can be used in combination with one or more expandable components to facilitate delivery, engagement with the aneurysm, or increase of the packing density. Any of these embodiments can allow increased packing density to avoid recanalization of the aneurysm.
- Referring now to the drawings,
FIG. 1 illustrates an embodiment of anintrasaccular device 10 positioned within ananeurysm 12 in ablood vessel 14. Theintrasaccular device 10 can be particularly adapted for use in the tortuous neurovasculature of a subject for at least partial deployment in a cerebral aneurysm. - A cerebral aneurysm may present itself in the shape of a berry, i.e., a so-called berry or saccular aneurysm, which is a bulge in the neurovascular vessel. Berry aneurysms may be located at bifurcations or other branched vessels. Other types of aneurysms, including fusiform aneurysms, can also be treated using embodiments of the intrasaccular devices disclosed herein.
- The
intrasaccular device 10 can comprise at least one expandable component. In some embodiments, theintrasaccular device 10 can comprise a plurality of expandable components. Further, a given expandable component of theintrasaccular device 10 can have one or more different characteristics than another of the expandable components of theintrasaccular device 10. - An expandable component can be formed from a material that can be highly compressed and later expanded when released into the aneurysm and contacted by a fluid, such as a fluid within the aneurysm. In some embodiments, the expandable component can be formed at least in part of biocompatible, solid foam. As disclosed herein, “foam” can include a solid or semisolid gel, a swellable material (whether swellable upon hydration or swellable/self-expanding without hydration), a material having pores and interstices. “Foam” can include hydrophobic or hydrophilic materials. “Foam” can also include materials that can be highly compressed and configured to expand upon contact with a fluid, upon exposure to a thermal agent, upon exposure to a chemical agent, or self-expanding, upon release from engagement with the delivery mechanism. In some embodiments, the foam material can be configured to expand by about two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, seventeen, eighteen, nineteen, twenty, or more times its collapsed size when expanding to its expanded size.
- For example,
FIG. 2 illustrates a schematic view of afoam material 20. Suitable foam materials can comprise biocompatible foams such as a PVA (polyvinyl alcohol). Further, suitable foam materials can comprise reticulated foam. “Reticulated” foam can, in some embodiments, comprise a random arrangement of holes that has irregular shapes and sizes or a nonrandom arrangement of holes that has regular, patterned shapes and sizes. Suitable foam is also known under the trade name PacFoam, made available through UFP Technologies of Costa Mesa, Calif. In some embodiments, the foam material from which the expandable component is formed can be configured to include at least about 20 pores per inch (“PPI”), at least about 30 PPI, at least about 40 PPI, at least about 50 PPI, at least about 60 PPI, at least about 70 PPI, or at least about 80 PPI, or combinations thereof. - Other materials can also be used to form one or more portions of an intrasaccular device or an expandable component thereof. Such materials can include, but are not limited to polyvinyl alcohol (PVA) materials, water-soluble synthetic polymers, such as poly ethylene glycol (PEG), polyvinyl pyrrolidone (PVP), and other similar materials.
- The porosity of the expandable component may vary along any portion(s) thereof, including any combination of pore sizes of 1 micron or greater. Further, the pore sizes can range from about 1 μm to about 400 μm, from about 5 μm to about 300 μm, from about 8 μm to about 200 μm, from about 10 μm to about 150 μm, from about 15 μm to about 80 μm, or in some embodiments, from about 20 μm to about 50 μm. Further, at least a portion or section of the device can comprise an average porosity of between about 1 μm and about 150 μm. Further, at least a portion or section can comprise an average porosity of between about 100 μm and about 200 μm. Furthermore, at least a portion or section can comprise an average porosity of between about 200 μm and about 300 μm. When a composite expandable component is formed using multiple sections or portions, each section or portion can have an average porosity within any of the ranges discussed above.
- According to some embodiments, in a compressed state, an expandable component of the intrasaccular device may be compressed down to 50%, 40%, 30%, 20%, 10% or less of its expanded state (which can be measured by its maximum diameter or cross-sectional dimension) for delivery through a standard microcatheter. In some embodiments, the foam material can be configured to expand by about two to twenty times its collapsed size when expanding to its expanded size.
- In the event the intrasaccular device is not self-expandable, but expandable through a chemical reaction, a chemical may be introduced within the lumen of the delivery catheter for delivery to the intrasaccular device. In the alternative, the delivery catheter may include a separate lumen for introduction of the catalyst. Thermally expansive foam may be activated through introduction of heated saline or some other suitable biocompatible fluid through any of the aforementioned lumens of the delivery catheter. In the alternative, a heating element may be incorporated within the delivery catheter to deliver heat to the foam structure to cause corresponding expansion. A suitable heating element, identified schematically as reference numeral, may include resistive element(s), a microwave antenna, radio-frequency means, ultrasonic means or the like.
- As noted above, some embodiments of the expandable component can be configured to provide a specific porosity profile. The porosity profile can comprise a single, consistent average porosity throughout the entire expandable component, or multiple average porosity zones, portions, or materials having different average porosities that are joined to form a composite expandable component.
- For example, the embodiment illustrated in
FIG. 3 can be configured to have a low average porosity structure. For purposes of illustration, low porosity structures are illustrated in the figures using hexagonal patterns with larger spaces compared to hexagonal patterns with smaller spaces, which are used to illustrate medium and high porosity structures. Low porosity structures can provide higher packing densities, which can facilitate thrombogenesis by providing higher resistance to flow therethrough. When such low porosity structures are implanted into an aneurysm, such structures can substantially pack the aneurysm with a relatively high packing density, thereby isolating the aneurysm from the parent vessel and minimizing blood flow velocity within the aneurysm while supporting the aneurysm wall. - Conversely, as porosity increases, the packing density decreases, which compared to low porosity structures, provides less support for thrombogenesis due to lower resistance to flow therethrough. Nevertheless, the realization of some embodiments disclosed herein is that high porosity structures can also support the aneurysm wall, beneficially aid in healing and thrombogenesis for select aneurysm morphologies, permit flow to other vessels (e.g., branch vessels, perforating arteries, or arterioles), and/or permit the introduction of other materials, such as a liquid embolic, etc.
- Further, in some embodiments, composite, variable, or multi-porosity expandable components (whether using a single expandable component having multiple porosities or using multiple expandable components each having different porosities) can advantageously allow the intrasaccular device to mimic natural function of the vasculature while promoting healing through thrombogenesis, pressure moderation or reduction, or aneurysm deflation. Further, in embodiments using a single expandable component, the single expandable component can be configured to advantageously secure the intrasaccular device within a wide-neck aneurysm by facilitating engagement with a sufficient amount of the aneurysm wall, thereby avoiding dislodgement or herniation of the device from the aneurysm into the parent vessel.
-
FIG. 3 illustrates anexpandable component 50 having a relatively less dense or high porosity due to a larger pore size. As noted above, thefoam component 50 can permit some blood flow therethrough to maintain branch vessels while still providing support for the aneurysm wall. Further, in accordance with some embodiments, theexpandable component 50 or a portion of theexpandable component 50 can be packed with a liquid embolic during or subsequent to placement of the intrasaccular device. The injection of a liquid embolic can increase the overall packing density within theexpandable component 50. - One suitable liquid embolic is the Onyx™ liquid embolic system manufactured by Covidien LP, Irvine, Calif. Onyx™ liquid embolic system is a non-adhesive liquid used in the treatment of brain arteriovenous malformations. Onyx™ liquid embolic system is comprised of an EVOH (ethylene vinyl alcohol) copolymer dissolved in DMSO (dimethyl sulfoxide), and suspended micronized tantalum powder to provide contrast for visualization under fluoroscopy. Other liquid embolic solutions are also envisioned.
-
FIGS. 4-9 illustrate additional embodiments of expandable components. For example,FIG. 4 illustrates anexpandable component 60 having first andsecond portions second portions first portion 62 can comprise a higher average porosity first material, and thesecond portion 64 can comprise a lower average porosity second material. The first andsecond portions second portions -
FIGS. 5-6 illustrate enlarged views of atransition zone 66 of theexpandable component 60 ofFIG. 4 . In accordance with some embodiments,FIG. 5 illustrates that atransition zone 66 a can comprise an immediate, abrupt transition between the porosities of the first andsecond portions transition zone 66 a provides an open flow pathway between the first andsecond portions transition zone 66 a may not act as a barrier to fluid flow. However, in some embodiments, thetransition zone 66 a can provide at least a partial or full barrier to fluid flow between the first andsecond portions expandable component 60 may incorporate individual, separately formed segments or sections of material that are later joined together to create a composite unit or whole. The individual segments or first andsecond portions second portions -
FIG. 6 illustrates that atransition zone 66 b can comprise anintermediate portion 68 having an average porosity that is higher than the average porosity of thesecond section 64, but lower than the average porosity of thefirst section 62. Thetransition zone 66 b provides an open flow pathway between the first, second, and/orintermediate portions transition zone 66 a, thetransition zone 66 b may not act as a barrier to fluid flow. However, in some embodiments, thetransition zone 66 b can provide at least a partial or full barrier to fluid flow between the first, second, and/orintermediate portions intermediate portion 68 can have a porosity that gradually transitions spatially from a low porosity to a high porosity, or vice versa. Thetransition zone 66 b can be formed by varying the gas used in the fabrication of the variable porosity structure. Further, during manufacturing of theexpandable component 60, regions within the blank can be identified based on an average porosity and the expandable component can be trimmed therefrom. In some embodiments, certain regions can be identified that have a porosity that varies spatially from one end of the region to another, opposite end. -
FIGS. 7-9 illustrate schematic views of additional embodiments of expandable components shown inFIGS. 1-4 . These figures illustrate expandable components that each include a composite structure having two or more foam segments with different respective porosities (or pore densities), sizes, and/or shapes. - For example,
FIG. 7 illustrates anexpandable component 80 having first, second, andthird portions second portion 84 can comprise a lower porosity than the first andthird portions third portions third portions third portions third portions third portions -
FIG. 8 similarly illustrates anexpandable component 90 having first, second, andthird portions second portion 94 comprises a higher porosity than the first andthird sections FIG. 9 also illustratesexpandable component 100 having first, second, third, andfourth sections expandable components FIG. 7 . Accordingly, the discussion of such characteristics will not be repeated except to indicate thatFIGS. 8-9 illustrate that some embodiments can incorporate varied porosities, sizes, and shapes different from those illustratedFIG. 7 . - The foam composites may be formed to provide different support and/or flow profiles. As addressed herein, a material, such as bismuth or tantalum, can be blended with the foam to provide radiopacity. Also, radiopaque markers can be attached to the foam by bonding or mechanically crimping them to the foam.
- As noted above, in some embodiments, only a single expandable component would be required for introduction into an aneurysm. In some embodiments, this may prove advantageous over conventional methodologies such as the insertion of, for example, multiple embolic coils, by significantly reducing time for performance of the embolization procedure.
- Additionally, in some embodiments, multiple expandable components can be provided for insertion into an aneurysm. For example, a plurality of expandable components, having different average porosities, can be implanted into an aneurysm and have a composite or cumulative porosity profile spatially across the aneurysm, which can allow the plurality of expandable components to operate as a unit in much the same way as a single expandable component, if packing the same aneurysm itself, would operate. Such embodiments are discussed in greater detail below in
FIGS. 36-42 . The expandable components can be arranged and positioned within a lumen of the catheter or otherwise arrange for delivery into the aneurysm. The size of each expandable component can be compressed to a fraction of its normal, expanded size and delivered into the target aneurysm. - Further, in some embodiments, the expandable component(s) can include one or more flow regions. The flow region can be used alone or combination with any of the variable porosity profiles disclosed herein, including those illustrated in
FIGS. 4-9 . - For example,
FIGS. 10-11 illustrate expandable components having at least one flow region.FIG. 10 illustrates anexpandable component 30 having a pair offlow regions 32 formed in abody 34.FIG. 11 similarly illustrates another embodiment of anexpandable component 40 having asingle flow region 42 formed in abody 44. While thebody flow regions flow regions expandable components expandable components components - According to some embodiments, the
flow regions body flow regions flow regions body FIGS. 10-11 illustrate only single or dual flow regions, some embodiments can be configured to comprise three, four, or more flow regions formed therein. - In some embodiments, the flow region can be separated from other portions of the body by a partial or full barrier. For example, the flow region can comprise a lumen formed through the body and the lumen can comprise an inner wall (not shown) extending therealong. The inner wall can comprise a continuous surface. However, the inner wall can also comprise one or more perforations extending through the wall, by which the lumen of the flow region is in fluid communication with the surrounding areas of the body. Thus, the flow region can provide isolated flow through the body or a flow that is in communication with other areas of the body of the expandable component.
-
FIGS. 12A-12R illustrate various examples of shapes that can be used in accordance with some embodiments. Variations, whether by proportions, combinations, or other modifications of the disclosed shapes can be made, as taught herein. Without limitation, the shapes illustrated inFIGS. 12A-12R can comprise asphere 120, ahemisphere 121, a cuboid 122, apyramid 123, anoctahedron 124, anoctagonal prism 125, apentagonal prism 126, acoil 127, aprolate spheroid 128, anoblate spheroid 129, aclover plate 130, astar plate 131, a paraboloid ofrevolution 132, ahollow sphere 133, abowl 134, atorus 135, acylinder 136, acone 137, or combinations thereof. - In particular, in some embodiments, an intrasaccular device can be provided that comprises first and second expandable components of which at least one has a shape selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof. Additional expandable components can be provided that have substantially spherical shapes.
- In accordance with some embodiments, an intrasaccular device can comprise first and second expandable components having different shapes. Further, the first and second expandable components can have different sizes. A third expandable component can be used, which can have the same or different sizes or shapes compared to either or both of the first and second expandable components. Thus, the first, second, and third expandable components can each have a different size and/or shape compared to each other. Such principles can apply to additional components, such as fourth, fifth, sixth components, and so forth.
- Further, the shapes mentioned above can be solid or at least partially hollow (e.g., having a cavity or void therewithin). Hollow expandable components can comprise braided structures (e.g., braided spheres), foam structures, and the like. A hollow expandable component can be released into the aneurysm by itself or in combination with other occlusive material, such as a liquid embolic, additional expandable components, or coils.
- For example,
FIGS. 13-15 illustrate hollow structures that can be used in accordance with embodiments of an intrasaccular device.FIGS. 13-15 each illustrates anintrasaccular device device hollow body cavity hollow body intrasaccular devices body intrasaccular devices intrasaccular device intrasaccular device - Additionally, in some embodiments, the
intrasaccular device aperture cavity aperture intrasaccular device intrasaccular device - For example, the
intrasaccular device intrasaccular device aperture FIGS. 40 and 44 ). According to some embodiments, although the intrasaccular device extends across the neck, it may not touch or contact the neck of the aneurysm. Further, in embodiments that comprise an open end, theintrasaccular device aperture - Alternately, the
aperture FIGS. 13 , 14, and 15 illustrate spheroid, ellipsoid and prism-shaped foam structures 402, respectively. - In alternate embodiments, the
intrasaccular device cavity -
FIGS. 16-18 illustrate interlocking structures of an intrasaccular device, according to some embodiments. For example,FIGS. 16-17 illustrate acomposite intrasaccular device components second portions respective engagement structures - The
intrasaccular devices FIGS. 16-17 can be configured such that therespective engagement structures second portions respective engagement structures respective engagement structures first portion second portion second portions - Further, in embodiments having only two interconnecting portions, such interconnecting portions can be configured to restrict at least two degrees of freedom of motion of the opposing portion. Motion can be restricted in two or more of the following directions: up-and-down translation, forward and backward translation, left and right translation, side to side pivoting or rolling, left and right rotating or yawing, and forward and backwards tilting or pitching. Further, in some embodiments, such as those illustrated in
FIGS. 16-17 , at least three degrees of the freedom of motion of a portion can be restricted. For example, the interconnection between portions of such embodiments can restrict four, five, or all six degrees of freedom of motion of a given portion. -
FIG. 18 illustrates anintrasaccular device 180 having a plurality of interconnectingportions portions portions - The mating expandable components, such as those embodiments illustrated in
FIGS. 16-18 can be delivered into the aneurysm and arranged in situ such that the engagement structures are aligned and interconnected appropriately such that the expandable components are mated. In some embodiments, the mating of the expandable components can interlock the components as a composite structure or unit, as inFIG. 16 . - As noted above, in accordance with some embodiments, at least a portion of the intrasaccular device can comprise a coating or material for enhancing therapeutic, expansive, or imaging properties or characteristics of at least one or every expandable component of the intrasaccular device.
- The intrasaccular device can be configured such that an expandable component thereof is coated with a biocompatible material to promote endothelialization or provide a therapeutic effect.
- For example,
FIG. 19 illustrates an alternate embodiment of the present disclosure. In accordance with this embodiment, theintrasaccular device 190 comprising anexpandable component 192 that can be coated and/or embedded with at least onecoating 194, such as a bioactive material or agent. - The
coating 194 may include thrombogenic coatings such as fibrin, fibrinogen or the like, anti-thrombogenic coatings such as heparin (and derivatives thereof), urukinase or t-PA, and endothelial promoting coatings or facilitators such as, e.g., VEGF and RGD peptide, and/or combinations thereof. Drug eluting coatings and a drug eluting foam composite, such as anti-inflammatory or antibiotic, coatings are also envisioned. These drug eluting components may include nutrients, antibiotics, anti-inflammatory agents, antiplatelet agents, anesthetic agents such as lidocaine, and anti-proliferative agents, e.g. taxol derivatives such as paclitaxel. Hydrophilic, hygroscopic, and hydrophobic materials/agents are also envisioned. - As also noted above, in some embodiments, the expandable component can also comprise an expansion-limiting coating that slows expansion of the component from its natural rate of expansion to a slower rate of expansion such that in the process of expanding, the position of the component can be adjusted within the aneurysm or the component can be removed from the aneurysm, if necessary. Examples of polymers that can be used as expansion-limiting coatings can include hydrophobic polymers, organic non-polar polymers, PTFE, polyethylene, polyphenylene sulfide, oils, and other similar materials.
- In embodiments, only specific segments of the intrasaccular device may be embedded or coated with an agent to provide desired characteristics to the expandable component(s). For example, as depicted in
FIG. 20 , anintrasaccular device 200 can comprise anon-thrombogenic coating 202 may be applied to alower half 204 of theexpandable component 206 to minimize clotting at this location. Such coatings may be desirable in aneurysms located at a bifurcation such that blood flow to branch arteries is permitted through the segment of the foam structure having the non-thrombogenic coating. Thecoated area 202 may be a different color than the remaining portion of theexpandable component 206 to assist the surgeon in identifying this area. - Optionally, the
coated area 202 can also comprise radiopaque material to assist the surgeon in visualization and placement of theexpandable component 206 in a desired orientation relative to the aneurysm. Theexpandable component 206 can have radiopacity characteristics either by adding radiopaque filler to the material (which in some embodiments comprises a foam material), such as bismuth, or attaching radiopaque markers. Alternatively, a radiopaque material can be attached to theexpandable component 206, such as by dipping, spraying, or otherwise mechanically, chemically, or thermally attached, injected into, or blended into to theexpandable component 206. -
FIG. 21 illustrates another embodiment of the intrasaccular devices illustrated inFIGS. 19-20 . InFIG. 21 , anintrasaccular device 220 is shown that comprises has a star-shapedexpandable component 222 which may be partially or fully coated and/or embedded with amaterial 224, such as any of the aforedescribed agents. The star shape can provide increased surface area due to the presence of theundulations 226 in the outer surface of theexpandable component 222. - Once the expandable component is delivered into the aneurysm, it can expand back to its full size or expanded state, confined within the neck of the aneurysm with minimal herniation within the parent vessel. The foam could be self-expandable, chemically expandable, thermally expandable, or expandable in response to pH changes or to light. Shape memory foams such as polyurethane foam can be used.
- Various delivery systems and procedures can be implemented for delivering an intrasaccular device comprising one or more expandable components, as discussed herein. Further, a system and method are provided for delivery of an intrasaccular device to an aneurysm and/or recapturing the device for removal or repositioning.
- For example, in accordance with some embodiments,
FIGS. 22-25 illustrate a delivery system and a procedure for implanting an intrasaccular device. In the illustrated embodiment, adelivery catheter 300 is advanced within avessel 302 until adistal end 304 of thedelivery catheter 300 is positioned adjacent to a target site, such as ananeurysm 306. - A
carrier assembly 320 can be configured to engage anintrasaccular device 330 and deliver theintrasaccular device 330 into theaneurysm 306. Thecarrier assembly 320 can comprise acore member 322 and anengagement member 324. Thecore member 322 can be interconnected with theengagement member 324. Theengagement member 324 can comprise at least twoarm members 340 having a closed position (seeFIG. 22 ) and an open position (seeFIG. 23 ). In the closed position, thearm members 340 can be engaged with at least a portion of theintrasaccular device 330 to facilitate distal advancement and retention of theintrasaccular device 330 within the lumen of thecatheter 300. - The
carrier assembly 320, disposed within a lumen of thedelivery catheter 300, can be advanced distally through thecatheter 300 until reaching thedistal end 304 of thecatheter 300. Upon reaching thedistal end 304, thecarrier assembly 320 can be actuated to release anintrasaccular device 330 into theaneurysm 306, as shown inFIG. 23 . - The
arm members 340 can be spring-loaded or configured to spring open from the closed position upon being advanced out of or distally beyond thedistal end 304 of thecatheter 300. However, thearm members 340 can also be manually actuated using a proximal control mechanism, thereby allowing thearm members 340 to continue engaging theintrasaccular device 330 even after thearm members 340 have moved out of the lumen of thecatheter 300. For example, such a proximal control mechanism can comprise a proximally extending wire coupled to a first of thearm members 340, the proximal retraction of which causes the first arm member 342 retract into thecatheter 300, thus releasing theintrasaccular device 330. Various other control mechanisms, such as those disclosed herein, can also be implemented in accordance with some embodiments. - After the
intrasaccular device 330 has been released into theaneurysm 306, theintrasaccular device 330 can begin to expand. The clinician can carefully monitor the orientation of theintrasaccular device 330 relative to the neck or surrounding the vasculature of theaneurysm 306. - According to some embodiments, if the
intrasaccular device 330 has a specific characteristic, such as a porosity profile, coating, shape, etc., intended for placement in a certain location of theaneurysm 306, the clinician can position theintrasaccular device 330 by manually rotating, moving, maintaining the position of, or otherwise adjusting the position of theintrasaccular device 330 within theaneurysm 306 as theintrasaccular device 330 expands. This procedure is illustrated inFIGS. 24-25 . Thus, by gently manipulating at least one of thearm members 340, the clinician can contact theintrasaccular device 330 to ensure proper orientation of theintrasaccular device 330 within theaneurysm 306. Although the manipulation of the position of the expandable device is shown in the context of thecarrier assembly 320 inFIGS. 22-25 , the position of the expandable device can be manipulated using various other deployment or delivery devices, such as those shown inFIGS. 31A-37 orFIGS. 61-63 . - In the performance of such procedures, the
intrasaccular device 330 can beneficially be coated with an expansion-limiting coating, such as those discussed above. In such embodiments, the expansion-limiting coating can allow the intrasaccular device 332 slowly expand, thus providing the clinician with a greater, and in some cases, a specified or expected period of time after releasing theintrasaccular device 330 to adjust the position of theintrasaccular device 330 within theaneurysm 306. -
FIG. 26 illustrates the placement of anintrasaccular device 370 within ananeurysm 306. Theintrasaccular device 370 can comprise aradiopaque material 372. Theradiopaque material 372 can be located at a specific end of the intrasaccular device 370 (in this case, on afirst portion 374 of theintrasaccular device 370, which has a lower porosity than asecond portion 376 thereof). In the illustration ofFIG. 26 , theintrasaccular device 370 is in an intermediate expanded state (i.e., it has not yet fully expanded), and as thedevice 370 expands, the clinician can adjust its position based on a visualization of theradiopaque material 372. The clinician can visualize the orientation of different sections or portions of an intrasaccular device relative to the neck or surrounding vasculature of an aneurysm, and here, align theradiopaque material 372 with theneck 380 of the aneurysm 306 (or in some embodiments, a fundus of the aneurysm 306) in order to maintain the lower porosityfirst portion 374 of theintrasaccular device 370 adjacent to or extending across theaneurysm neck 380. -
FIGS. 27-30 illustrate different aneurysm configurations and surrounding vasculature that may be treated best by achieving a specific orientation of an intrasaccular device within the aneurysm. - For example,
FIG. 27 illustrates anintrasaccular device 390 oriented such that alow porosity section 392 thereof is positioned or extends across theneck 380 of theaneurysm 306, with ahigher porosity section 396 positioned in the fundus of theaneurysm 306.FIG. 27 also provides an illustration of the final result of the process described above with respect toFIGS. 22-25 . Thus, after continued expansion, theintrasaccular device 330 shown inFIGS. 22-25 can achieve the position or state of expansion illustrated inFIG. 27 . -
FIG. 28 illustrates anartery 500 having ananeurysm 502 and a perforatingvessel 504 extending through theaneurysm 502 adjacent to aneck 506 of theaneurysm 502. In such circumstances, anintrasaccular device 520 can be positioned within theaneurysm 502 such that ahigh porosity section 522 extends across theneck 506 of theaneurysm 502 in order to permit blood flow into the perforatingvessel 504, as illustrated witharrows 530. -
FIG. 29 illustrates anartery 550 having ananeurysm 552 and a perforatingvessel 554 extending from the fundus of theaneurysm 552. In such situations, anintrasaccular device 560 can be positioned within theaneurysm 552 such that a first, high porosity section orchannel 562 of theintrasaccular device 560 provides a fluid pathway for blood to flow through theneck 564 of theaneurysm 552 toward and into theperforator vessel 554, as shown byarrow 570. Additionally, theintrasaccular device 560 can be configured to comprise one or morelow porosity sections -
FIG. 30 illustrates anintrasaccular device 590 oriented such that alow porosity section 592 thereof is positioned or extends across theneck 594 of ananeurysm 596 located at a vessel bifurcation. As illustrated, ahigher porosity section 598 can be positioned in the fundus of theaneurysm 596. Thus, flow through the bifurcation, as shown byarrows 600 can be diverted using thelow porosity section 592, thereby relieving pressure on theaneurysm 596. - Referring now to
FIGS. 31A-34 , engagement mechanisms for a delivery and recapture system, as shown inFIG. 22 , are provided. These engagement mechanisms can provide secure engagement and release of one or more expandable components. Further, the system can recapture the device for removal or repositioning. - As discussed above with respect to the engagement mechanism of
FIG. 22 , the engagement mechanisms illustrated inFIGS. 31A-34 can move between closed and open positions in order to facilitate engagement with and delivery of an intrasaccular device into an aneurysm. -
FIGS. 31A-31B illustrate a system and method for delivery an intrasaccular device to an aneurysm and/or recapturing the device for removal or repositioning. In one embodiment, the delivery system may include an introducer catheter orsheath 630. A delivery/retrieval member 680 can be disposed within a lumen of thecatheter 630. The delivery/retrieval member 680 may include anelongated element 682 having a plurality ofgripping elements 684 at one end. The delivery/retrieval member 680 can be dimensioned to traverse the longitudinal lumen of theintroducer sheath 630. Thegripping elements 684 can be adapted to open and close about theintrasaccular device 650. In some embodiments, thegripping elements 684 can be normally biased to an open position. - In some embodiments, the delivery/
retrieval member 680 can comprise the Alligator Retrieval Device, manufactured by Covidien LP, generally represented inFIGS. 31A-31B . The Alligator Retrieval Device can include a flexible wire having a plurality of gripping arms or elements, e.g., four arms, at the distal end of the flexible wire. Other embodiments for the gripping elements 58 include a clover leaf design, fish hook design, or dissolvable coupling, as shown inFIGS. 31A-34 , respectively. - In use, an access catheter is advanced within the neurovasculature as is conventional in the art. A suitable microcatheter adaptable for navigation through the tortuous neurovascular space to access the treatment site is disclosed in commonly assigned U.S. Pat. No. 7,507,229, the entire contents of which are hereby incorporated herein.
- The
gripping elements 684 of the delivery/retrieval member 680 are positioned about the intrasaccular device 650 (FIG. 31A ), and the delivery/retrieval member 680 is withdrawn into theintroducer sheath 630 such that thegripping elements 684 move inwardly during engagement with the inner wall surface of theintroducer sheath 630 to compress the foam structure of theintrasaccular device 650 as depicted inFIG. 31B . Theintrasaccular device 650 is withdrawn into theintroducer sheath 630. Theintroducer sheath 630 with the delivery/retrieval member 682 andintrasaccular device 650 positioned therein is advanced through the access catheter accessing the aneurysm. The access catheter may be removed if desired, or may be left in place. Thereafter, theintroducer sheath 630 is oriented at the desired orientation with respect to the aneurysm. Any of the engagement devices illustrated herein can be used for both delivery and retrieval of expandable components. - The delivery/
retrieval member 682 is advanced through theintroducer sheath 630 whereby upon clearing the distal end of theintroducer sheath 630 thegripping elements 684 of the delivery/retrieval member 682 open to release theintrasaccular device 650. In the event theintrasaccular device 650 is not properly positioned within the aneurysm or is dislodged, thegripping elements 684, in the open configuration, and extended beyond theintroducer sheath 630, are positioned to circumscribe theintrasaccular device 650 within the vasculature. The delivery/retrieval member 682 is withdrawn into theintroducer sheath 630 whereby thegripping elements 684 compress the foam material of theintrasaccular device 650 to permit reception of thedevice 650 within the lumen of theintroducer sheath 630. Thereafter, theintrasaccular device 650 can be removed from the neurovasculature or repositioned within the aneurysm by deployment of the delivery/retrieval member 682 in the manner discussed herein. -
FIGS. 32A-32B similarly illustrate anengagement mechanism 620 in the form of a “clover” pattern. Theengagement mechanism 620 can be disposed within acatheter 630 and advanced distally until exiting the lumen of thecatheter 630 at thedistal end 632. Upon exiting,wire loops 640 of theengagement mechanism 620 can be released from engaging theintrasaccular device 650. As illustrated inFIG. 31B , when released, theintrasaccular device 650 may not tend to snag or stick to thewire loops 640. Accordingly, theengagement mechanism 620 can provide fast and reliable disengagement with theintrasaccular device 650. -
FIGS. 33A-33B illustrate another embodiment of anengagement mechanism 670 having a “fish hook” design, similar to theengagement mechanisms distal end 632 of thecatheter 630 theengagement mechanism 670 can comprise a plurality ofhooks 672 configured to pierce or otherwise at least partially penetrate theintrasaccular device 650. Upon release, thehooks 672 can disengage from theintrasaccular device 650 in order to release theintrasaccular device 650 into the aneurysm. -
FIG. 34 illustrates an embodiment of a system in which adelivery member 690 is attached to anintrasaccular device 650 using adissolvable coupling 692. Thedissolvable coupling 692 can extend between theintrasaccular device 650 and an aperture or engagement member of thedelivery member 690. In accordance with some embodiments, engagement member of thedelivery member 690 can engage thedissolvable coupling 692 using a hook, wire loop, or other elongate member, such as those disclosed in other delivery systems above. Thedissolvable coupling 692 can be actuated by chemical corrosion (e.g., electrolytic detachment), thermal corrosion, pH changes, light changes, etc. Further, thereleasable connection 692 may be effected through an electrical, hydraulic or pneumatic connection where release of theintrasaccular device 650 is achieved through activation of any of these systems. For example, once theintrasaccular device 650 is positioned within the aneurysm, any of the aforementioned means may be actuated to release theintrasaccular device 650 from thedelivery member 690. -
FIG. 35 illustrates a microcatheter delivery system for implanting anintrasaccular device 720 within the aneurysm. Adelivery system 730 can comprise adelivery catheter 732 andpusher element 734 disposed within thedelivery catheter 732. Theintrasaccular device 720 in its normal configuration and predetermined geometry can be compressed and positioned within the lumen of thedelivery catheter 732. - The
delivery catheter 732 may be introduced within the neurovasculature and advanced to the treatment site. Once appropriately oriented with respect to the aneurysm, thepusher element 734 is actuated by, e.g., advancing a handle or actuator operatively connected to the proximal end of thepusher element 734 to cause the distal or remote end of thepusher element 734 to eject theintrasaccular device 720. Theintrasaccular device 720 can expand to pack the aneurysm. - Additionally, in accordance with some embodiments, the
pusher element 734 can comprise a radiopaque material orcomponent 736 disposed on acontact member 738 of thepusher element 734. As thepusher element 734 is advanced within the lumen of thecatheter 732, theradiopaque material 736 can enable the clinician to visualize the location of theintrasaccular device 720 to ensure proper positioning of thepusher element 734 within the lumen of thecatheter 732. -
FIG. 36 illustrates an alternate embodiment of the delivery system. In accordance with this embodiment,system 760 includesintroducer sheath 762 anddelivery member 764 disposed within theintroducer sheath 762. Thedelivery member 764 may be a push rod advanceable within theintroducer sheath 762. The intrasaccular device of this disclosure includes a plurality ofintrasaccular pellets introducer sheath 762 to be ejected in sequence via thedelivery member 764. For example, the plurality of pellets can comprise a framing shape, which has been compressed and folded as a framingpellet 770 a. Thepellet 770 a will be the last pellet to enter the aneurysm (afterpellets 770 b). Thus, the framingpellet 770 a can tend to expand so as to extend across a neck of the aneurysm (although not necessarily touching the ostium of the aneurysm. - These intrasaccular devices or
pellets pellets 770 a, 770B. Further, thedelivery member 764 can incorporate one or more radiopaque materials arecomponents 772 to facilitate visualization of the location of thedelivery member 764 within thesheath 762. -
FIG. 37 illustrates anotherdelivery system 790, in accordance with some embodiments. Thedelivery system 790 can comprise an over-the-wire system having aguide member 792 comprising aguide wire lumen 794. Theguide member 792 can also comprise adelivery lumen 796 in which apush rod 798 can be disposed for axial movement therewithin an order to deliver an intrasaccular device comprising a plurality ofexpandable components 800. Such an embodiment can allow thesystem 790 to define a minimal cross-sectional profile, thereby allowing thesystem 790 to extend into and through very narrow vessels to treat aneurysms in smaller vessels. -
FIGS. 38-42 illustrate various implementations of some of the embodiments disclosed herein. For example,FIG. 38 illustrates anintrasaccular component 820 that has been implanted into ananeurysm 830. As shown, theintrasaccular component 820 comprises a shape that is substantially an octahedron. Such a shape can be beneficial for securely anchoring theintrasaccular component 820 within theaneurysm 830 given the expanding waist and tapering ends that permit theintrasaccular component 820 to fit well within a berry or saccular aneurysm. In addition, theintrasaccular component 820 also comprises a radiopaque material ormarker 822 for use in locating and positioning theintrasaccular component 820 within theaneurysm 830. -
FIG. 39 illustrates anintrasaccular device 840 positioned within ananeurysm 830. Theintrasaccular device 840 comprises first and secondexpandable components expandable component 842 comprises a shape that is substantially conical or a paraboloid of revolution. The secondexpandable component 844 comprises a shape that is substantially hemispherical. The first and secondexpandable components second mating surface - When initially inserted into the aneurysm, prior to expansion, both the first and second
expandable components aneurysm 830. Upon expansion, neither the first nor secondexpandable components aneurysm 830. Thus, if either of the first or secondexpandable components aneurysm 830, significant movement and potential herniation of the respective component could occur from within theaneurysm 830. However, as the first and secondexpandable components aneurysm 830, the first and second mating surfaces 852, 854 can cause the first and secondexpandable components aneurysm 830. Such alignment, as illustrated inFIG. 39 , can tend to prevent dislocation of either the first or secondexpandable components intrasaccular device 840 within theaneurysm 830. - According to some embodiments, an intrasaccular the first and second mating surfaces 852, 854 can be substantially flat. However, as illustrated in
FIG. 40 , some embodiments can be configured such that anintrasaccular device 860, positioned within ananeurysm 830, comprises first and second mating surfaces 870, 872 of first and secondexpandable components engagement mechanism 884. Theengagement mechanism 884 can comprise engagement structures, such as a recess and a corresponding protrusion, as illustrated. Theengagement mechanism 884 can comprise one of a variety of structures, such as one or more recesses and one or more corresponding protrusions, including hemispherical, cylindrical, conical, or other such geometric mating recesses and protrusions. Accordingly, theengagement mechanism 84 can tend to prevent slippage between the first and second mating surfaces 870, 872, thus tending to cause the first and secondexpandable components - As noted above with respect to
FIGS. 13-15 , some embodiments of the intrasaccular device can comprise a hollow component that can be implanted into an aneurysm. Although a plurality of hollow components can be implanted into the aneurysm as a system, a single hollow component can also be set in place and later packed with one or more expandable components. Thus, the hollow component can act as a support or framing structure having an enclosed cavity configured to receive additional components therein. - For example,
FIG. 41 illustrates anintrasaccular device 900 in the form of a hollowexpandable component 902 that is implanted into ananeurysm 904 along with a plurality ofexpandable components 906. As shown, thehollow component 902 can be in the form of a hollow hemispherical shell that can act as a support or framing structure for the aneurysm and additional expandable components placed therein. Thehollow component 902 can have anouter surface 908 that is in contact against aninner wall 912 of theaneurysm 904. As illustrated, the contact between theouter surface 908 and theaneurysm wall 912 can be along a portion of theaneurysm wall 912 that has a cross-sectional profile greater than the size of the opening or passing profile of theneck 920 of theaneurysm 904. Further, contact between theouter surface 908 and theaneurysm wall 912 can be at least along the lower half of theaneurysm 904. - In some embodiments, the
outer surface 908 of thehollow component 902 can contact against a first section of theaneurysm wall 912 adjacent to theaneurysm neck 920, as well as against a second section of theaneurysm wall 912 adjacent to theaneurysm dome 918, opposite theaneurysm neck 920. For example, theaneurysm 904 oraneurysm wall 912 can be considered in terms of quadrants, and theouter surface 908 can contact at least three quadrants of theaneurysm wall 912. In some embodiments, theouter surface 908 can be caused to contact at least a portion of each quadrant of theaneurysm wall 912. The contact of theouter surface 908 against theaneurysm wall 912 can tend to secure thehollow component 902 within theaneurysm 904 to avoid dislocation or herniation of any portion of thehollow component 902 from theaneurysm 904. - Referring still to
FIG. 41 , theexpandable components 906 can be inserted or injected into a cavity of thehollow component 902 through anaperture 910 formed in a sidewall of thehollow component 902. Theaperture 910 can be sized such that theexpandable components 906 can be inserted through theaperture 910 in their compressed state, but upon expansion, theexpandable components 906 will be unable to exit through theaperture 910. As also illustrated, theexpandable components 906 can position themselves during expansion such that irregular shapes of thedome 918 of theaneurysm 904 can be packed. Additionally, theintrasaccular device 900 can provide a lower porosity adjacent to theneck 920 of theaneurysm 904 while having a relatively higher porosity adjacent to thedome 918. - In accordance with some embodiments, the support or framing component can comprise a stent that extends along a lumen adjacent to an aneurysm. The aneurysm can be a saccular or berry, wide neck, or fusiform aneurysm. For example, a stent can be used in combination with any of the variety of intrasaccular devices illustrated above, such as those shown in
FIGS. 22-30 and 38-41, which are shown as treating saccular aneurysms. In some embodiments, the framing component can advantageously secure the intrasaccular device within a wide-neck aneurysm by facilitating engagement with a sufficient amount of the aneurysm wall to avoid dislodgement or herniation of the device from the aneurysm into the parent vessel. -
FIG. 42 illustrates an implementation of anintrasaccular device 940 in a method for treating afusiform aneurysm 950. As illustrated, theintrasaccular device 940 can comprise astent 952 that extends across theaneurysm 950. Thestent 952 can be released at the target location using a catheter and any of a variety of release methods, such as balloon expansion or self-expansion. - When expanded into contact against the inner wall of the
lumen 954, thestent 952 can isolate, separate, or divide theinner cavity 956 of thefusiform aneurysm 950 from a central portion of thelumen 954. - When the
stent 952 is in place, at least oneexpandable component 960 can be released into theinner cavity 956 between the inner wall of theaneurysm 950 and anouter surface 962 of thestent 952. The expandable component(s) 960 can be inserted into thecavity 956 through an opening in a wall of the stent 952 (or if thestent 952 is braided, through an interstice of the braid). - As discussed herein, the expandable component(s) 960 can have one or more characteristics that improve the effectiveness of the
intrasaccular device 940. Further, the characteristics of theexpandable component 960 can be selected based on the shape or configuration of theaneurysm 950, as discussed above. As shown inFIG. 42 , the expandable components can have a specific shape to pack the cavity 956 (e.g., a sectioned sphere with a luminal void extending through the sections, thus providing a flatter cylindrically shaped surface that can abut the outer surface of the stent 952). However, any of a variety of other shapes can also be selected and inserted into thecavity 956. - In accordance with some embodiments, after an intrasaccular device has been implanted into an aneurysm, a material such as a liquid embolic (as discussed above), a drug, a radiopaque material, a contrast agent, or other agent can be injected or inserted into the aneurysm. The injection or insertion can occur prior to, concurrently with, or after expansion of the intrasaccular device within the aneurysm. As such, the material can be absorbed into at least a portion of the intrasaccular device or pack any remaining voids within the aneurysm around the intrasaccular device. The injection of a liquid embolic can advantageously increase the overall packing density of the device.
FIGS. 43 and 44 illustrate embodiments in which a liquid embolic is inserted into the aneurysm in combination with an intrasaccular device. - For example,
FIG. 43 illustrates that a material 980 (e.g., a liquid embolic, drug, radiopaque material, contrast agent, or other agent) is being inserted into ananeurysm 982 along with anintrasaccular device 984. Theintrasaccular device 984 can have a high porosity, which can allow thematerial 980 to penetrate theintrasaccular device 984. -
FIG. 44 illustrates injection of a material 990 into an aneurysm 992. As shown, thematerial 990 can flow into theaneurysm 982 into the interstice is formed between expandable components of theintrasaccular device 994. In such an embodiment, the components of theintrasaccular device 994 can have a lower porosity such that the material 998 may not tend to penetrate the components of theintrasaccular device 994 as much as in the embodiment illustrated inFIG. 43 . - Thus, various materials can be injected or inserted into the aneurysm to supplement or complement the treatment provided by an intrasaccular device.
-
FIGS. 45-52 illustrate additional embodiments of an intrasaccular device that uses a support or framing component or structure in combination with secondary expandable components. -
FIGS. 45-46 illustrates an embodiment in which ananeurysm 1000 is treated using anintrasaccular device 1100 a, which comprises aframing structure 1102 a having aclosed end 1104 and anopen end 1106. In some embodiments, theframing structure 1102 a can be formed from a braided material. - In one embodiment, the
closed end 1104 of the framing structure is sealed via aclamp 1108, an adhesive, or may be heat welded via known techniques. Theclosed end 1104 may be inverted relative to the remainingframing structure 1102 a and depend inwardly within the interior thereof. Theopen end 1106 of theframing structure 1102 a may be in diametrical opposed relation to theclosed end 1104. The individual filaments ends 1110 of the framing structure at theopen end 1106 also may be inverted and disposed within the interior of theframing structure 1102 a. -
FIG. 45 depicts the introduction of the coils through theopen end 1106 of theframing structure 1102 a. Suitable braid materials, structures, and method for manufacturing theframing structure 1102 a are disclosed in commonly assigned U.S. Pat. No. 6,168,622 to Mazzocchi, U.S. Pat. No. 8,142,456, issued Mar. 27, 2012, U.S. Patent Application Publication No. 2011/0319926, filed on Nov. 11, 2010, and U.S. Patent Application Publication No. 2012/0330341, filed on Jun. 22, 2011, the entireties of each of which are incorporated herein by reference. Braid materials may include stainless steel, nitinol cobalt chromium or the like. - As shown in the embodiment of
FIGS. 45-46 , theframing structure 1102 a can be deployed in theaneurysm 1000 and packed withcoils 1120. However, as shown inFIG. 47-49 , anintrasaccular device framing structure expandable component 1130, 1140 (e.g., a foam component). The configuration, selection, and use of theexpandable components framing structure 1102 a. Further, in embodiments using an expandable component, such as a foam component, the foam can advantageously provide a higher packing density compared to traditional coil packing and accomplish this in a single device. - The
framing structure 1102 a, combined with coils, an expandable component, or other materials, can also provide the benefit of providing good neck coverage while preventing embolic devices from herniating into the parent artery. Additionally, the use of such a system can also increase packing volume efficiency and achieve stasis. - As illustrated, the
framing structure 1102 a may provide a support or scaffold for the supplemental intrasaccular components or materials, including coils, expandable components, or other materials (e.g., a liquid embolic, drug, radiopaque material, contrast agent, or other agent). Thecoils 1120 orexpandable component 1130 may contain or be coated with bioactive coating that promotes specific clinical theory such as endothelialization, thrombosis, etc. - Referring briefly to
FIGS. 50-52 , these figures illustrate examples of framing structures that can be used as support or framing components, according to some embodiments. InFIG. 50 , abraided device 1200 can comprise a single-layerouter portion 1202 that is formed by inverting a tubular braid such that aninner portion 1204 of the braid extends through a center portion of thedevice 1200. Ends of the inner andouter portions first end 1206. Although the filament ends of the inner andouter portions first end 1206 can comprise a hub orcoupling device 1208 that bundles the inner andouter portions coupling device 1208 can be recessed within an interior of thedevice 1200, although it is shown protruding inFIG. 50 . -
FIG. 51 illustrates another embodiment of a framing structure in which abraided device 1230 comprises at least onelayer 1232 extending around the periphery of thedevice 1230. In some embodiments, a single layer can be used, but multiple braided layers are also possible. Thedevice 1230 can comprise first andsecond ends device 1232 formed a smooth outer surface for thedevice 1230. The first and second ends 134, 136 can be open or closed. As shown, the first andsecond ends coupling devices second ends -
FIG. 52 illustrates yet another embodiment of the framing structure in which abraided device 1250 comprises adual layer shell 1252 having a substantiallyclosed end 1254 and anopen end 1256. Theopen end 1256 can be inverted or recessed into thedevice 1250. - Referring again to
FIGS. 45-46 and 48-49, after aframing structure aneurysm 1000, the procedure of implanting coils, an expandable component, or other materials into theframing structure catheter 1112, such as adistal end 1114 thereof, between filaments of the framing structure (seeFIG. 48 ) or into an open end of the framing structure (seeFIGS. 45 and 49 ). - In implementing a method for placing a framing structure within an aneurysm and injecting coils, expandable component(s), or other materials into the framing structure, the open end or widest interstices of the framing structure can be positioned at the neck of the aneurysm so as to facilitate insertion of the
distal end 1114 of thecatheter 1112 into the open end or between the filaments (i.e., into an interstice) of the framing structure. In embodiments having a braided material for the framing structure, the braid pattern can be properly aligned to facilitate entry of the materials into the framing structure. As in other embodiments disclosed herein, the framing structure can comprise a radiopaque material or component that facilitates visualization and enables the clinician to align the framing structure as needed within the aneurysm. - As illustrated in
FIGS. 46-47 and 49, after the coils, expandable component, or other materials have been inserted into the interior of the braided device through its open end, the open end can collapse onto itself or onto an inner surface of the framing structure as the coils, expandable component, or other materials settle or expand within the cavity of the framing structure. As shown inFIG. 49 , thedistal end 1114 of thecatheter 1112 can be withdrawn, thus allowing theopen tube portion 1162 to close onto itself in response to expansive forces from the expanding component(s) or materials. Further, in some embodiments, as illustrated inFIG. 52 , anopen end 1256 can define a generally tubular portion that can be deflected into contact with the inner wall of the framing structure when at least one expandable component is released into and expand within the cavity of the framing structure. As such, the open end can tend to self-seal, thus preventing herniation of the coils, expandable component, or other materials disposed within the framing structure. - The composite effect of the coils, expandable component, and/or other materials inserted into the framing structure can provide the advantages and benefits discussed above with respect to various other expandable components. As such, the clinician can determine and control various intrasaccular implant characteristics, including porosity, composition, material, shape, size, interconnectedness, inter-engagement, coating, etc.
- According to some embodiments, systems or kits having a framing structure and at least one coil, expandable component, and/or other material can be provided.
- Intrasaccular implant devices and procedures for treating aneurysms can be improved by interconnecting individual components of the intrasaccular device. According to some embodiments, a plurality of expandable components can be interconnected along a wire, filament, or other disconnectable or breakable material. The expandable components can be connected in a linear configuration (see
FIGS. 53-58C ), a planar matrix (seeFIGS. 59A-60B ), or in a three-dimensional matrix (seeFIGS. 61A-61B ). The expandable components of such interconnected linear, planar, or three-dimensional matrices can be sized and configured in accordance with desired porosity, size, shape, radiopacity, or other characteristics disclosed herein, which will not be repeated here for brevity. - In some embodiments, methods are provided by which interconnected expandable components can be released into an aneurysm. The interconnected components can be preconfigured (e.g., a select number of components can be removed from a larger strand or array of components) prior to implantation and later inserted into a delivery catheter. Thereafter, the entire strand or assembly of interconnected expandable components of the intrasaccular device can be released into the aneurysm.
- However, in accordance with some embodiments, an entire strand or array of components (which would, in their expanded state, exceed the available space in the aneurysm) can be loaded into a delivery catheter, and while implanting and observing the packing behavior, a clinician can determine that a select portion of the interconnected expandable components is sufficient for a given aneurysm. Thereafter, the select portion of the interconnected expandable components can be broken or cut in situ so as to be released into the aneurysm.
- Referring now to
FIGS. 53-57C , various embodiments of linearly interconnected expandable components are shown. As illustrated in these figures, anintrasaccular device expandable components strip strip - The
expandable components FIG. 53 illustrates anintrasaccular device 1300 a having a plurality of indentations or 1304 a (which can also include or be substituted by perforation lines) that separate adjacent expandable components.FIG. 54 illustrates anintrasaccular device 1300 b having a plurality of expandable components that are formed or molded along a filament orstring 1304 b. Further,FIGS. 55-56 can include filaments or reduced diameterexpandable portions - In accordance with some embodiments, the strings, filaments, carriers, indentations, reduced size sections, or perforation lines extending between adjacent expandable components can enhance pushability of the
intrasaccular device - Further, as illustrated in
FIGS. 57A-57C , the expandable components of theintrasaccular device FIG. 57A ), a square shape 1330 (seeFIG. 57B ), or a round, e.g., circular, shape 1340 (seeFIG. 57C ). Various other cross-sectional profiles can be provided, such as polygons having three, five, six, seven or eight sides, star shapes, clover shapes, and the like. Additionally, a single intrasaccular device can comprise expandable components that have different cross-sectional shapes or that have identical cross-sectional shapes, according to some embodiments. - Further, in accordance with some embodiments, consecutive expandable components of an
intrasaccular device intrasaccular device -
FIGS. 58A-60B illustrate additional embodiments of intrasaccular devices that can have nonlinear configurations. For example,FIG. 58A illustrates an embodiment of anintrasaccular device 1400 comprising a layer or planar array of a plurality of interconnectedexpandable components 1402 in a compressed state, according to some embodiments. Theexpandable components 1402 can be interconnected by one or more strings, filaments, carriers, indentations, reduced size sections, or perforation lines (which may include or be devoid of a filament or string) 1406. Theexpandable components 1402 can have the same or different shapes, sizes, or material properties as each other. For example, as illustrated inFIGS. 58A-58B , theintrasaccular device 1400 can comprise a centralexpandable component 1404 having an expanded size that is much greater than the expanded sizes of surroundingexpandable components 1402. Thus, as shown inFIG. 58B , when released into an aneurysm, theintrasaccular device 1400 can expand into a configuration in which thecentral component 1404 is anchored in theaneurysm 1420 by the surroundingexpandable components 1402. - Similar to the embodiment illustrated in
FIGS. 58A-58B , various embodiments can be provided in which surrounding or anchoring expandable components can be interconnected with other components in a matrix to enhance the fit or engagement of the intrasaccular device within an aneurysm. Further, such surrounding expandable components can have characteristics different from those of the central expandable component, such as having coatings or other properties that beneficially affect the efficacy of the intrasaccular device within the aneurysm. -
FIG. 59A-59B illustrate embodiments ofintrasaccular devices expandable components 1452, 1462 in a compressed state. Theexpandable components 1452, 1462 can be interconnected by one or more strings, filaments, carriers, indentations, reduced size sections, or perforation lines (which may include or be devoid of a filament or string) 1454, 1464. For example, each of theexpandable components 1452, 1462 can be connected to at least two otherexpandable components 1452, 1462. -
FIG. 60A-60B illustrate embodiments ofintrasaccular devices expandable components expandable components expandable components expandable components FIGS. 58A-59B , a three-dimensional array can have expandable components that each have characteristics different from those of other components, such as having coatings or other properties that beneficially affect the efficacy of the intrasaccular device within the aneurysm. - The advantageous features of intrasaccular devices having strip configurations can allow a clinician to quickly and readily assess a target aneurysm and tailor an intrasaccular device specifically for the procedure. The customization of an intrasaccular device strip can be done before implantation or in situ. Further, the interconnectedness of the components tends to ensure that no component is lost.
-
FIGS. 61-63 illustrate a delivery system and procedure for delivering a strip of interconnected expandable components, according to some embodiments. As discussed, the configuration of thestrip - Prior to initiating the implantation of an strip of interconnected intrasaccular device, a clinician, through imaging means, can determine the size and dimension of an
aneurysm 1500. Once the dimensioning is determined, the clinician can determine decide upon a configuration for the intrasaccular device orstrip 1502 of interconnected expandable components to be implanted. As shown inFIG. 61 , thestrip 1502 can be delivered using animplant delivery assembly 1504, which can comprise acatheter 1506 and apusher component 1508. - In some embodiments of the delivery procedure, after determining the configuration for the
strip 1502, the clinician can prepare thestrip 1502 by separating any unnecessary expandable components there from prior to inserting thestrip 1502 into thedelivery assembly 1504. Thereafter, thestrip 1502 is then introduced within the aneurysm in accordance with any of the aforedescribed methodologies. - However, in some embodiments of the delivery procedure, the clinician can load a
strip 1502 into thecatheter 1506 before trimming any expandable components from thestrip 1502. The clinician can then push thestrip 1502 out through adistal end 1510 of thecatheter 1506, which causes the individualexpandable components 1520 to begin to expand within theaneurysm 1500. As the expansion is taking place, the clinician can determine whether additionalexpandable components 1520 should be deployed into theaneurysm 1500. If needed, thepusher component 1508 can be moved distally to urge one or more additionalexpandable components 1520 out of thecatheter 1506. When it is determined that a sufficient number ofexpandable components 1520 are inserted into theaneurysm 1500, the clinician can break or separate thestrip 1502 by separating the respectiveexpandable components 1520 via trimming or tearing along the breaks, indentations or score lines and separating theexpandable components 1520. - The breaking or separating of adjacent expandable components can be performed by actuating the
cutting device 1540. In some embodiments, thecutting device 1540 can comprise asecond catheter 1542 that is nested within thecatheter 1506. Thesecond catheter 1542 can comprise adistal portion 1544 having anopening 1546 that extends from a side of thesecond catheter 1542. Thedistal portion 1544 can have a rounded shape that can guide theexpandable components 1520 out through theopening 1546. In order to trim thestrip 1502, thesecond catheter 1542 can be retracted proximally relative to thecatheter 1506, thus causing theopening 1546 to close against thedistal end 1510 of thecatheter 1506, thereby severing a tie or filament extending between adjacentexpandable components 1520. - Thereafter, the
distal portion 1544 of thesecond catheter 1542 can be further withdrawn into thecatheter 1506 and thedelivery assembly 1504 can be removed from the target site. - Many of the features discussed herein can be used with any of the disclosed embodiments. For example, any of the embodiments can comprise an average porosity that varies spatially, any of the variety of disclosed shapes, any of the various disclosed materials or coatings, any of the disclosed 2-D or 3-D interconnected configurations, any of the disclosed inter-engagement configurations or structures, any of the disclosed delivery systems, etc.
- The apparatus and methods discussed herein are not limited to the deployment and use of a medical device or stent within the vascular system but may include any number of further treatment applications. Other treatment sites may include areas or regions of the body including any hollow anatomical structures.
- The foregoing description is provided to enable a person skilled in the art to practice the various configurations described herein. While the subject technology has been particularly described with reference to the various figures and configurations, it should be understood that these are for illustration purposes only and should not be taken as limiting the scope of the subject technology.
- There may be many other ways to implement the subject technology. Various functions and elements described herein may be partitioned differently from those shown without departing from the scope of the subject technology. Various modifications to these configurations will be readily apparent to those skilled in the art, and generic principles defined herein may be applied to other configurations. Thus, many changes and modifications may be made to the subject technology, by one having ordinary skill in the art, without departing from the scope of the subject technology.
- It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplary approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.
- As used herein, the phrase “at least one of” preceding a series of items, with the term “and” or “or” to separate any of the items, modifies the list as a whole, rather than each member of the list (i.e., each item). The phrase “at least one of” does not require selection of at least one of each item listed; rather, the phrase allows a meaning that includes at least one of any one of the items, and/or at least one of any combination of the items, and/or at least one of each of the items. By way of example, the phrases “at least one of A, B, and C” or “at least one of A, B, or C” each refer to only A, only B, or only C; any combination of A, B, and C; and/or at least one of each of A, B, and C.
- Terms such as “top,” “bottom,” “front,” “rear” and the like as used in this disclosure should be understood as referring to an arbitrary frame of reference, rather than to the ordinary gravitational frame of reference. Thus, a top surface, a bottom surface, a front surface, and a rear surface may extend upwardly, downwardly, diagonally, or horizontally in a gravitational frame of reference.
- Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.
- The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments.
- A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” Pronouns in the masculine (e.g., his) include the feminine and neuter gender (e.g., her and its) and vice versa. The term “some” refers to one or more. Underlined and/or italicized headings and subheadings are used for convenience only, do not limit the subject technology, and are not referred to in connection with the interpretation of the description of the subject technology. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the subject technology. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.
- Although the detailed description contains many specifics, these should not be construed as limiting the scope of the subject technology but merely as illustrating different examples and aspects of the subject technology. It should be appreciated that the scope of the subject technology includes other embodiments not discussed in detail above. Various other modifications, changes and variations may be made in the arrangement, operation and details of the method and apparatus of the subject technology disclosed herein without departing from the scope of the present disclosure. Unless otherwise expressed, reference to an element in the singular is not intended to mean “one and only one” unless explicitly stated, but rather is meant to mean “one or more.” In addition, it is not necessary for a device or method to address every problem that is solvable (or possess every advantage that is achievable) by different embodiments of the disclosure in order to be encompassed within the scope of the disclosure. The use herein of “can” and derivatives thereof shall be understood in the sense of “possibly” or “optionally” as opposed to an affirmative capability.
Claims (23)
1. A system for treatment of an aneurysm, comprising:
an intrasaccular device comprising first and second expandable components adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm, the first and second components being interconnected by a non-helical coupling such that the first and second components can be advanced as an interconnected unit, into the aneurysm;
wherein the first component comprises at least one of a shape or an average porosity different from a shape or an average porosity of the second component.
2. The system of claim 1 , wherein the first component shape is selected from the group consisting of cylinders, hemispheres, polyhedrons, prolate spheroids, oblate spheroids, plates, bowls, hollow structures, clover shapes, non-spherical surface of revolution, and combinations thereof.
3. The system of claim 1 , wherein the second component comprises a substantially spherical shape.
4. The system of claim 1 , wherein at least one of the first or second components comprises a foam or a braided structure.
5. The system of claim 1 , wherein at least one of the first or second components comprises a coil.
6. The system of claim 1 , further comprising a third component interconnected with the second component such that the first, second, and third components are interconnected in series.
7. The system of claim 1 , wherein the coupling interconnecting the first and second components comprises a filament.
8. The system of claim 1 , wherein the coupling has a preset shape such that in an expanded position, the first and second components are spaced relative to each other at a preset orientation.
9. A system for treatment of an aneurysm, comprising:
an intrasaccular device comprising at least three expandable components adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm, each of the at least three components being interconnected to at least two of the at least three components such that at least three expandable components can be advanced as an interconnected unit, into the aneurysm.
10. The system of claim 9 , wherein the at least three expandable components comprises at least four expandable components.
11. The system of claim 10 , wherein at least two of the at least four expandable components is interconnected with at least three of the at least four expandable components such that the device comprises a multi-planar shape.
12. The system of claim 9 , wherein the at least three components are interconnected by filaments.
13. The system of claim 9 , wherein at least three components are interconnected by filaments having preset shapes such that in an expanded position, the at least three components are spaced relative to each other at a preset orientation.
14. The system of claim 9 , wherein the device comprises at least one central expandable component positioned such that, when the device is in an expanded configuration, the central expandable component is centrally interconnected with a plurality of the expandable components.
15. The system of claim 14 , wherein the at least one central expandable component has an expanded size greater than an expanded size of each remaining one of the plurality of components.
16. The system of claim 11 , wherein the multi-planar shape comprises a polyhedron.
17. A method for treatment of an aneurysm, comprising:
advancing an intrasaccular device toward the aneurysm through a lumen of a catheter, the device comprising a plurality of expandable components each adapted to transition from a compressed configuration to an expanded configuration when deployed into the aneurysm from the catheter, each of the plurality of components being interconnected by a coupling.
18. The method of claim 17 , further comprising:
advancing the device into the aneurysm such that a first component is disposed within the aneurysm and a second component, interconnected with the first component by the coupling, is disposed within the catheter lumen;
severing the coupling between the first and second components to release the first component into the aneurysm;
retaining the second component within the lumen; and
withdrawing the catheter.
19. The method of claim 17 , further comprising advancing a plurality of expandable components into the aneurysm prior to the severing.
20. The method of claim 17 , wherein each of the plurality of components is interconnected in series by the coupling.
21. The method of claim 17 , wherein the severing comprises proximally withdrawing the catheter relative to a second catheter such that the coupling between the first and second components is pinched between a distal end of the catheter and a rim of the second catheter.
22. The method of claim 17 , wherein the plurality of expandable components is arranged in descending size, and the advancing comprises allowing an initial expandable component deployed into the aneurysm to expand prior to advancing a subsequent expandable component into the aneurysm.
23. The method of claim 22 , wherein the advancing comprises observing a fit of expanded components within the aneurysm to determine whether to advance additional components into the aneurysm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/079,587 US20140135810A1 (en) | 2012-11-13 | 2013-11-13 | Occlusive devices |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261725768P | 2012-11-13 | 2012-11-13 | |
US14/079,587 US20140135810A1 (en) | 2012-11-13 | 2013-11-13 | Occlusive devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140135810A1 true US20140135810A1 (en) | 2014-05-15 |
Family
ID=49681180
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/079,587 Abandoned US20140135810A1 (en) | 2012-11-13 | 2013-11-13 | Occlusive devices |
US14/079,590 Abandoned US20140135811A1 (en) | 2012-11-13 | 2013-11-13 | Occlusive devices |
US14/079,591 Active 2035-08-17 US10327781B2 (en) | 2012-11-13 | 2013-11-13 | Occlusive devices |
US16/412,967 Active 2035-06-12 US11690628B2 (en) | 2012-11-13 | 2019-05-15 | Occlusive devices |
US16/424,095 Active 2035-12-15 US11786253B2 (en) | 2012-11-13 | 2019-05-28 | Occlusive devices |
US16/523,163 Pending US20190343532A1 (en) | 2012-11-13 | 2019-07-26 | Occlusive devices |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/079,590 Abandoned US20140135811A1 (en) | 2012-11-13 | 2013-11-13 | Occlusive devices |
US14/079,591 Active 2035-08-17 US10327781B2 (en) | 2012-11-13 | 2013-11-13 | Occlusive devices |
US16/412,967 Active 2035-06-12 US11690628B2 (en) | 2012-11-13 | 2019-05-15 | Occlusive devices |
US16/424,095 Active 2035-12-15 US11786253B2 (en) | 2012-11-13 | 2019-05-28 | Occlusive devices |
US16/523,163 Pending US20190343532A1 (en) | 2012-11-13 | 2019-07-26 | Occlusive devices |
Country Status (5)
Country | Link |
---|---|
US (6) | US20140135810A1 (en) |
EP (2) | EP3574850B1 (en) |
KR (2) | KR102309795B1 (en) |
CN (2) | CN108354645A (en) |
WO (1) | WO2014078458A2 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9307998B2 (en) | 1997-07-10 | 2016-04-12 | Stryker Corporation | Methods and devices for the treatment of aneurysms |
US9314326B2 (en) | 2002-04-12 | 2016-04-19 | Stryker Corporation | System and method for retaining vaso-occlusive devices within an aneurysm |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US20170079662A1 (en) * | 2015-09-23 | 2017-03-23 | Covidien Lp | Occlusive devices |
CN107636053A (en) * | 2015-07-25 | 2018-01-26 | 劳伦斯·利弗莫尔国家安全有限责任公司 | Surface modification is carried out to polymer foam using plasma |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10159490B2 (en) | 2015-05-08 | 2018-12-25 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
FR3070853A1 (en) * | 2017-09-10 | 2019-03-15 | Stsat Ag | SYSTEM FOR TREATING ANEURYSM |
FR3072014A1 (en) * | 2017-10-05 | 2019-04-12 | Stsat Ag | SYSTEM FOR TREATING ANEURYSM |
FR3072018A1 (en) * | 2017-10-05 | 2019-04-12 | Stsat Ag | SYSTEM FOR TREATING ANEURYSM |
US10314593B2 (en) | 2015-09-23 | 2019-06-11 | Covidien Lp | Occlusive devices |
US10376267B2 (en) | 2017-02-24 | 2019-08-13 | Inceptus Medical, Llc | Vascular occlusion devices and methods |
US10577733B2 (en) | 2016-10-14 | 2020-03-03 | Inceptus Medical, Llc | Braiding machine and methods of use |
JP2020516350A (en) * | 2017-12-21 | 2020-06-11 | ザ テキサス エーアンドエム ユニバーシティ システムThe Texas A&M University System | Vascular prosthesis for leak prevention during endovascular aneurysm repair |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10729445B2 (en) | 2012-02-09 | 2020-08-04 | Stryker European Holdings I, Llc | Vaso-occlusive devices including a friction element |
US10874402B2 (en) | 2017-10-10 | 2020-12-29 | Boston Scientific Scimed, Inc. | Detachable RF energized occlusive device |
US10980545B2 (en) | 2016-02-10 | 2021-04-20 | Microvention, Inc. | Devices for vascular occlusion |
US11000287B2 (en) | 2017-08-15 | 2021-05-11 | Boston Scientific Scimed, Inc. | Occlusive medical device system |
WO2021113130A1 (en) * | 2019-12-03 | 2021-06-10 | Boston Scientific Scimed, Inc. | Medical delivery device |
US11154412B2 (en) | 2018-02-01 | 2021-10-26 | Boston Scientific Scimed, Inc. | Medical device release system |
US11191927B2 (en) | 2017-07-31 | 2021-12-07 | Boston Scientific Scimed, Inc. | Dilator with engagement region |
US11284902B2 (en) | 2018-02-01 | 2022-03-29 | Boston Scientific Scimed, Inc. | Method of making a vascular occlusion device |
US11633190B2 (en) | 2014-05-28 | 2023-04-25 | Stryker European Holdings I, Llc | Vaso-occlusive devices and methods of use |
US11633818B2 (en) | 2019-11-04 | 2023-04-25 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11672946B2 (en) | 2019-09-24 | 2023-06-13 | Boston Scientific Scimed, Inc. | Protection and actuation mechanism for controlled release of implantable embolic devices |
US11690628B2 (en) | 2012-11-13 | 2023-07-04 | Covidien Lp | Occlusive devices |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
JP7317499B2 (en) | 2017-12-22 | 2023-07-31 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | Aneurysm device and delivery system |
US11813282B2 (en) | 2016-10-21 | 2023-11-14 | Covidien Lp | Injectable scaffold for treatment of intracranial aneurysms and related technology |
US11839380B2 (en) | 2014-08-08 | 2023-12-12 | Covidien Lp | Electrolytic and mechanical detachment for implant delivery systems |
US11844528B2 (en) | 2008-04-21 | 2023-12-19 | Covidien Lp | Multiple layer filamentary devices for treatment of vascular defects |
US11885051B2 (en) | 2017-10-14 | 2024-01-30 | Inceptus Medical, Llc | Braiding machine and methods of use |
Families Citing this family (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11464518B2 (en) | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
US11471164B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant |
US11484322B2 (en) | 2018-01-03 | 2022-11-01 | Aneuclose Llc | Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac |
US11357511B2 (en) | 2008-05-01 | 2022-06-14 | Aneuclose Llc | Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration |
US11583289B2 (en) | 2008-05-01 | 2023-02-21 | Aneuclose Llc | Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation |
US11471163B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies |
US9402707B2 (en) | 2008-07-22 | 2016-08-02 | Neuravi Limited | Clot capture systems and associated methods |
EP2629684B1 (en) | 2010-10-22 | 2018-07-25 | Neuravi Limited | Clot engagement and removal system |
US11484318B2 (en) | 2011-01-17 | 2022-11-01 | Artio Medical, Inc. | Expandable body device and method of use |
CA2824284C (en) | 2011-01-17 | 2020-10-27 | Novita Therapeutics, Llc | Ballstent device and methods of use |
US11259824B2 (en) | 2011-03-09 | 2022-03-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US9301769B2 (en) | 2011-03-09 | 2016-04-05 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
WO2012167156A1 (en) | 2011-06-03 | 2012-12-06 | Pulsar Vascular, Inc. | Aneurysm devices with additional anchoring mechanisms and associated systems and methods |
ES2809210T3 (en) | 2011-10-05 | 2021-03-03 | Pulsar Vascular Inc | Systems and devices for wrapping an anatomical opening |
CN104203126B (en) | 2012-01-17 | 2018-10-02 | 美它克医药公司 | Expandable bodies device and application method |
US10342546B2 (en) * | 2013-01-14 | 2019-07-09 | Microvention, Inc. | Occlusive device |
US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
US9662119B2 (en) * | 2013-03-13 | 2017-05-30 | Lawrence Livermore National Security, Llc | Shape-memory polymer foam device for treating aneurysms |
US9433429B2 (en) | 2013-03-14 | 2016-09-06 | Neuravi Limited | Clot retrieval devices |
WO2014140092A2 (en) | 2013-03-14 | 2014-09-18 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
ES2960917T3 (en) | 2013-03-14 | 2024-03-07 | Neuravi Ltd | Clot retrieval device to remove occlusive clots from a blood vessel |
US10285720B2 (en) | 2014-03-11 | 2019-05-14 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US10441301B2 (en) | 2014-06-13 | 2019-10-15 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US10265086B2 (en) | 2014-06-30 | 2019-04-23 | Neuravi Limited | System for removing a clot from a blood vessel |
US9918718B2 (en) | 2014-08-08 | 2018-03-20 | DePuy Synthes Products, Inc. | Embolic coil delivery system with retractable mechanical release mechanism |
TWI789782B (en) | 2014-09-17 | 2023-01-11 | 美商亞提歐醫藥公司 | Medical system |
US11253278B2 (en) | 2014-11-26 | 2022-02-22 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
EP3223723B1 (en) | 2014-11-26 | 2020-01-08 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
US10617435B2 (en) | 2014-11-26 | 2020-04-14 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
WO2017106567A1 (en) | 2015-12-15 | 2017-06-22 | Nsvascular, Inc. | Intrasaccular thin-film flow diverters and related methods |
US10555738B2 (en) * | 2016-05-18 | 2020-02-11 | Microvention, Inc. | Embolic containment |
WO2017201316A1 (en) * | 2016-05-18 | 2017-11-23 | Microvention, Inc. | Embolic containment |
US10285710B2 (en) | 2016-06-01 | 2019-05-14 | DePuy Synthes Products, Inc. | Endovascular detachment system with flexible distal end and heater activated detachment |
AU2017312421A1 (en) | 2016-08-17 | 2019-03-07 | Neuravi Limited | A clot retrieval system for removing occlusive clot from a blood vessel |
MX2019002565A (en) | 2016-09-06 | 2019-09-18 | Neuravi Ltd | A clot retrieval device for removing occlusive clot from a blood vessel. |
US10292851B2 (en) | 2016-09-30 | 2019-05-21 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
JP7183153B2 (en) * | 2016-10-04 | 2022-12-05 | マイクロベンション インコーポレイテッド | Methods and apparatus for stent delivery |
US10517708B2 (en) | 2016-10-26 | 2019-12-31 | DePuy Synthes Products, Inc. | Multi-basket clot capturing device |
US20200069836A1 (en) * | 2016-12-13 | 2020-03-05 | Beijing Advanced Medical Technologies, Ltd. Inc. | Polymer-based arterial hemangioma embolization device, manufacturing method and application of same |
US10905853B2 (en) | 2017-01-17 | 2021-02-02 | DePuy Synthes Products, Inc. | System and method for delivering a catheter |
US10881497B2 (en) | 2017-01-26 | 2021-01-05 | DePuy Synthes Products, Inc. | Composite vascular flow diverter |
CN110545739A (en) * | 2017-02-23 | 2019-12-06 | 德普伊新特斯产品公司 | aneurysm devices and delivery systems |
US20210386429A1 (en) * | 2017-03-24 | 2021-12-16 | Metactive Medical, Inc. | Medical devices comprising detachable balloons and methods of manufacturing and use |
WO2018183624A1 (en) | 2017-03-29 | 2018-10-04 | The Regents Of The University Of Colorado, A Body Corporate | Reverse thermal gels and their use as vascular embolic repair agents |
CN107007316A (en) * | 2017-05-22 | 2017-08-04 | 杨澄宇 | It is implanted into the device of the abnormal swelling part of ductus arteriosus wall |
US10806462B2 (en) | 2017-12-21 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube and cylindrical coupling |
CN107865681A (en) * | 2017-12-22 | 2018-04-03 | 贺迎坤 | A kind of intracapsular embolism guiding device and aneurysm treatment device |
US10751065B2 (en) | 2017-12-22 | 2020-08-25 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
WO2019188663A1 (en) * | 2018-03-29 | 2019-10-03 | テルモ株式会社 | Embolic material and method of manufacturing same |
US10786259B2 (en) | 2018-03-30 | 2020-09-29 | DePuy Synthes Products, Inc. | Split balloon assist device and method for using the same |
US10918390B2 (en) | 2018-03-30 | 2021-02-16 | DePuy Synthes Products, Inc. | Helical balloon assist device and method for using the same |
US10806461B2 (en) | 2018-04-27 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube |
US11058430B2 (en) | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11596412B2 (en) | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10898216B2 (en) | 2018-06-13 | 2021-01-26 | DePuy Synthes Products, Inc. | Vasculature obstruction capture device |
AU2019204522A1 (en) | 2018-07-30 | 2020-02-13 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US10905431B2 (en) | 2018-08-03 | 2021-02-02 | DePuy Synthes Products, Inc. | Spiral delivery system for embolic braid |
US10456280B1 (en) | 2018-08-06 | 2019-10-29 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US11051825B2 (en) | 2018-08-08 | 2021-07-06 | DePuy Synthes Products, Inc. | Delivery system for embolic braid |
US10813780B2 (en) | 2018-08-08 | 2020-10-27 | DePuy Synthes Products, Inc. | Intraluminal implant delivery system and method |
US10842498B2 (en) | 2018-09-13 | 2020-11-24 | Neuravi Limited | Systems and methods of restoring perfusion to a vessel |
JP2020044335A (en) | 2018-09-20 | 2020-03-26 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | Stent with shaped wire |
US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
US11406416B2 (en) | 2018-10-02 | 2022-08-09 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
US11076861B2 (en) | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11147562B2 (en) | 2018-12-12 | 2021-10-19 | DePuy Synthes Products, Inc. | Systems and methods for embolic implant detachment |
US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
US11272939B2 (en) | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
US11273285B2 (en) | 2019-02-07 | 2022-03-15 | DePuy Synthes Products, Inc. | Ancillary device for detaching implants |
JP2020142074A (en) | 2019-03-04 | 2020-09-10 | ニューラヴィ・リミテッド | Actuated clot retrieval catheter |
US11382633B2 (en) | 2019-03-06 | 2022-07-12 | DePuy Synthes Products, Inc. | Strut flow diverter for cerebral aneurysms and methods for preventing strut entanglement |
US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
USD959659S1 (en) | 2019-05-10 | 2022-08-02 | DePuy Synthes Products, Inc. | Implant release handle |
US11602350B2 (en) | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
US10653425B1 (en) | 2019-05-21 | 2020-05-19 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
US11109939B2 (en) | 2019-06-14 | 2021-09-07 | DePuy Synthes Products, Inc. | Intravascular devices with radiopaque body markers |
US11406403B2 (en) | 2019-06-14 | 2022-08-09 | Neuravi Limited | Visibility of mechanical thrombectomy device during diagnostic imaging |
US11253265B2 (en) | 2019-06-18 | 2022-02-22 | DePuy Synthes Products, Inc. | Pull wire detachment for intravascular devices |
US11207494B2 (en) | 2019-07-03 | 2021-12-28 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11426174B2 (en) | 2019-10-03 | 2022-08-30 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant mechanical release |
US11395675B2 (en) | 2019-07-11 | 2022-07-26 | DePuy Synthes Products, Inc. | Clot retriever cleaning for reinsertion |
EP3791815A1 (en) | 2019-09-11 | 2021-03-17 | Neuravi Limited | Expandable mouth catheter |
US11439403B2 (en) | 2019-09-17 | 2022-09-13 | DePuy Synthes Products, Inc. | Embolic coil proximal connecting element and stretch resistant fiber |
US11712231B2 (en) | 2019-10-29 | 2023-08-01 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
US11376013B2 (en) | 2019-11-18 | 2022-07-05 | DePuy Synthes Products, Inc. | Implant delivery system with braid cup formation |
US11628282B2 (en) | 2019-11-25 | 2023-04-18 | Neuravi Limited | No preparation balloon guide catheter |
US11779364B2 (en) | 2019-11-27 | 2023-10-10 | Neuravi Limited | Actuated expandable mouth thrombectomy catheter |
US11839725B2 (en) | 2019-11-27 | 2023-12-12 | Neuravi Limited | Clot retrieval device with outer sheath and inner catheter |
US11517340B2 (en) | 2019-12-03 | 2022-12-06 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
US11457922B2 (en) | 2020-01-22 | 2022-10-04 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11432822B2 (en) | 2020-02-14 | 2022-09-06 | DePuy Synthes Products, Inc. | Intravascular implant deployment system |
US11944327B2 (en) | 2020-03-05 | 2024-04-02 | Neuravi Limited | Expandable mouth aspirating clot retrieval catheter |
US11633198B2 (en) | 2020-03-05 | 2023-04-25 | Neuravi Limited | Catheter proximal joint |
US11883043B2 (en) | 2020-03-31 | 2024-01-30 | DePuy Synthes Products, Inc. | Catheter funnel extension |
US11759217B2 (en) | 2020-04-07 | 2023-09-19 | Neuravi Limited | Catheter tubular support |
US11871946B2 (en) | 2020-04-17 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11730501B2 (en) | 2020-04-17 | 2023-08-22 | Neuravi Limited | Floating clot retrieval device for removing clots from a blood vessel |
US11717308B2 (en) | 2020-04-17 | 2023-08-08 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
US11737771B2 (en) | 2020-06-18 | 2023-08-29 | Neuravi Limited | Dual channel thrombectomy device |
US11937836B2 (en) | 2020-06-22 | 2024-03-26 | Neuravi Limited | Clot retrieval system with expandable clot engaging framework |
US11439418B2 (en) | 2020-06-23 | 2022-09-13 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11395669B2 (en) | 2020-06-23 | 2022-07-26 | Neuravi Limited | Clot retrieval device with flexible collapsible frame |
US11951026B2 (en) | 2020-06-30 | 2024-04-09 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with flexible braid section |
US11864781B2 (en) | 2020-09-23 | 2024-01-09 | Neuravi Limited | Rotating frame thrombectomy device |
US11786698B2 (en) | 2020-12-08 | 2023-10-17 | DePuy Synthes Products, Inc. | Catheter with textured surface |
US11826520B2 (en) | 2020-12-08 | 2023-11-28 | DePuy Synthes Products, Inc. | Catheter designs for enhanced column strength |
US11937837B2 (en) | 2020-12-29 | 2024-03-26 | Neuravi Limited | Fibrin rich / soft clot mechanical thrombectomy device |
US11872354B2 (en) | 2021-02-24 | 2024-01-16 | Neuravi Limited | Flexible catheter shaft frame with seam |
EP4308013A1 (en) | 2021-03-16 | 2024-01-24 | Covidien LP | Injectable biopolymer compositions and associated systems and methods |
CN113180753B (en) * | 2021-04-29 | 2023-06-09 | 中国人民解放军总医院第六医学中心 | Bead blanket type room interval perforation progressive repair sheet |
US11937839B2 (en) | 2021-09-28 | 2024-03-26 | Neuravi Limited | Catheter with electrically actuated expandable mouth |
WO2023086680A1 (en) * | 2021-11-15 | 2023-05-19 | Raney Aidan | Three-dimensional protective device |
US11937824B2 (en) | 2021-12-30 | 2024-03-26 | DePuy Synthes Products, Inc. | Implant detachment systems with a modified pull wire |
US11844490B2 (en) | 2021-12-30 | 2023-12-19 | DePuy Synthes Products, Inc. | Suture linkage for inhibiting premature embolic implant deployment |
US11937825B2 (en) | 2022-03-02 | 2024-03-26 | DePuy Synthes Products, Inc. | Hook wire for preventing premature embolic implant detachment |
WO2023168081A2 (en) * | 2022-03-03 | 2023-09-07 | Polyembo, LLC | Occlusive device with self-expanding struts |
US11937826B2 (en) | 2022-03-14 | 2024-03-26 | DePuy Synthes Products, Inc. | Proximal link wire for preventing premature implant detachment |
WO2023248986A1 (en) * | 2022-06-22 | 2023-12-28 | 株式会社カネカ | Embolic device |
US20240032932A1 (en) | 2022-07-29 | 2024-02-01 | Covidien Lp | Devices, systems, and methods for treating aneurysms |
US20240032933A1 (en) | 2022-07-30 | 2024-02-01 | Covidien Lp | Devices, systems, and methods for treating aneurysms |
Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5304194A (en) * | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5749891A (en) * | 1995-06-06 | 1998-05-12 | Target Therapeutics, Inc. | Multiple layered vaso-occlusive coils |
US6238403B1 (en) * | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US6322576B1 (en) * | 1997-08-29 | 2001-11-27 | Target Therapeutics, Inc. | Stable coil designs |
US20020026210A1 (en) * | 2000-08-11 | 2002-02-28 | Abdel-Gawwad Hesham M. | Endovascular aneurysm treatment device and method |
US20030212419A1 (en) * | 2001-06-14 | 2003-11-13 | West Clinton B. | Aneurysm embolization device and deployment system |
US20050267527A1 (en) * | 2002-04-01 | 2005-12-01 | Bobby Presley | Method and barrier for limiting fluid movement through a tissue rent |
US20050267510A1 (en) * | 2004-05-26 | 2005-12-01 | Nasser Razack | Device for the endovascular treatment of intracranial aneurysms |
US20050278023A1 (en) * | 2004-06-10 | 2005-12-15 | Zwirkoski Paul A | Method and apparatus for filling a cavity |
US7029494B2 (en) * | 2002-02-08 | 2006-04-18 | Scimed Life Systems, Inc. | Braided modular stent with hourglass-shaped interfaces |
US20060116712A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US20060116713A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US7481821B2 (en) * | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
US20090025820A1 (en) * | 2007-07-25 | 2009-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090076540A1 (en) * | 1999-06-02 | 2009-03-19 | Marks Michael P | Intracorporeal Occlusive Device And Method |
US20090112251A1 (en) * | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090155367A1 (en) * | 2005-10-31 | 2009-06-18 | Neuwirth Robert S | Occlusion of Fallopian Tubes |
US20090187214A1 (en) * | 2008-01-18 | 2009-07-23 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion device |
US20090306702A1 (en) * | 2004-08-23 | 2009-12-10 | Elina Miloslavski | Device for the Removal of Thrombi |
US7744583B2 (en) * | 2003-02-03 | 2010-06-29 | Boston Scientific Scimed | Systems and methods of de-endothelialization |
US20100228184A1 (en) * | 2008-09-04 | 2010-09-09 | Curaseal Inc. | Inflatable device for enteric fistula treatment |
US20120330341A1 (en) * | 2011-06-22 | 2012-12-27 | Becking Frank P | Folded-Flat Aneurysm Embolization Devices |
US8398670B2 (en) * | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US9301769B2 (en) * | 2011-03-09 | 2016-04-05 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US9314248B2 (en) * | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
Family Cites Families (342)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3012210A (en) | 1959-06-04 | 1961-12-05 | Donald J Nigg | Directional couplers |
US5041090A (en) * | 1988-01-12 | 1991-08-20 | Scheglov Viktor I | Occluding device |
USRE42625E1 (en) | 1990-03-13 | 2011-08-16 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5354295A (en) | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5405379A (en) | 1990-07-26 | 1995-04-11 | Lane; Rodney J. | Self expanding vascular endoprosthesis for aneurysms |
US5749895A (en) * | 1991-02-13 | 1998-05-12 | Fusion Medical Technologies, Inc. | Method for bonding or fusion of biological tissue and material |
US5326350A (en) | 1992-05-11 | 1994-07-05 | Li Shu Tung | Soft tissue closure systems |
DE69332865T2 (en) | 1992-09-22 | 2003-12-04 | Boston Scient Ltd | Arrangement of a detachable embolic coil spring |
US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5284488A (en) | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
RU2089131C1 (en) | 1993-12-28 | 1997-09-10 | Сергей Апполонович Пульнев | Stent-expander |
FR2714815B1 (en) | 1994-01-10 | 1996-03-08 | Microfil Ind Sa | Elastic prosthesis to widen a duct, in particular a blood vessel. |
US5417708A (en) | 1994-03-09 | 1995-05-23 | Cook Incorporated | Intravascular treatment system and percutaneous release mechanism therefor |
US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5846261A (en) | 1994-07-08 | 1998-12-08 | Aga Medical Corp. | Percutaneous catheter directed occlusion devices |
US6123715A (en) | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
DE69529338T3 (en) | 1994-07-08 | 2007-05-31 | Ev3 Inc., Plymouth | Intravascular filter device |
US5814062A (en) | 1994-12-22 | 1998-09-29 | Target Therapeutics, Inc. | Implant delivery assembly with expandable coupling/decoupling mechanism |
DE69624525T2 (en) | 1995-03-30 | 2003-03-20 | Boston Scient Ltd | System for implanting liquid spirals with a secondary structure |
BE1009278A3 (en) | 1995-04-12 | 1997-01-07 | Corvita Europ | Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as. |
US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US8790363B2 (en) | 1995-04-20 | 2014-07-29 | DePuy Synthes Products, LLC | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US5911731A (en) | 1995-04-20 | 1999-06-15 | Target Therapeutics, Inc. | Anatomically shaped vasoocclusive devices |
US5749894A (en) | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5823198A (en) | 1996-07-31 | 1998-10-20 | Micro Therapeutics, Inc. | Method and apparatus for intravasculer embolization |
US5964797A (en) | 1996-08-30 | 1999-10-12 | Target Therapeutics, Inc. | Electrolytically deployable braided vaso-occlusion device |
US5941249A (en) | 1996-09-05 | 1999-08-24 | Maynard; Ronald S. | Distributed activator for a two-dimensional shape memory alloy |
US5980554A (en) | 1997-05-05 | 1999-11-09 | Micro Therapeutics, Inc. | Wire frame partial flow obstruction for aneurysm treatment |
US5951599A (en) | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US7569066B2 (en) | 1997-07-10 | 2009-08-04 | Boston Scientific Scimed, Inc. | Methods and devices for the treatment of aneurysms |
GB9715241D0 (en) | 1997-07-18 | 1997-09-24 | Jeffree Martin A | Device for treating aneurysms |
JP4060528B2 (en) | 1997-08-04 | 2008-03-12 | ボストン サイエンティフィック コーポレーション | Occlusion system for aneurysm treatment |
US6063070A (en) | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
DE69834920T2 (en) | 1997-08-05 | 2007-05-24 | Boston Scientific Ltd., St. Michael | REMOVABLE SYSTEM FOR CLOSING AN ANEURYSMAS NECK |
US5916235A (en) * | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US6086577A (en) | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US6159165A (en) | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
US6036720A (en) | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US6022374A (en) | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US5976169A (en) | 1997-12-16 | 1999-11-02 | Cardiovasc, Inc. | Stent with silver coating and method |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
EP1054635B1 (en) | 1998-02-10 | 2010-01-06 | Artemis Medical, Inc. | Occlusion, anchoring, tensioning or flow direction apparatus |
CN1177570C (en) | 1998-02-12 | 2004-12-01 | 托马斯·R·马罗塔 | Endovassular prosthesis |
US5925060A (en) | 1998-03-13 | 1999-07-20 | B. Braun Celsa | Covered self-expanding vascular occlusion device |
US6096021A (en) | 1998-03-30 | 2000-08-01 | The University Of Virginia Patent Foundation | Flow arrest, double balloon technique for occluding aneurysms or blood vessels |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
WO1999062432A1 (en) | 1998-06-04 | 1999-12-09 | New York University | Endovascular thin film devices and methods for treating and preventing stroke |
US6139564A (en) | 1998-06-16 | 2000-10-31 | Target Therapeutics Inc. | Minimally occlusive flow disruptor stent for bridging aneurysm necks |
US5935148A (en) | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US6165193A (en) * | 1998-07-06 | 2000-12-26 | Microvention, Inc. | Vascular embolization with an expansible implant |
US6093199A (en) | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
AU5905599A (en) | 1998-09-04 | 2000-03-27 | Boston Scientific Limited | Detachable aneurysm neck closure patch |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US7713282B2 (en) * | 1998-11-06 | 2010-05-11 | Atritech, Inc. | Detachable atrial appendage occlusion balloon |
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US6569179B2 (en) | 1998-11-10 | 2003-05-27 | Scimed Life Systems, Inc. | Bioactive three loop coil |
US6723112B2 (en) | 1998-11-10 | 2004-04-20 | Scimed Life Systems, Inc. | Bioactive three loop coil |
US6591472B1 (en) | 1998-12-08 | 2003-07-15 | Medtronic, Inc. | Multiple segment catheter and method of fabrication |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US6309384B1 (en) * | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US6368338B1 (en) | 1999-03-05 | 2002-04-09 | Board Of Regents, The University Of Texas | Occlusion method and apparatus |
US6613074B1 (en) | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US6428558B1 (en) | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
AU4606700A (en) | 1999-05-07 | 2000-11-21 | Salviac Limited | A tissue engineering scaffold |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US20020169473A1 (en) | 1999-06-02 | 2002-11-14 | Concentric Medical, Inc. | Devices and methods for treating vascular malformations |
US6379329B1 (en) * | 1999-06-02 | 2002-04-30 | Cordis Neurovascular, Inc. | Detachable balloon embolization device and method |
DE29909888U1 (en) * | 1999-06-07 | 2000-10-19 | Novomed Gmbh | Fistula blocker |
US6309367B1 (en) | 1999-07-23 | 2001-10-30 | Neurovasx, Inc. | Aneurysm shield |
US6159531A (en) | 1999-08-30 | 2000-12-12 | Cardiovasc, Inc. | Coating having biological activity and medical implant having surface carrying the same and method |
US6371980B1 (en) | 1999-08-30 | 2002-04-16 | Cardiovasc, Inc. | Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method |
US6602261B2 (en) | 1999-10-04 | 2003-08-05 | Microvention, Inc. | Filamentous embolic device with expansile elements |
US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6652555B1 (en) | 1999-10-27 | 2003-11-25 | Atritech, Inc. | Barrier device for covering the ostium of left atrial appendage |
US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US6994092B2 (en) | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
US7004977B2 (en) | 1999-11-24 | 2006-02-28 | A Enterprises, Inc. | Soft tissue substitute and method of soft tissue reformation |
US6350270B1 (en) | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
US20020043456A1 (en) | 2000-02-29 | 2002-04-18 | Ho Ken K. | Bimorphic, compositionally-graded, sputter-deposited, thin film shape memory device |
US6346117B1 (en) | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6391037B1 (en) * | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6632241B1 (en) | 2000-03-22 | 2003-10-14 | Endovascular Technologies, Inc. | Self-expanding, pseudo-braided intravascular device |
US20030114918A1 (en) | 2000-04-28 | 2003-06-19 | Garrison Michi E. | Stent graft assembly and method |
US6451050B1 (en) | 2000-04-28 | 2002-09-17 | Cardiovasc, Inc. | Stent graft and method |
US7153323B1 (en) * | 2000-06-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Aneurysm liner with multi-segment extender |
US20020147462A1 (en) | 2000-09-11 | 2002-10-10 | Closure Medical Corporation | Bronchial occlusion method and apparatus |
US6723108B1 (en) | 2000-09-18 | 2004-04-20 | Cordis Neurovascular, Inc | Foam matrix embolization device |
US6605101B1 (en) | 2000-09-26 | 2003-08-12 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
US6589265B1 (en) | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
US6852330B2 (en) | 2000-12-21 | 2005-02-08 | Depuy Mitek, Inc. | Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
US6547804B2 (en) * | 2000-12-27 | 2003-04-15 | Scimed Life Systems, Inc. | Selectively permeable highly distensible occlusion balloon |
US6494884B2 (en) | 2001-02-09 | 2002-12-17 | Concentric Medical, Inc. | Methods and devices for delivering occlusion elements |
JP2004524909A (en) | 2001-03-09 | 2004-08-19 | ジョージア テック リサーチ コーポレイション | Intravascular device and method for axial extension of blood vessels |
US6878384B2 (en) | 2001-03-13 | 2005-04-12 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
US6855153B2 (en) * | 2001-05-01 | 2005-02-15 | Vahid Saadat | Embolic balloon |
WO2002089865A2 (en) | 2001-05-04 | 2002-11-14 | Concentric Medical | Coated combination vaso-occlusive device |
WO2002089676A2 (en) | 2001-05-04 | 2002-11-14 | Concentric Medical | Hydrogel filament vaso-occlusive device |
US20030004533A1 (en) | 2001-05-04 | 2003-01-02 | Concentric Medical | Bioactive polymer vaso-occlusive device |
EP1392182A1 (en) | 2001-05-04 | 2004-03-03 | Concentric Medical | Hydrogel vaso-occlusive device |
EP1401338B1 (en) | 2001-05-29 | 2011-07-20 | Microvention, Inc. | Method of manufacturing expansile filamentous embolization devices |
US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US7011671B2 (en) | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8715312B2 (en) * | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US20030028209A1 (en) | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
US7687053B2 (en) | 2001-08-20 | 2010-03-30 | Boston Scientific Scimed, Inc. | Embolic compositions with non-cyanoacrylate rheology modifying agents |
US6802851B2 (en) | 2001-09-20 | 2004-10-12 | Gordia Neurovascular, Inc. | Stent aneurysm embolization method using collapsible member and embolic coils |
US6811560B2 (en) | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
US20030093111A1 (en) | 2001-10-26 | 2003-05-15 | Concentric Medical | Device for vaso-occlusion and interventional therapy |
JP4429589B2 (en) | 2001-11-15 | 2010-03-10 | コーディス・ニューロバスキュラー・インコーポレイテッド | Aneurysm embolization device using an occluding member |
JP2003190175A (en) | 2001-11-15 | 2003-07-08 | Cordis Neurovascular Inc | Aneurysm neck cover for sealing aneurysm |
US20030113478A1 (en) | 2001-12-12 | 2003-06-19 | Dang Mai Huong | Surface coating method and coated device |
CA2470824A1 (en) | 2001-12-21 | 2003-08-28 | Cardiovasc, Inc. | Composite stent with polymeric covering and bioactive coating |
US6723116B2 (en) | 2002-01-14 | 2004-04-20 | Syde A. Taheri | Exclusion of ascending/descending aorta and/or aortic arch aneurysm |
US6908784B1 (en) | 2002-03-06 | 2005-06-21 | Micron Technology, Inc. | Method for fabricating encapsulated semiconductor components |
US7695488B2 (en) * | 2002-03-27 | 2010-04-13 | Boston Scientific Scimed, Inc. | Expandable body cavity liner device |
US20030195553A1 (en) | 2002-04-12 | 2003-10-16 | Scimed Life Systems, Inc. | System and method for retaining vaso-occlusive devices within an aneurysm |
US20080086196A1 (en) * | 2002-06-05 | 2008-04-10 | Dfine,Inc. | Polymer matrix devices for treatment of vascular malformations |
US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
US6746890B2 (en) | 2002-07-17 | 2004-06-08 | Tini Alloy Company | Three dimensional thin film devices and methods of fabrication |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US20040034386A1 (en) | 2002-08-19 | 2004-02-19 | Michael Fulton | Aneurysm stent |
US6991617B2 (en) | 2002-08-21 | 2006-01-31 | Hektner Thomas R | Vascular treatment method and device |
US20040044391A1 (en) | 2002-08-29 | 2004-03-04 | Stephen Porter | Device for closure of a vascular defect and method of treating the same |
US8075585B2 (en) | 2002-08-29 | 2011-12-13 | Stryker Corporation | Device and method for treatment of a vascular defect |
DE60330478D1 (en) | 2002-10-10 | 2010-01-21 | Micro Therapeutics Inc | WIRE-STRENGTH MICRO-CATHETER |
AU2003303289A1 (en) * | 2002-10-23 | 2004-09-28 | Biomerix Corporation. | Aneurysm treatment devices and methods |
US20040115164A1 (en) | 2002-12-17 | 2004-06-17 | Pierce Ryan K. | Soft filament occlusive device delivery system |
US7229454B2 (en) | 2003-01-07 | 2007-06-12 | Boston Scientific Scimed, Inc. | Occlusive cinching devices and methods of use |
US7169177B2 (en) | 2003-01-15 | 2007-01-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US7943810B2 (en) | 2003-02-04 | 2011-05-17 | Buckman Robert F | Method and apparatus for hemostasis |
US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
US7569626B2 (en) | 2003-06-05 | 2009-08-04 | Dfine, Inc. | Polymer composites for biomedical applications and methods of making |
JP2007020590A (en) | 2003-08-19 | 2007-02-01 | Institute Of Physical & Chemical Research | Material for aneurysm curing |
BRPI0413867A (en) | 2003-08-26 | 2006-10-24 | Alza Corp | device and method for intradermal cell implantation |
US20070135907A1 (en) * | 2003-10-02 | 2007-06-14 | The Regents Of The University Of California | Stent with expandable foam |
US7232461B2 (en) | 2003-10-29 | 2007-06-19 | Cordis Neurovascular, Inc. | Neck covering device for an aneurysm |
WO2005051176A2 (en) | 2003-11-25 | 2005-06-09 | Boston Scientific Limited | Hemostatic pressure plug |
US20080109057A1 (en) | 2003-12-10 | 2008-05-08 | Calabria Marie F | Multiple point detacher system |
US8012210B2 (en) * | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
WO2005087114A1 (en) * | 2004-03-10 | 2005-09-22 | Philips Intellectual Property & Standards Gmbh | Catheter, apparatus and method for therapeutic embolization |
US20050228434A1 (en) | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) * | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
EP1734897A4 (en) | 2004-03-31 | 2010-12-22 | Merlin Md Pte Ltd | A method for treating aneurysms |
CA2549323C (en) | 2004-04-08 | 2009-07-21 | Aga Medical Corporation | Flanged occlusion devices and methods |
US8628564B2 (en) * | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
JP2008502378A (en) * | 2004-05-25 | 2008-01-31 | チェストナット メディカル テクノロジーズ インコーポレイテッド | Flexible vascular closure device |
BE1016067A3 (en) * | 2004-06-03 | 2006-02-07 | Frid Noureddine | Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT. |
US20050277978A1 (en) | 2004-06-09 | 2005-12-15 | Secant Medical, Llc | Three-dimensional coils for treatment of vascular aneurysms |
US7699056B2 (en) * | 2004-06-10 | 2010-04-20 | Conceptus, Inc. | Medical devices and methods of making and using such devices |
US20060028209A1 (en) | 2004-08-03 | 2006-02-09 | Michael Walker | Device to identify compression in an automotive engine cylinder |
EP1827250B1 (en) * | 2004-08-31 | 2018-05-16 | Cook Medical Technologies LLC | Device for treating an aneurysm |
US20070270902A1 (en) | 2004-09-17 | 2007-11-22 | Slazas Robert R | Thin Film Metallic Devices for Plugging Aneurysms or Vessels |
EP1788956B1 (en) | 2004-09-17 | 2011-11-09 | Codman & Shurtleff, Inc. | Vascular occlusion device with an embolic mesh ribbon |
CA2581272A1 (en) | 2004-09-22 | 2006-05-18 | Lee R. Guterman | Cranial aneurysm treatment arrangement |
CA2622893A1 (en) | 2004-10-26 | 2006-05-04 | Medical College Of Georgia Research Institute | Devices and methods for aneurysm treatment |
US20060106421A1 (en) | 2004-11-16 | 2006-05-18 | Clifford Teoh | Expansible neck bridge |
US20060116709A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US20090297582A1 (en) | 2004-11-26 | 2009-12-03 | Biomerix Corporation | Vascular occlusion devices and methods |
US20060116714A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Coupling and release devices and methods for their assembly and use |
US20060122548A1 (en) | 2004-12-06 | 2006-06-08 | Leonard Abrams | Devices and methods of treatment of wounds and burns and related impaired blood circulation problems |
US20060155323A1 (en) | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
US20060206139A1 (en) * | 2005-01-19 | 2006-09-14 | Tekulve Kurt J | Vascular occlusion device |
WO2006082493A2 (en) | 2005-02-04 | 2006-08-10 | Zuli Holdings, Ltd. | Device and methods for non-surgical clipping of aneurysms |
US20060190070A1 (en) | 2005-02-23 | 2006-08-24 | Dieck Martin S | Rail stent and methods of use |
US20060206140A1 (en) | 2005-02-24 | 2006-09-14 | Samuel Shaolian | Adjustable embolic aneurysm coil |
WO2006096449A2 (en) | 2005-03-03 | 2006-09-14 | Hines Richard A | Endovascular aneurysm treatment device and delivery system |
US20060206198A1 (en) | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices and methods |
US20060206199A1 (en) | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices |
US7799052B2 (en) | 2005-06-02 | 2010-09-21 | Codman & Shurtleff, Inc. | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7708754B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff, Pc | Stretch resistant embolic coil delivery system with mechanical release mechanism |
WO2007006139A1 (en) * | 2005-07-12 | 2007-01-18 | Smart Biotech Inc. | Aneurysm occlusion device |
US20070014831A1 (en) | 2005-07-12 | 2007-01-18 | Hsing-Wen Sung | Biodegradable occlusive device with moisture memory |
JP2009506802A (en) | 2005-08-10 | 2009-02-19 | エヌフォーカス ニューロメディカル, インコーポレイテッド | Restenosis prevention treatment device |
US8007509B2 (en) | 2005-10-12 | 2011-08-30 | Boston Scientific Scimed, Inc. | Coil assemblies, components and methods |
WO2007051179A2 (en) | 2005-10-27 | 2007-05-03 | Nfocus Neuromedical Inc. | Partially covered stent devices and methods of use |
WO2007076179A2 (en) | 2005-11-17 | 2007-07-05 | Microvention, Inc. | Three-dimensional complex coil |
WO2007076480A2 (en) | 2005-12-23 | 2007-07-05 | Levy Elad I | Bifurcated aneurysm treatment arrangement |
WO2007079402A2 (en) | 2005-12-31 | 2007-07-12 | Levy Elad I | Bifurcation aneurysm treatment stent with distal web |
US20070167877A1 (en) | 2006-01-17 | 2007-07-19 | Euteneuer Charles L | Medical catheters and methods |
US20070167972A1 (en) | 2006-01-17 | 2007-07-19 | Euteneuer Charles L | Balloon apparatus and methods |
US20070167876A1 (en) | 2006-01-17 | 2007-07-19 | Euteneuer Charles L | Occluding guidewire and methods |
US7744652B2 (en) | 2006-01-23 | 2010-06-29 | Hesham Morsi | Aneurysm sealing device |
WO2007090127A2 (en) * | 2006-01-30 | 2007-08-09 | Surgica Corporation | Compressible intravascular embolization particles and related methods and delivery systems |
WO2007090150A2 (en) | 2006-01-31 | 2007-08-09 | Cook Biotech Incorporated | Fistula grafts and related methods and systems for treating fistulae |
US7942894B2 (en) | 2006-01-31 | 2011-05-17 | Codman & Shurtleff, Inc. | Embolic device delivery system |
US20070179507A1 (en) * | 2006-01-31 | 2007-08-02 | Bhavin Shah | Fistula graft deployment systems and methods |
US20070185442A1 (en) | 2006-02-03 | 2007-08-09 | Starfire Medical, Inc. | Rapid balloon coupling system |
US20070185443A1 (en) | 2006-02-03 | 2007-08-09 | Starfire Medical, Inc. | Vascular therapy delivery system |
US20070185444A1 (en) | 2006-02-03 | 2007-08-09 | Starfire Medical, Inc. | Vascular clip-on occlusion system |
US20070185457A1 (en) | 2006-02-03 | 2007-08-09 | Starfire Medical, Inc. | Vascular occlusion delivery |
US20090318941A1 (en) * | 2006-03-24 | 2009-12-24 | Biomerix Corporation | Self-Expandable Endovascular Device For Aneurysm Occlusion |
CN2904981Y (en) * | 2006-04-03 | 2007-05-30 | 孟坚 | Medical occluding device |
CA2649702C (en) | 2006-04-17 | 2014-12-09 | Microtherapeutics, Inc. | System and method for mechanically positioning intravascular implants |
WO2007134266A2 (en) | 2006-05-12 | 2007-11-22 | Electroformed Stents, Inc. | Exclusion device and system for delivery |
US20070276427A1 (en) | 2006-05-26 | 2007-11-29 | Charles Louis Euteneuer | Torquable balloon catheters and methods |
US20070276426A1 (en) | 2006-05-26 | 2007-11-29 | Charles Louis Euteneuer | Steerable balloon catheters and methods |
CN101500623B (en) | 2006-06-15 | 2016-08-24 | 微温森公司 | A kind of embolization device being made up of expandable polymer |
EP2056745A2 (en) | 2006-08-17 | 2009-05-13 | Nfocus Neuromedical Inc. | Aneurysm covering devices and delivery devices |
AU2007285800A1 (en) | 2006-08-17 | 2008-02-21 | Nfocus Neuromedical, Inc. | Isolation devices for the treatment of aneurysms |
US8460335B2 (en) | 2006-09-11 | 2013-06-11 | Embrella Cardiovascular, Inc. | Method of deflecting emboli from the cerebral circulation |
US7557167B2 (en) | 2006-09-28 | 2009-07-07 | Gore Enterprise Holdings, Inc. | Polyester compositions, methods of manufacturing said compositions, and articles made therefrom |
US7901444B2 (en) | 2006-09-29 | 2011-03-08 | Codman & Shurtleff, Inc. | Embolic coil delivery system with mechanical release mechanism |
DE102006050385A1 (en) * | 2006-10-05 | 2008-04-10 | pfm Produkte für die Medizin AG | Implantable mechanism for use in human and/or animal body for e.g. closing atrium septum defect, has partial piece that is folded back on another partial piece from primary form into secondary form of carrying structure |
WO2008063455A1 (en) | 2006-11-13 | 2008-05-29 | Hines Richard A | Over-the wire exclusion device and system for delivery |
WO2008064206A2 (en) | 2006-11-20 | 2008-05-29 | Boston Scientific Scimed, Inc. | Mechanically detachable vaso-occlusive device |
WO2008074027A1 (en) * | 2006-12-13 | 2008-06-19 | Biomerix Corporation | Aneurysm occlusion devices |
US8333783B2 (en) | 2007-02-16 | 2012-12-18 | Reverse Medical Corporation | Occlusion device and method of use |
US8425541B2 (en) | 2007-04-27 | 2013-04-23 | Wisconsin Alumni Research Foundation | Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent |
US20110022149A1 (en) | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
US8540760B2 (en) * | 2007-07-11 | 2013-09-24 | Cook Medical Technologies Llc | Tubular devices having reversible components for deployment of endoluminal occluders and related methods and systems |
US20090024224A1 (en) * | 2007-07-16 | 2009-01-22 | Chen Silvia S | Implantation of cartilage |
EP2180839A4 (en) | 2007-08-06 | 2013-08-28 | Michael R Henson | Thrombectomy system and method |
US8100129B2 (en) | 2007-08-28 | 2012-01-24 | Conceptus, Inc. | Methods and devices for occluding an ovarian pathway |
WO2009036219A1 (en) | 2007-09-11 | 2009-03-19 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
WO2009052432A2 (en) * | 2007-10-19 | 2009-04-23 | Coherex Medical, Inc. | Medical device for modification of left atrial appendange and related systems and methods |
US8980299B2 (en) * | 2007-10-31 | 2015-03-17 | Cordis Corporation | Method of making a vascular closure device |
US9492149B2 (en) * | 2007-11-13 | 2016-11-15 | Cook Biotech Incorporated | Fistula grafts and related methods and systems useful for treating gastrointestinal and other fistulae |
WO2009070686A1 (en) * | 2007-11-30 | 2009-06-04 | Cook Biotech Incorporated | Expandable plugs and related delivery apparatuses and methods |
EP2217151A1 (en) | 2007-12-03 | 2010-08-18 | Kolo Technologies, Inc. | Ultrasound scanner built with capacitive micromachined ultrasonic transducers (cmuts) |
US8956475B2 (en) | 2007-12-11 | 2015-02-17 | Howard Riina | Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen |
WO2009089016A1 (en) | 2008-01-08 | 2009-07-16 | Southeastern Medical Technologies, Llc | A methods and apparatuses for the treatment of wounds with pressures altered from atmospheric |
EP2262443A2 (en) | 2008-03-10 | 2010-12-22 | NFocus Neuromedical, Inc. | Stents and stent grafts |
WO2009121006A1 (en) | 2008-03-27 | 2009-10-01 | Nfocus Neuromedical, Inc. | Friction-release distal latch implant delivery system and components |
JP2011517424A (en) | 2008-04-08 | 2011-06-09 | リバース メディカル コーポレイション | Occlusion device and method of use |
EP2633823B1 (en) | 2008-04-21 | 2016-06-01 | Covidien LP | Braid-ball embolic devices and delivery systems |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
CN102083493A (en) * | 2008-05-01 | 2011-06-01 | 安纽克罗斯有限责任公司 | Aneurysm occlusion device |
US11464518B2 (en) | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
US20160206321A1 (en) | 2008-05-01 | 2016-07-21 | Aneuclose Llc | Aneurysm Occlusion Device with Sequence of Shape-Changing Embolic Members |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
CN106974691A (en) | 2008-05-02 | 2017-07-25 | 斯昆特医疗公司 | Thread device for treating vascular defects |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US20090318892A1 (en) | 2008-06-20 | 2009-12-24 | Maria Aboytes | Removable Core Implant Delivery Catheter |
CA2729750C (en) | 2008-07-03 | 2017-06-06 | Hotspur Technologies, Inc. | Apparatus and method comprising an expandable balloon or member for treating obstructions within body lumens |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
GB0813542D0 (en) | 2008-07-24 | 2008-08-27 | Brightwake Ltd | Material for use as a wound packing element in particulary negative pressure wound therapy (NPWT) |
US9351715B2 (en) | 2008-07-24 | 2016-05-31 | St. Jude Medical, Cardiology Division, Inc. | Multi-layered medical device for treating a target site and associated method |
US9232992B2 (en) * | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
US8388650B2 (en) * | 2008-09-05 | 2013-03-05 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
WO2010027363A1 (en) | 2008-09-05 | 2010-03-11 | Merlin Md Pte Ltd | Endovascular device |
EP2522376B1 (en) | 2008-10-17 | 2020-01-08 | Sofradim Production | Method for preparing auto-sealant matrix for tissue repair |
US8470013B2 (en) | 2008-10-20 | 2013-06-25 | Imds Corporation | Systems and methods for aneurysm treatment and vessel occlusion |
US9211202B2 (en) | 2008-10-24 | 2015-12-15 | Wisconsin Alumni Research Foundation | Apparatus and method for treating an aneurysm |
US8986338B2 (en) | 2008-10-29 | 2015-03-24 | Cook Biotech Incorporated | Vascular plugs |
US20100131002A1 (en) | 2008-11-24 | 2010-05-27 | Connor Robert A | Stent with a net layer to embolize and aneurysm |
US10363389B2 (en) | 2009-04-03 | 2019-07-30 | Scientia Vascular, Llc | Micro-fabricated guidewire devices having varying diameters |
CN105459189B (en) | 2008-12-08 | 2018-05-08 | 血管科学有限公司 | Multiple notch are formed to form the system and method for product along the length of stock |
JP4312255B1 (en) | 2008-12-22 | 2009-08-12 | 規方 田熊 | Aneurysm embolizer and method of handling the same |
CN101779992B (en) | 2009-01-19 | 2012-08-22 | 加奇生物科技(上海)有限公司 | Conveying device for retrievable self-eject nervi cerebrales stent |
WO2010102254A2 (en) | 2009-03-06 | 2010-09-10 | The Regents Of The University Of California | Thin film vascular stent and biocompatible surface treatment |
US9067332B2 (en) | 2009-04-03 | 2015-06-30 | Scientia Vascular, Llc | Micro-fabricated catheter devices formed with hybrid materials |
US20100256603A1 (en) | 2009-04-03 | 2010-10-07 | Scientia Vascular, Llc | Micro-fabricated Catheter Devices Formed Having Elastomeric Fill Compositions |
US9067333B2 (en) | 2009-04-03 | 2015-06-30 | Scientia Vascular, Llc | Micro-fabricated guidewire devices having elastomeric fill compositions |
US20100256604A1 (en) | 2009-04-03 | 2010-10-07 | Scientia Vascular, Llc | Micro-fabricated Catheter Devices Formed Having Elastomeric Compositions |
US9950137B2 (en) | 2009-04-03 | 2018-04-24 | Scientia Vascular, Llc | Micro-fabricated guidewire devices formed with hybrid materials |
US9616195B2 (en) | 2009-04-03 | 2017-04-11 | Scientia Vascular, Llc | Micro-fabricated catheter devices having varying diameters |
CN102596083B (en) | 2009-04-15 | 2016-11-16 | 微排放器公司 | Implant delivery system |
EP2421482B1 (en) | 2009-04-20 | 2019-11-13 | Achieva Medical Limited | Delivery assembly for occlusion device using mechanical interlocking coupling mechanism |
US20100274276A1 (en) | 2009-04-22 | 2010-10-28 | Ricky Chow | Aneurysm treatment system, device and method |
US8475490B2 (en) | 2009-06-05 | 2013-07-02 | Ethicon Endo-Surgery, Inc. | Methods and devices for providing access through tissue to a surgical site |
US20120010644A1 (en) * | 2009-07-09 | 2012-01-12 | Sideris Eleftherios B | Method and apparatus for occluding a physiological opening |
GB0916689D0 (en) * | 2009-09-23 | 2009-11-04 | Parton Adrian | Sample preparation device |
US20110077620A1 (en) | 2009-09-30 | 2011-03-31 | Debeer Nicholas C | Guide Catheters |
US20110152993A1 (en) | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
US20110202085A1 (en) | 2009-11-09 | 2011-08-18 | Siddharth Loganathan | Braid Ball Embolic Device Features |
US8137293B2 (en) * | 2009-11-17 | 2012-03-20 | Boston Scientific Scimed, Inc. | Guidewires including a porous nickel-titanium alloy |
DE102009056449A1 (en) | 2009-12-01 | 2011-06-09 | Acandis Gmbh & Co. Kg | Medical device |
US8906057B2 (en) * | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
US9468442B2 (en) * | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
CN102933161A (en) | 2010-02-08 | 2013-02-13 | 萨帕斯医药有限公司 | Method and device for treating cerebrovascular pathologies and delivery system therefor |
US9247942B2 (en) | 2010-06-29 | 2016-02-02 | Artventive Medical Group, Inc. | Reversible tubal contraceptive device |
US20120116350A1 (en) | 2010-07-07 | 2012-05-10 | Reverse Medical Corporation | Translation dilator and stand alone vascular guide catheter |
CN101933839B (en) | 2010-08-26 | 2013-09-25 | 先健科技(深圳)有限公司 | Connecting device for mediatory type medical devices and using method thereof |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
EP3354210B1 (en) | 2010-09-10 | 2022-10-26 | Covidien LP | Devices for the treatment of vascular defects |
US20130066357A1 (en) | 2010-09-10 | 2013-03-14 | Maria Aboytes | Devices and methods for the treatment of vascular defects |
US20120143243A1 (en) * | 2010-12-03 | 2012-06-07 | Boston Scientific Scimed, Inc. | Closure devices |
WO2012078678A1 (en) * | 2010-12-06 | 2012-06-14 | Tyco Healthcare Group Lp | Vascular remodeling device |
US11484318B2 (en) | 2011-01-17 | 2022-11-01 | Artio Medical, Inc. | Expandable body device and method of use |
CA2824284C (en) | 2011-01-17 | 2020-10-27 | Novita Therapeutics, Llc | Ballstent device and methods of use |
DE102011011869A1 (en) | 2011-02-22 | 2012-08-23 | Phenox Gmbh | implant |
US10028745B2 (en) | 2011-03-30 | 2018-07-24 | Noha, Llc | Advanced endovascular clip and method of using same |
CN202313544U (en) * | 2011-04-27 | 2012-07-11 | 郭伟 | Aorta interlayer crevasse plugging umbrella |
US20120283768A1 (en) * | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
DE102011102933B4 (en) | 2011-05-31 | 2018-05-03 | Acandis Gmbh & Co. Kg | Medical implant for placement within a hollow body, in particular an aneurysm |
US8641777B2 (en) | 2011-06-03 | 2014-02-04 | Reverse Medical Corporation | Embolic implant and method of use |
US9427233B2 (en) | 2011-06-06 | 2016-08-30 | Cook Medical Technologies, LLC | Vascular occlusion devices and methods |
US20120316632A1 (en) | 2011-06-13 | 2012-12-13 | Bulang Gao | Retrievable covered stent for bifurcation aneurysms |
US8915941B2 (en) | 2011-06-14 | 2014-12-23 | Cook Medical Technologies Llc | Fistula closure devices and methods |
US8621975B2 (en) | 2011-09-20 | 2014-01-07 | Aga Medical Corporation | Device and method for treating vascular abnormalities |
US8993831B2 (en) * | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
WO2013112944A1 (en) | 2012-01-26 | 2013-08-01 | Endoshape, Inc. | Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control |
EP2825242A4 (en) | 2012-03-15 | 2016-03-30 | Medina Medical Inc | Devices and methods for the treatment of vascular defects |
WO2014028913A1 (en) | 2012-08-17 | 2014-02-20 | The Regents Of The University Of California | Dual rotational stent apparatus and method for endovascular treatment of aneurysms |
WO2014029835A1 (en) | 2012-08-22 | 2014-02-27 | Phenox Gmbh | Implant |
CA2889805C (en) | 2012-10-31 | 2018-05-01 | Evysio Medical Devices Ulc | Endovascular prosthesis and method for delivery of an endovascular prosthesis |
KR102309795B1 (en) | 2012-11-13 | 2021-10-08 | 코비디엔 엘피 | Occlusive devices |
US10716549B2 (en) | 2013-03-05 | 2020-07-21 | St. Jude Medical, Cardiology Division, Inc. | Medical device for treating a target site |
US9681861B2 (en) | 2013-03-11 | 2017-06-20 | St. Jude Medical, Cardiology Division, Inc. | Percutaneous catheter directed collapsible medical closure device |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
CN108433769B (en) | 2013-03-15 | 2021-06-08 | 柯惠有限合伙公司 | Occlusion device |
US20140316012A1 (en) | 2013-03-15 | 2014-10-23 | Toby Freyman | In-Situ Forming Foams for Embolizing or Occluding a Cavity |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
GB2520482B (en) | 2013-11-15 | 2015-12-23 | Cook Medical Technologies Llc | Aneurysm closure device |
JP5695259B1 (en) | 2014-02-19 | 2015-04-01 | 株式会社World Medish | High flexibility stent |
US20160066921A1 (en) | 2014-02-21 | 2016-03-10 | Neuravi Limited | DEVICE AND METHOD FOR ENDOVASCULAR TREATMENT OF ANEURYSMS USING EMBOLIC ePTFE |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
WO2015160721A1 (en) | 2014-04-14 | 2015-10-22 | Sequent Medical Inc. | Devices for therapeutic vascular procedures |
US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
MX2016014236A (en) | 2014-04-30 | 2017-05-30 | Cerus Endovascular Ltd | Occlusion device. |
JP2017515567A (en) | 2014-05-12 | 2017-06-15 | トマス,ジェフリー,イー. | Intracranial stent and embolic coil coated with photon activated gel |
US10182801B2 (en) | 2014-05-16 | 2019-01-22 | Silk Road Medical, Inc. | Vessel access and closure assist system and method |
US10595875B2 (en) | 2014-12-31 | 2020-03-24 | Endostream Medical Ltd. | Device for restricting blood flow to aneurysms |
JP6763864B2 (en) | 2015-01-20 | 2020-09-30 | ニューロガミ メディカル インコーポレイテッド | Micrografts and usage for the treatment of intracranial aneurysms |
BR112017017882B1 (en) | 2015-02-25 | 2023-04-11 | Galaxy Therapeutics, Inc | Apparatus for treating an aneurysm in a blood vessel |
CN105105812A (en) | 2015-09-18 | 2015-12-02 | 王奎重 | Intracranial aneurysm interventional embolization treatment device |
US10814045B2 (en) | 2015-10-30 | 2020-10-27 | Balt Usa | Devices and methods for aneurysm treatment |
JP6892188B2 (en) | 2015-12-07 | 2021-06-23 | シーラス エンドバスキュラー リミテッド | Blocking device |
CN114732470A (en) | 2015-12-30 | 2022-07-12 | 斯瑞克公司 | Embolization device and method of making same |
CN109620333B (en) | 2016-02-10 | 2022-03-08 | 微仙美国有限公司 | Occlusion device for medical treatment of vascular diseases |
EP3912569A1 (en) | 2016-06-10 | 2021-11-24 | Terumo Corporation | Vessel occluder |
US20180049859A1 (en) | 2016-08-16 | 2018-02-22 | Spartan Micro, Inc. | Intravascular flow diversion devices |
US20190209178A1 (en) | 2016-09-14 | 2019-07-11 | Medinol Ltd. | Aneurysm closure device |
US10576099B2 (en) | 2016-10-21 | 2020-03-03 | Covidien Lp | Injectable scaffold for treatment of intracranial aneurysms and related technology |
CN108056798B (en) | 2016-11-08 | 2021-06-04 | 艾柯医疗器械(北京)有限公司 | Support pushing system, corresponding blood flow guiding device and blood flow guiding device assembling method |
US20180206848A1 (en) | 2016-12-05 | 2018-07-26 | Daniel E. Walzman | Alternative Use for Hydrogel Intrasaccular Occlusion Device with Radial Bars for Structural Support |
US20180161185A1 (en) | 2016-12-14 | 2018-06-14 | eLum Technologies, Inc. | Electrospun stents, flow diverters, and occlusion devices and methods of making the same |
US10653426B2 (en) | 2017-01-06 | 2020-05-19 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
GB2558920A (en) | 2017-01-20 | 2018-07-25 | Cook Medical Technologies Llc | Aneurysm treatment apparatus |
EP3668417B1 (en) | 2017-08-17 | 2022-10-05 | Arissa Medical, Inc. | Flow attenuation device |
US11185335B2 (en) | 2018-01-19 | 2021-11-30 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US11076861B2 (en) | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11504816B2 (en) | 2019-11-04 | 2022-11-22 | Covidien Lp | Systems and methods for treating aneurysms |
-
2013
- 2013-11-13 KR KR1020207012039A patent/KR102309795B1/en active IP Right Grant
- 2013-11-13 US US14/079,587 patent/US20140135810A1/en not_active Abandoned
- 2013-11-13 WO PCT/US2013/069955 patent/WO2014078458A2/en active Application Filing
- 2013-11-13 EP EP19173571.1A patent/EP3574850B1/en active Active
- 2013-11-13 CN CN201810340348.3A patent/CN108354645A/en active Pending
- 2013-11-13 US US14/079,590 patent/US20140135811A1/en not_active Abandoned
- 2013-11-13 EP EP13798839.0A patent/EP2919668A2/en not_active Withdrawn
- 2013-11-13 US US14/079,591 patent/US10327781B2/en active Active
- 2013-11-13 CN CN201380070058.7A patent/CN104918565B/en active Active
- 2013-11-13 KR KR1020157015397A patent/KR20150084959A/en active Application Filing
-
2019
- 2019-05-15 US US16/412,967 patent/US11690628B2/en active Active
- 2019-05-28 US US16/424,095 patent/US11786253B2/en active Active
- 2019-07-26 US US16/523,163 patent/US20190343532A1/en active Pending
Patent Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5304194A (en) * | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5749891A (en) * | 1995-06-06 | 1998-05-12 | Target Therapeutics, Inc. | Multiple layered vaso-occlusive coils |
US6322576B1 (en) * | 1997-08-29 | 2001-11-27 | Target Therapeutics, Inc. | Stable coil designs |
US20090076540A1 (en) * | 1999-06-02 | 2009-03-19 | Marks Michael P | Intracorporeal Occlusive Device And Method |
US6238403B1 (en) * | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US20020026210A1 (en) * | 2000-08-11 | 2002-02-28 | Abdel-Gawwad Hesham M. | Endovascular aneurysm treatment device and method |
US20030212419A1 (en) * | 2001-06-14 | 2003-11-13 | West Clinton B. | Aneurysm embolization device and deployment system |
US7029494B2 (en) * | 2002-02-08 | 2006-04-18 | Scimed Life Systems, Inc. | Braided modular stent with hourglass-shaped interfaces |
US20050267527A1 (en) * | 2002-04-01 | 2005-12-01 | Bobby Presley | Method and barrier for limiting fluid movement through a tissue rent |
US9629636B2 (en) * | 2002-11-12 | 2017-04-25 | Thomas J. Fogarty | Embolization device and a method of using the same |
US7481821B2 (en) * | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
US7744583B2 (en) * | 2003-02-03 | 2010-06-29 | Boston Scientific Scimed | Systems and methods of de-endothelialization |
US8398670B2 (en) * | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US20050267510A1 (en) * | 2004-05-26 | 2005-12-01 | Nasser Razack | Device for the endovascular treatment of intracranial aneurysms |
US20050278023A1 (en) * | 2004-06-10 | 2005-12-15 | Zwirkoski Paul A | Method and apparatus for filling a cavity |
US20090306702A1 (en) * | 2004-08-23 | 2009-12-10 | Elina Miloslavski | Device for the Removal of Thrombi |
US20060116713A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US20060116712A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US20090155367A1 (en) * | 2005-10-31 | 2009-06-18 | Neuwirth Robert S | Occlusion of Fallopian Tubes |
US20090112251A1 (en) * | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090025820A1 (en) * | 2007-07-25 | 2009-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090187214A1 (en) * | 2008-01-18 | 2009-07-23 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion device |
US20100228184A1 (en) * | 2008-09-04 | 2010-09-09 | Curaseal Inc. | Inflatable device for enteric fistula treatment |
US9301769B2 (en) * | 2011-03-09 | 2016-04-05 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US20120330341A1 (en) * | 2011-06-22 | 2012-12-27 | Becking Frank P | Folded-Flat Aneurysm Embolization Devices |
US9314248B2 (en) * | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
Cited By (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9307998B2 (en) | 1997-07-10 | 2016-04-12 | Stryker Corporation | Methods and devices for the treatment of aneurysms |
US9314326B2 (en) | 2002-04-12 | 2016-04-19 | Stryker Corporation | System and method for retaining vaso-occlusive devices within an aneurysm |
US11844528B2 (en) | 2008-04-21 | 2023-12-19 | Covidien Lp | Multiple layer filamentary devices for treatment of vascular defects |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US10729445B2 (en) | 2012-02-09 | 2020-08-04 | Stryker European Holdings I, Llc | Vaso-occlusive devices including a friction element |
US11786253B2 (en) | 2012-11-13 | 2023-10-17 | Covidien Lp | Occlusive devices |
US11690628B2 (en) | 2012-11-13 | 2023-07-04 | Covidien Lp | Occlusive devices |
US11633190B2 (en) | 2014-05-28 | 2023-04-25 | Stryker European Holdings I, Llc | Vaso-occlusive devices and methods of use |
US11839380B2 (en) | 2014-08-08 | 2023-12-12 | Covidien Lp | Electrolytic and mechanical detachment for implant delivery systems |
US11751880B2 (en) | 2015-05-08 | 2023-09-12 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
US10159490B2 (en) | 2015-05-08 | 2018-12-25 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
US10925612B2 (en) | 2015-05-08 | 2021-02-23 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
US11459439B2 (en) | 2015-07-25 | 2022-10-04 | Lawrence Livermore National Security, Llc | Surface modification of polymer foams using plasma |
US20180208735A1 (en) * | 2015-07-25 | 2018-07-26 | Lawrence Livermore National Security, Llc | Surface modification of polymer foams using plasma |
CN107636053A (en) * | 2015-07-25 | 2018-01-26 | 劳伦斯·利弗莫尔国家安全有限责任公司 | Surface modification is carried out to polymer foam using plasma |
US10478194B2 (en) * | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US11864770B2 (en) | 2015-09-23 | 2024-01-09 | Covidien Lp | Occlusive devices |
US10314593B2 (en) | 2015-09-23 | 2019-06-11 | Covidien Lp | Occlusive devices |
US11357510B2 (en) * | 2015-09-23 | 2022-06-14 | Covidien Lp | Occlusive devices |
EP3153114A1 (en) * | 2015-09-23 | 2017-04-12 | Covidien LP | Occlusive devices |
JP2017060751A (en) * | 2015-09-23 | 2017-03-30 | コヴィディエン リミテッド パートナーシップ | Occlusion device |
EP3808284A1 (en) * | 2015-09-23 | 2021-04-21 | Covidien LP | Occlusive devices |
US20170079662A1 (en) * | 2015-09-23 | 2017-03-23 | Covidien Lp | Occlusive devices |
US10980545B2 (en) | 2016-02-10 | 2021-04-20 | Microvention, Inc. | Devices for vascular occlusion |
US11678888B2 (en) | 2016-02-10 | 2023-06-20 | Microvention, Inc. | Devices for vascular occlusion |
US10577733B2 (en) | 2016-10-14 | 2020-03-03 | Inceptus Medical, Llc | Braiding machine and methods of use |
US11346027B2 (en) | 2016-10-14 | 2022-05-31 | Inceptus Medical, Llc | Braiding machine and methods of use |
US11898282B2 (en) | 2016-10-14 | 2024-02-13 | Inceptus Medical, Llc | Braiding machine and methods of use |
US11813282B2 (en) | 2016-10-21 | 2023-11-14 | Covidien Lp | Injectable scaffold for treatment of intracranial aneurysms and related technology |
US11304701B2 (en) | 2017-02-24 | 2022-04-19 | Inceptus Medical, Llc | Vascular occlusion devices and methods |
US10376267B2 (en) | 2017-02-24 | 2019-08-13 | Inceptus Medical, Llc | Vascular occlusion devices and methods |
US10660648B2 (en) | 2017-02-24 | 2020-05-26 | Inceptus Medical, Llc | Vascular occlusion devices and methods |
US11191927B2 (en) | 2017-07-31 | 2021-12-07 | Boston Scientific Scimed, Inc. | Dilator with engagement region |
US11000287B2 (en) | 2017-08-15 | 2021-05-11 | Boston Scientific Scimed, Inc. | Occlusive medical device system |
FR3070853A1 (en) * | 2017-09-10 | 2019-03-15 | Stsat Ag | SYSTEM FOR TREATING ANEURYSM |
FR3072018A1 (en) * | 2017-10-05 | 2019-04-12 | Stsat Ag | SYSTEM FOR TREATING ANEURYSM |
FR3072014A1 (en) * | 2017-10-05 | 2019-04-12 | Stsat Ag | SYSTEM FOR TREATING ANEURYSM |
US10874402B2 (en) | 2017-10-10 | 2020-12-29 | Boston Scientific Scimed, Inc. | Detachable RF energized occlusive device |
US11885051B2 (en) | 2017-10-14 | 2024-01-30 | Inceptus Medical, Llc | Braiding machine and methods of use |
JP2020516350A (en) * | 2017-12-21 | 2020-06-11 | ザ テキサス エーアンドエム ユニバーシティ システムThe Texas A&M University System | Vascular prosthesis for leak prevention during endovascular aneurysm repair |
US11839702B2 (en) | 2017-12-21 | 2023-12-12 | The Texas A&M University System | Vascular prosthesis for leak prevention during endovascular aneurysm repair |
JP7433590B2 (en) | 2017-12-21 | 2024-02-20 | ザ テキサス エーアンドエム ユニバーシティ システム | Vascular prosthesis for leak prevention during endovascular aneurysm repair |
US11338070B2 (en) | 2017-12-21 | 2022-05-24 | The Texas A&M University System | Vascular prosthesis for leak prevention during endovascular aneurysm repair |
JP2022023848A (en) * | 2017-12-21 | 2022-02-08 | ザ テキサス エーアンドエム ユニバーシティ システム | Vascular prosthesis for leak prevention during endovascular aneurysm repair |
JP7317499B2 (en) | 2017-12-22 | 2023-07-31 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | Aneurysm device and delivery system |
US11154412B2 (en) | 2018-02-01 | 2021-10-26 | Boston Scientific Scimed, Inc. | Medical device release system |
US11284902B2 (en) | 2018-02-01 | 2022-03-29 | Boston Scientific Scimed, Inc. | Method of making a vascular occlusion device |
US11672946B2 (en) | 2019-09-24 | 2023-06-13 | Boston Scientific Scimed, Inc. | Protection and actuation mechanism for controlled release of implantable embolic devices |
US11685007B2 (en) | 2019-11-04 | 2023-06-27 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11679458B2 (en) | 2019-11-04 | 2023-06-20 | Covidien Lp | Devices, systems, and methods for treating aneurysms |
US11633818B2 (en) | 2019-11-04 | 2023-04-25 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11717924B2 (en) | 2019-11-04 | 2023-08-08 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
WO2021113130A1 (en) * | 2019-12-03 | 2021-06-10 | Boston Scientific Scimed, Inc. | Medical delivery device |
Also Published As
Publication number | Publication date |
---|---|
KR20200047753A (en) | 2020-05-07 |
US20190282242A1 (en) | 2019-09-19 |
US11690628B2 (en) | 2023-07-04 |
WO2014078458A3 (en) | 2014-07-31 |
EP2919668A2 (en) | 2015-09-23 |
CN104918565B (en) | 2018-04-27 |
US20140135811A1 (en) | 2014-05-15 |
CN104918565A (en) | 2015-09-16 |
CN108354645A (en) | 2018-08-03 |
US11786253B2 (en) | 2023-10-17 |
WO2014078458A2 (en) | 2014-05-22 |
EP3574850A1 (en) | 2019-12-04 |
KR20150084959A (en) | 2015-07-22 |
US20190290286A1 (en) | 2019-09-26 |
KR102309795B1 (en) | 2021-10-08 |
EP3574850B1 (en) | 2022-07-06 |
US20190343532A1 (en) | 2019-11-14 |
US20140135812A1 (en) | 2014-05-15 |
US10327781B2 (en) | 2019-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11690628B2 (en) | Occlusive devices | |
US11389309B2 (en) | Occlusive device | |
JP6605663B2 (en) | Apparatus and method for treating vascular disorder | |
US9962164B2 (en) | Wing bifurcation reconstruction device | |
US20120283768A1 (en) | Method and apparatus for the treatment of large and giant vascular defects | |
US20130268046A1 (en) | Systems and methods for supporting or occluding a physiological opening or cavity | |
WO2014145005A2 (en) | Occlusive device | |
WO2021222938A1 (en) | Expandable devices for treating body lumens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COVIDIEN LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DIVINO, VINCENT;BARDSLEY, EARL FREDERICK;RHEE, RICHARD;AND OTHERS;REEL/FRAME:032263/0434 Effective date: 20131113 |
|
STCV | Information on status: appeal procedure |
Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS |
|
STCV | Information on status: appeal procedure |
Free format text: BOARD OF APPEALS DECISION RENDERED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |